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In the past 15 years, the nonmedical use of opioids in the United States has reached 
epidemic proportions, resulting in a 21% increase in overdose fatalities. This surge in 
opioid use and dependence represents a shift in the demographic from inner-city 
populations over the age of 40 to young adults between the ages of 20 and 34 who dwell 
in primarily white suburban neighborhoods. Research has identified physicians’ liberal 
prescribing practices as one cause of this epidemic and has documented the 
ineffectiveness of current interventions with young addicts. The purpose of this narrative 
study was to gain insight into what contributes to young opioid users’ motivation to seek 
treatment, an area of research that is underrepresented in the literature. Maslow’s theory 
of human motivation and Deci and Ryan’s self-determination theory were the theoretical 
bases for understanding drive states related to drug use and the relationship between 
motivation and treatment outcomes, respectively. Face-to-face interviews were conducted 
with 8 opioid addicts aged 22 to 37 in treatment for opioid use disorder. Participants 
shared their experiences of the initiation, progression, and treatment of their disorder. 
Their stories revealed a motivation process different from their adult counterparts and is 
part of a deeply personal and solitary experience that could not be forced upon them 
through coercion. These findings indicate that less coercion, more realistic expectations 
regarding treatment readiness based on developmental norms, fostering autonomous 
support, and the use of medically assisted treatments may be the key to effective 
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Chapter 1: Introduction to the Study 
My intent for this study was to explore the lived experiences of Millennials (born 
between 1981-1996) with opioid use disorder with respect to their motivation to seek 
treatment and recovery. This current and youngest generation of opioid users are unique 
in ways that set them apart from previous generations such as those of the 1960s-1980s, 
which has created a need for relevant data to inform treatment interventions (Jones, 
2013). Two of the most prominent distinctions between these opioid users and their 
predecessors are their demographic-specific characteristics and the way in which they 
were introduced to their drug of choice. These young adults were raised in predominately 
white, suburban neighborhoods. They have access to financial support from their families 
who enjoy a higher socioeconomic status than the inner-city addicts of the 1960s-1980s. 
Their dependence upon their parents for financial support and healthcare extends well 
into young adulthood, which relieves much of the burden of maintaining their drug habit 
and often helps them to forestall involvement in criminal activity and incarceration 
(Cicero, Ellis, Surratt, & Kurtz, 2014).  
Regarding their introduction to opioids, 80% of today’s opiate users were initiated 
into drug use through the use of prescribed pain medications (Jones, 2013). This trend has 
been linked to an increase in the prescriptions for opioid medications for pain 
management over the past 20 years, with nearly 15% written for people under the age of 
29 (Substance Abuse and Mental Health Services Administration [SAMHSA], 2012). 
The unique cultural and etiological features of addictive disorder as manifested in this 
generation sets them apart from others. Thus, it is not surprising that current interventions 
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designed to motivate and engage young addicts in treatment have been largely ineffective 
(Adams, Knopf, & Park, 2014). This study contributed to current scientific knowledge of 
substance use disorder (SUD) by providing an understanding of how this cohort 
experiences addiction and what motivates them to seek help. The insights gained from 
this study can be applied to the development of relevant and effective treatment options. 
The loss of young lives and the burdens on the U.S. healthcare system brought about by 
this surge in opioid addiction underscore the importance of studying this issue at the 
current time. 
This chapter begins with a description of the problem and its background, 
including a brief review of the research on the current prevalence of opioid dependence in 
the United States.  The purpose, theoretical framework, and operational definitions of the 
study follow. Successive sections include a review of the assumptions, limitations, scope, 
and delimitations of the study. The chapter closes with an explanation of the significance 
of the study regarding Millennials’ perceptions of their disorder. 
Background of the Study 
The nonmedical use of opioids has become so widespread in the United States in 
the past 15 years that it has been characterized as an epidemic by the U.S. Department of 
Health and Human Services (HHS, 2017). Prolific use of opiates resulted in a 21% 
increase in deaths due to opioid overdose from 2015-2017, with the largest number of 
deaths occurring in those aged 25-44. This increase in opioid-related fatalities is viewed 
as the primary cause of a decline in the life expectancy of Americans over the past 2 
consecutive years, an event that has not occurred since the onset of the AIDS epidemic in 
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1993. The current surge in opioid use is not unique in American history except for the 
fact that it represents a shift to a much younger demographic of opioid abusers. In 2014 
alone, admissions to treatment for addicts aged 20 to 34 exceeded all other age groups 
combined (SAMHSA, 2016). The epidemic has justifiably been blamed on the prolific 
opioid prescribing practices of American physicians. Indeed, 80% of young opioid 
addicts report that their initiation into habitual opioid use began with the use of 
nonprescribed pain medications. In some cases, these medications are purchased from 
drug dealers, but many young people have easy access to their family members’ unused 
medications stored in the home medicine cabinet. Others are introduced to opioids for the 
first time when they receive a prescription from their family physician to alleviate pain 
from an injury or following surgery. Addiction that is precipitated by the legitimate use 
of a prescribed pain medication is known as iatrogenic addiction (iatrogenic, 2018). 
While prescribing opioid medication for the relief of pain is an established medical 
intervention, statistics indicate physicians’ rising prescribing rates do not correspond to 
an increase in the number of Americans seeking pain relief (Chang, Daubresse, 
Kruszewski, & Alexander, 2014). Due the addictive properties of opioids and a variety of 
genetic, developmental, and environmental factors, some patients find themselves unable 
to discontinue the drug while others do so without issue (Volkow, Koob & McLellan, 
2016).  
Allostasis, a process that occurs within the brain to maintain balance in its internal 
environment, is involved in the neurochemical basis of opioid use disorder (Volkow, 
Koob & McLellan, 2016). The brain responds to the initial use of opioids with 
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adaptations in neural processes that alter the availability of certain neurotransmitters 
involved in the brain’s reward circuits, such as dopamine, which is reduced by 25% to 
64% during periods of opioid withdrawal (Baskin-Sommers & Foti, 2015). This 
downregulation of dopamine and corresponding alterations in the areas of brain involved 
in arousal and mood regulation is believed to be responsible for increased tolerance, 
physical dependence, and the painful physical and affective states associated with opiate 
withdrawal (Koob, 2015).  
Once these profound changes in the brain are well-established, an opioid addict 
will experience acute withdrawal symptoms following every episode of use, occurring 
within a short period after the euphoric effects of the drug have dissipated. For short-
acting substances such as heroin, this begins within 4–12 hours depending on the 
individual’s level of tolerance and drug use. The acute withdrawal stage in heroin 
addiction typically lasts for 3–4 days. The onset of acute withdrawal from longer-acting 
opioids such as methadone begins after several days and is resolved by day 10. 
Symptoms experienced in withdrawal from any opioid during the acute stage include: (a) 
rapid pulse > 120 bpm; (b) chills and excessive diaphoresis; (c) severe, diffuse aching of 
joints and/or muscles; (d) stomach cramps, nausea, vomiting and/or diarrhea; (e) gross 
tremors; and (f) severe anxiety. Protracted withdrawal symptoms, which are experienced 
by those who maintain abstinence, can persist for weeks or months after the acute 
withdrawal stage. These symptoms include: (a) fatigue, (b) insomnia, (c) anhedonia, and 
(d) loss of appetite (Schuckit, 2016). This physical and emotional suffering is believed to 
be among the primary motivators for habitual drug use (Koob, 2015).  
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Impulsivity plays an equally important role in the onset and maintenance of 
addiction (Argyriou, Um, Carron, & Cyders, 2018). Impulsivity is understood as a 
function of behavior influenced by personality, environment, and cognition and involves 
executive function (Argyriou et al., 2018). While personality traits tend to be stable 
attributes, cognitive impulsivity in young adults is an artifact of immaturity, as the areas 
of the brain involved in cognitive control mature at a later age than those involving 
affective control (Argyriou et al., 2018). For this reason, an individual who is exposed to 
a potentially addictive substance at an early age faces a greater risk of developing 
dependency due to its impact on normal brain maturation in the areas involved in 
executive function (Brown et al., 2015; Volkow & Morales, 2015).  
This underscores the contribution of medical professionals to the opioid epidemic, 
because 15% of the recipients of opioid prescriptions over the past 2 decades have been 
patients under the age of 30 (SAMHSA, 2012). Once addicted, young adults with SUDs  
are the least likely to seek help, and when they do enter treatment, they typically 
experience a poor response (Adams et al., 2014). Young adult clients are more likely than 
adolescents or older adults to leave against medical advice, they are less likely to follow-
up treatment with continuing care when they do complete treatment, and their 
posttreatment abstinence rates are the lowest when compared to younger and older 
clients. These treatment failures are reflected in the soaring death rates from overdose 
occurring in the 25 to 44-year-old age group (HHS, 2017).  
Meeting the needs of this new generation of opioid users calls for making 
adjustments in treatment approaches based on their unique characteristics (Hilton & 
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Pilkonis, 2015; Jones, Clark, Weintraub, & Zia, 2016). SUD is characterized as a 
complex illness caused and exacerbated by a variety of genetic, environmental, and 
attributional factors (Marlatt, Baer, Donovan, & Kivlahan, 1988). The changing 
demographic of opioid addiction presents the challenge of identifying the complicating 
factors of addiction in the context of an entirely new and, in many respects, very different 
generation from its predecessors. An exhaustive review of the literature revealed that 
research has not kept pace with these changes. The majority of studies involving addicts 
consist of cohort studies and surveys of older populations. Many of the populations 
investigated began using drugs in a different period of history, in different settings, and 
for different reasons (Cicero et al., 2014). 
Additionally, those who have maintained abstinence for several years or more are 
not representative of this new demographic of substance users who have been shown 
either to avoid treatment or fail to become engaged when they do submit to treatment 
(Cicero et al., 2014; Fleury et al., 2016). The few studies conducted with contemporary 
substance users tend to be highly specific regarding target samples, treatment settings or 
geographic location, and noting limitations, have called for further exploration. Such 
studies include Opsal, Kristensen, Vederhus, & Clausen (2016), which calls for 
additional research into substance users’ perceptions of coercion, and Fleury et al. (2016), 
noting the need for studies of issues related to contemporary substance users. A variety of 
new technologies, integrative treatments, and therapeutic approaches are now at the 
disposal of clinicians who treat those with opioid use disorder (Volkow et al., 2016). This 
study was designed to provide a deeper understanding of the contemporary opioid user, 
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with the intent that such knowledge may provide some guidance in the appropriate 
application of these new approaches. 
Problem Statement 
The intent of this study was to examine young opioid users’ motivations for 
entering treatment for their disorder and for embracing recovery. This study differed from 
previous research in its focus on the changing demographic of opioid users noted in the 
literature (Cicero et al., 2014). The need for information regarding this changing 
demographic is well-documented. Kelly et al. (2015) called for studies aimed at 
promoting an understanding of the trend towards prescription drug abuse by young 
people. Majumder et al. (2016) concluded that additional studies were needed to explore 
the personal factors related to enhanced motivation and commitment to treatment in 
young addicts. Sinha, Easton, and Kemp (2003) noted the need to include both voluntary 
and involuntary clients in any study of young adults with SUD as the similarities found 
among all young adults (e.g., early onset of drug use) are worthy of investigation related 
to designing treatment interventions.  
Purpose of the Study 
The purpose of this qualitative study was to explore the experiences and 
perceptions of the young opioid user. The intent was to learn how young addicts’ 
experiences are involved in their motivation to seek help through treatment. I used 
Maslow’s theory of human motivation (1943) and Deci and Ryan’s self-determination 
theory (1985) as a framework for interpreting these experiences. In the study I explored 
the cognitive and emotional processes activated (a) at the onset of drug use, (b) during the 
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progression to habitual drug use, and (c) upon entering treatment, for insight into how the 
motivational process unfolds.  
Research Questions 
RQ1: What do narratives of young opioid addicts reveal about their motivation to 
enter treatment?  
RQ2: What do narratives of young opioid addicts reveal about their motivation for 
recovery? 
Theoretical Frameworks 
Maslow’s theory of human motivation (1943) provided a framework through 
which SUD may be understood in relationship to drive states. Maslow conceptualized 
human behavior as an upward journey from the most basic physiological needs to 
ultimate self-actualization or spiritual evolution. Maslow illustrated his theory of human 
motivation using a pyramid known as the hierarchy of needs. The base of the pyramid 
represents physiological needs, including only that which a person needs to survive 
physically. These include breathing, eating, hydration, and sleep (Maslow, 1973). Higher 
levels of the pyramid represent the human being’s continued development, reaching 
upward towards self-actualization as each of the lower needs are met in succession.  
As the use of mood-altering substances involves the reward systems of the brain, 
it can be compared to behaviors motivated by the biological imperative of survival. 
Highly addictive substances such as opioids activate the pleasure centers of the brain and 
create a cascade of chemical messages designed to ensure that the pleasurable experience 
can be repeated (Volkow & Morales, 2015). The initial euphoric experiences of the 
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opioid addict may accurately be compared to those experienced during sexual 
intercourse, breast-feeding, falling in love, or consuming a palatable meal. Details of 
these experiences such as environmental cues are stored in the brain to allow for ready 
replication of the experience (Volkow & Morales, 2015). Unfortunately, repeated 
exposure to the euphoria of opioid intoxication results in profound changes in the brain’s 
architecture. Shortly after the onset of these changes, the addict will begin to experience 
agonizing withdrawal and an inability to experience pleasure without chemicals (Volkow 
& Morales, 2015). Finally, the use of the preferred drug no longer results in pleasure, but 
only serves to relieve pain. The salience of pleasurable memories of past intoxication in 
the brain’s reward center combined with the constant need to ease the pain of withdrawal 
eventually creates an obsession to seek out the drug of choice at all costs (Volkow & 
Morales, 2015). This is the reality of addiction for those afflicted with the disorder.  
In the latter stages of addiction, the brain interprets the absence of the substance 
as a life-threatening circumstance, and the addict’s drive to find and use opioids aligns 
metaphorically and experientially with Maslow’s lowest level of needs. When prolonged 
exposure of the brain to opioids ultimately results in unrelenting emotional, physical, and 
psychological pain, the addict looks elsewhere for relief. This is the “bottom” often 
referred to in the literature of Alcoholics Anonymous (Wilson, 1976) which brings the 
addict to a point of surrender and willingness to submit to treatment. From that point, if 
the treatment is successful, the recovering addict begins to experience quality of life 
without drugs, and motivation for continued growth reflects the movement toward self-
fulfillment represented in the pyramid (Maslow, 1973). 
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Deci and Ryan’s (1985) self-determination theory was useful in understanding the 
varieties and sources of motivation, the ways in which motivation is experienced, and the 
relationship between the locus of motivation and outcomes. Where Maslow’s theory was 
useful for understanding the addict’s motivation with regard to drive states, Deci and 
Ryan provided a context for exploring motivation in the presence of intrinsic and 
extrinsic factors such as legal coercion for treatment.  
Self-determination theory has been widely applied in addictions research to 
ascertain if the once common practice of exerting pressure on the addict to seek treatment 
in the absence of internal motivation is an effective approach. This intervention has been 
viewed as acceptable as it was believed that waiting for the individual to become willing 
might result in a worsening of their condition and possibly death (Inaba & Cohen, 2014; 
Wilson, 1976). However well-intended this approach may have been, research indicates 
that factors associated with positive treatment outcomes, such as engagement in 
therapeutic activities and completion of treatment, are negatively associated with 
coercion (Urbanoski, 2010; Wild et al., 2006). This is especially true of young adults 
(Van Petegem, Soenens, Vansteenkiste, & Beyers, 2015). Research has shown that 
positive treatment outcomes are most likely to occur when the client is internally 
motivated to seek help (Majumder, 2016). For this reason, the practice of exerting 
external pressure through family members or employers is being replaced in 
contemporary treatment by the transtheoretical model, which employs interventions such 
as motivational interviewing (Prochaska & DiClemente, 1994; Vansteenkiste & Sheldon, 
2006). The validity of this approach is supported by research that demonstrates treatment 
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engagement and retention are enhanced when sources of perceived coercion are identified 
and eliminated (Opsal et al., 2016). 
This study employed self-determination theory as a basis for understanding the 
context through which young substance users experience motivation to address their 
addiction. This involved exploring the ways in which the addicts’ inner cognitive and 
emotional processes result in internal readiness to seek treatment. In this way, the 
research questions generated information that might be used to inform the design of 
treatment methods that encourage intrinsic motivation rather than surface compliance 
(Wild, 2006). Chapter 2 describes the theoretical frameworks of this study in greater 
depth. 
Nature of the Study 
The intent of this study was to add to the current body of research regarding 
motivation for treatment and recovery. SUDs  have been the focus of research for 
decades, yet a new generation of substance users presents a new opportunity for 
exploration. The recent epidemic of opioid addiction and fatalities has occurred primarily 
in this younger age group, which calls for investigation into the unique experiences of 
this generation. I chose narrative inquiry as the research method for its focus on the 
subjective experiences of individuals over time. The general characteristics of young 
opioid addicts have been revealed through statistical data but their individual lived 
experiences as addicts have not been explored. My intent for this study was to understand 
how addiction disorders are experienced by the individual on an emotional and cognitive 
level rather than to determine the cause of addiction in young adults. In the tradition of 
12 
 
narrative research, each participant was interviewed in-depth, followed by a repeated 
immersion in the data until themes and patterns of common experience emerged through 
exhaustive analysis. Ultimately these findings will contribute to positive social change by 
providing insight into factors that motivate these individuals to seek treatment and 
commit to recovery, thereby informing future treatment interventions.  
Definition of Terms 
Continuing care: Outpatient counseling that provides ongoing therapeutic support 
for those with SUDs following higher levels of treatment (Hazelden, 2018).  
Diagnostic and Statistical Manual of Mental Disorders (DSM-V): The 5th 
revision of a manual regarded by healthcare professionals as an authoritative guide to the 
diagnosis of mental disorders (Inaba & Cohen, 2014). 
Drug of choice: The preferred substance of the addict, which they use habitually 
and to which they become addicted (Inaba & Cohen, 2014). 
Iatrogenic addiction: Addiction caused by medical treatment (e.g., administration 
of opiates in a hospital setting following surgery, or prescribed by a physician for an 
injury, which leads to addiction; iatrogenic, 2018). 
Millennial: An individual born between 1981 and 1996 (Gallup, 2016). 
Addict: An individual who meets the DSM-V criteria for SUD (Inaba & Cohen, 
2014). 
Opioid (or opiates): Natural or synthetic controlled substances chemically similar 
to morphine that are prescribed for pain management (Inaba & Cohen, 2014). 
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Opioid use disorder: A DSM-V substance use disorder diagnosis specific to 
opioid use (American Psychiatric Association, 2013).  
Recovery: A period of self-imposed abstinence often accompanied by positive 
changes in thinking and behavior intended to support abstinence (Marlatt et al. 1988) 
Relapse (with regard to drug addiction): The resumption of drug or alcohol use 
after a period of self-imposed abstinence (Marlatt et al. 1988) 
Using: A term used by addicts to describe active periods of substance use (Inaba 
& Cohen, 2014). 
Substance use disorder (SUD): Also known as addictive disorder, a disorder that 
meets the criteria set forth in the DSM-V, which includes but is not limited to loss of 
control over substance use, preoccupation with using, and failed attempts to abstain 
(American Psychiatric Association, 2013).  
Treatment: Any one or combination of several levels of clinical interventions 
(e.g., detoxification, inpatient, partial-hospitalization, intensive outpatient) designed to 
arrest and stabilize SUD (Inaba & Cohen, 2014). 
Assumptions 
In considering the design of this study, I assumed that my topic of interest was 
relevant and would contribute in some meaningful way to the existing literature. A 
narrative approach was assumed to yield the richest data. I assumed that the interview 
questions would stimulate detailed, honest accounts from the participants of their lived 
experiences as opioid addicts. As all participants were in treatment at the time of the 
interview, I assumed they would have undergone detoxification and were not 
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experiencing acute withdrawal or were not under the influence of a mood-altering 
chemical, which would have compromised the veracity of their self-report. I assumed that 
my sampling strategy would result in a sufficient number of participants and that the 
participation criteria would be adequate to attract appropriate participants with personal 
experience in the topic of study. Regarding my role as a researcher, I assumed that I 
would be able to sufficiently bracket my beliefs so as to provide an objective 
interpretation of the data. 
Scope and Delimitations 
As the participants were drawn from a convenience sample located in my general 
geographic area, their experiences did not necessarily represent all Millennials. 
Recruitment of participants took place at three outpatient treatment centers, one located 
in Philadelphia, Pennsylvania, and two in suburbs of New Jersey. All three treatment 
centers were state-licensed and staffed by appropriately credentialed personnel. All 
offered the three levels of care typically found in nonresidential treatment programs: (a) 
partial hospitalization, (b) intensive outpatient (IOP) and (c) outpatient. All three 
programs accept adult clients who have successfully completed detoxification treatment 
and who are not involved in agonist maintenance therapies such as methadone.   
This study was limited to a sample of 6-12 adult individuals between the ages of 
22 and 37 years at the time of data collection, as this is the age-range of those who are 
known in contemporary culture as Millennials. This focus was taken to address the gap in 
the literature specific to this demographic. As the research problem specifically involved 
motivation to seek treatment and recovery, participants were needed who had 
15 
 
experienced periods of time during which they contemplated the need to seek help. 
Therefore, the participant criterion was restricted to those with at least two previous 
treatment experiences in order to ensure that they had sufficient experiences to relate 
during the interview. Individuals with SUD and a co-occurring psychiatric diagnosis were 
not included in the study, as their experiences of addiction may have been complicated by 
psychiatric symptoms and medications (Inaba & Cohen, 2014). Participants were limited 
to those who were willing and able to participate in the lengthy (60 to 90 minute) face-to-
face interview required for the collection of the kind of rich, thick data used in narrative 
inquiry. Transferability is not guaranteed by any qualitative study, but the credibility and 
validity of the results may be supported by the research design, rigor of data analysis, and 
provision of details sufficient to replicate the study with other populations (Guba, 1981; 
Miles, Huberman & Saldaña, 2014). Details of these safeguards are described at length in 
Chapter 3.  
Limitations 
While the primary intent of narrative inquiry is not to produce results that 
generalize, rich, thick descriptions were used to describe the data analysis process, 
procedural details, and results to allow others to replicate this study in their chosen 
setting. A potential for bias existed due to my personal and professional experiences in 
the field of addictions treatment and my empathic stance towards those with SUD. I 
addressed this through the process of clinical supervision and by bracketing my 
assumptions before and throughout the study. I also included measures to enhance the 
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dependability of my data such as member-checking and triangulation (Miles et al., 2014), 
which are addressed in greater detail in Chapter 3.  
The participants were engaged in treatment at the time of their interview, which 
imposed limits on my time with them based on the constraints of their treatment 
programs. Finally, as the sole researcher, I was limited in the number of interviews I 
could accomplish at the level of total data immersion required by narrative inquiry. I 
recruited the smallest number of participants that would allow saturation without 
sacrificing depth and richness of data (see Guba, 1981; Lincoln & Guba, 1985). The 
results of this study will be disseminated through a presentation at the New Jersey 
Prevention Network conference in 2020, by incorporation into the Graduate Addictions 
Studies Program curricula at Monmouth University, and submitted for publication in the 
Journal of Substance Abuse Treatment. 
Significance of the Study 
This study contributes to the body of knowledge of SUD through an exploration 
of the experiences of a heretofore unexamined population of substance users, those 
known in contemporary culture as Millennials. The purpose of this study was to increase 
understanding of how young opiate addicts perceive their disorder and what motivates 
them to seek treatment and sustain abstinence. This information will be useful in 
informing the design of treatment approaches that are relevant to this new generation of 
drug users and in training addiction professionals in the most effective ways to connect 
therapeutically with this population.  
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Although addiction has been the focus of much investigation in the past several 
decades, there is a paucity of information on Millennials with opioid use disorder. 
Individuals aged 21-45 compose the majority of Americans with opioid use disorder, yet 
only 11% will seek-out and receive treatment (Adams et al., 2014). When they do enter 
treatment, their response is poor compared to their adult counterparts. This is borne out in 
overdose statistics, with the greatest proportion of fatalities due to opioid overdoses 
occurring in 25 to 44-year-olds (HHS, 2017). Learning about the experiences and 
perceptions of this vulnerable population may result in new approaches to stimulate 
motivation for treatment and enhance treatment outcomes.  
Summary 
Chapter 1 familiarized the reader with the information supporting the study’s 
value through a preliminary review of the following topics: (a) background, (b) problem, 
(c) purpose, (d) conceptual framework, (e) significance, and (f) nature of the study. 
Chapter 2 leads the reader into a deeper understanding of the foundation and objectives of 
the study through an exhaustive review of the literature. This review includes a summary 
of the theoretical foundations of the study as well as a critical analysis of current 
literature regarding the relative issues heretofore addressed, as well as demonstrating the 
gap in the body of research this study was designed to address. 
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Chapter 2: Literature Review 
In the past decade, the nonmedical use of opioid medications in the United States 
has reached epidemic proportions (HHS, 2017). The surge in the number of Americans 
using nonprescribed pain medications and illegal opiates such as heroin is concerning by 
virtue of its magnitude, but perhaps even more so in that it represents a shift to a much 
younger demographic of opioid abusers. One indicator of this shift is a 20% increase in 
treatment admissions for addicts aged 20 to 34, which exceeded that of all other age 
groups in 2014 (SAMHSA, 2016). As might be expected with a rise in opioid use, 
overdose rates have also increased dramatically. From 2015 through 2016, there was a 
statistically significant increase in overdose deaths in 27 states, where the previous year 
saw such increases in only 18 states (CDC, 2016). Deaths from opioid overdose in 2016 
alone totaled 42,249, which is a five-fold increase since 1999. Again, the largest number 
of deaths occurred in younger populations, those aged 25–44. This represents an increase 
of 90%, from 1.5 to 5.5 per 100,000 people (HHS, 2017). 
The purpose of this study was to explore what motivates young opioid users to 
seek treatment and consider changing their drug-use behavior. Unlike previous research, 
this study focused on contemporary addicts from suburban settings who most closely met 
the description of the new generation of opioid user noted in the literature (Cicero et al., 
2014).  
Establishing the Relevance of the Problem 
Unlike their counterparts in previous decades, the majority of young adults who 
are currently addicted to opioids were initiated into illicit drug use by way of prescription 
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medications (HHS, 2015). Moreover, four in five young heroin addicts in the United 
States report an initiation into opioid abuse through the misuse of prescription pain 
medications (HHS, 2015). Therefore, understanding the present opioid abuse crisis 
begins with a retrospective view of prescribing practices by U.S. physicians. Beginning 
in 1991, the distribution of opioid medications such as Vicodin and OxyContin began to 
rise and had quadrupled by 2010 (SAMHSA, 2012; U.S. Department of Justice, 2011) 
even though this trend was not justified by corresponding numbers of Americans seeking 
treatment for pain (Chang et al., 2014). Of the total number of prescriptions for pain 
medications in the past two decades, roughly 15% were for people under 30 years-of-age 
(SAMHSA, 2012).  
Attempts by the federal government to rein-in prolific prescribing practices of 
medical practitioners included the rescheduling of Hydrocodone to a schedule II drug in 
2014 (U.S. Department of Justice, 2014) and the publication of guidelines for prescribing 
(Dowell, Haegerich & Chou, 2016). Despite clear recommendations to reduce the 
nonessential use of opioids for pain management and thereby lowering their availability 
and, hopefully, the risk of chemical dependency, the prescribing rate in 2016 was triple 
that of what it was in 1999, reaching over 200 million in the United States alone (Guy et 
al., 2017). This continued supply of opioids into American homes fed the epidemic of 
addiction in young people by ensuring a readily available supply. The practice of 
“pharming,” accessing left-over pain medications from the family medicine cabinets, 
became common practice for drug-seeking youth (Solecki & Turchi, 2014), and by 2015, 
1 in 20 adolescents had used nonprescribed pain medication (SAMHSA, 2016). 
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As the demographic of opioid addiction has changed, so has the personality 
profile and environmental factors that complicate addiction. Yet research has not kept 
pace with these changes. The preponderance of studies on opioid addicts have been 
cohort studies or surveys of older populations who have managed to maintain abstinence 
for several years or more and are therefore not representative of this new demographic of 
substance users (Cicero et al., 2014). The few contemporary studies of substance users 
represented in the literature are narrow with respect to geographic locations, target 
samples, and/or treatment settings, yet not specific to opioid use. Such studies have noted 
these limitations and called for further exploration of issue (Fleury et al., 2016). 
This chapter provides an overview of substance abuse by way of an examination 
of its origins in ancient history through its present role in American culture. This 
exploration is divided into several areas key to fully understanding the current epidemic 
of SUD. Such areas include evolution of the medical criteria for addictive disorders, the 
neurochemical basis of addiction, policies developed by public health agencies and the 
criminal justice system to address substance use, and various approaches to treatment,  
with a specific emphasis on young adults. This approach provides a view from the many 
perspectives that initiate and perpetuate the problem of substance abuse and addiction. 
The theoretical foundations upon which this study is based were examined through a 
review of the current literature. I used Maslow’s theory of motivation to understand the 
opioid users drug-seeking behaviors as a survival mechanism, based on the most primary 
of human needs (Maslow, 1943). I explored self-determination theory as a means of 
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understanding the ways in which desired outcomes for the treatment experience may 
influence the motivational drives of each individual.  
Literature Search Strategy 
The literature search was confined to peer-reviewed articles published within the 
past 3 years in professional journals, with the exception of historical documents, in which 
case no limit was specified. The primary data bases accessed were Science Direct, 
Medline, PubMed Central, Academic Search Premier and ProQuest. The search for 
statistics was primarily conducted on various federal HHS websites due to the volume of 
data collected yearly by these agencies that are made available to the general public. Such 
websites included (a) The Centers for Disease Control and Prevention, (b) The National 
Institute on Drug Abuse (NIDA), and (c) SAMHSA. No methodologies were excluded 
from the search, which began with broad terms related to the main focus of the study as 
well as information needed to provide a foundation of knowledge for the layperson not 
versed in the history and terminology of SUD. As such, each topic was researched 
separately as a subcategory of the study.  
A search for information on the theoretical foundation began using the key terms 
Maslow’s motivation theory and self-determination theory (no date range). I located 
research that represented addiction studies incorporated each foundational theory by 
combining the name of the theory and keywords related to substance use treatment. This 
resulted in the following search terms: (a) Maslow’s theory of human motivation and 
substance use disorder, (b) self-determination theory and readiness for treatment, (c) 
hierarchy of needs and motivation for substance use treatment, and (d) self-determination 
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theory and addiction treatment outcomes.  This search was then made specific to the 
target sample by adding the key words in emerging adults and in young adults, while 
limiting the date range to literature published after 2014. Information on the Millennial 
generation was found using the terms Millennials, Millennial characteristics, and the 
changing face of heroin addiction. Additional information related to the cognitive and 
moral development of young adults was obtained using the terms transition into 
adulthood, moral development, individuation, and emerging adulthood. 
I accessed national databases directly through the search function of their 
respective websites using the terms non-medical opioid use –past 20 years, overdose 
rates in U. S., national mortality rates –past 10 years, physician prescribing rates of 
opioids –past 20 years, and comparison of substance use by demographic data. I 
conducted a search for information on the history of substance use globally and in the 
United States using the terms history of substance use in ancient cultures and history of 
substance use in the U.S. with an unlimited date range. Articles related to aspects of drug 
use other than addictive disease were located using psychedelics and spirituality, 
psychedelics and psychiatric treatment, and culture of drug use.  
In a final search, I used Google Scholar to locate additional articles germane to 
the topic by title that were referenced in the research that was collected through the 
above-mentioned databases. I also used the Google Scholar “Cited By” feature to locate 
additional research or articles with more recent publication dates in the topics of interest. 





I used Maslow’s theory of human motivation and self-determination theory to 
gain insight into possible motivational processes through which young opioid users come 
to seek treatment (Deci & Ryan, 1985; Maslow, 1943). Maslow’s theory of motivation is 
useful in understanding motivation as a function by which human beings strive to meet 
their physiological, emotional, and transcendent needs. This was a suitable framework as 
SUD is inextricably entrenched in the brain’s reward circuits, historically having been 
characterized as a biological/psychological/social illness (Marlatt et al.,1988). 
Self-determination theory is a more contemporary model that explains motivation 
as a complex system of both internal and external processes, each impacting different 
aspects of a person’s life such as culture, relationships, and self-concepts. Such a model 
was useful for its explanation of the ways in which autonomy and coercion impact 
treatment engagement and goal achievement. This is particularly useful with respect to 
patient retention in the treatment milieu, as many of those who use nonprescribed 
medications find themselves coerced into treatment by employers, family members, or 
the legal system (Blanco et al., 2015; Opsal et al., 2016). 
Maslow’s Theory of Human Motivation 
Abraham Maslow (1943) formulated his theory in response to what he perceived 
to be the lack of a single, satisfactory theory explaining human motivation. His goal was 
to create a unified-dynamic theory that encompassed existing theories of motivation. The 
result was his theory of human motivation based on his hierarchy of needs, one of the 
more prominent and well-known theories of its kind in contemporary psychology 
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(DeSouza` & Gurin, 2016). Maslow identified five needs, arranged sequentially, in what 
he postulated to be the natural trajectory of human survival and personal growth. Maslow 
regarded all drives as interdependent, with the drive to satisfy each successive need 
activated by the attainment of the one preceding (Maslow, 1943). The needs identified in 
Maslow’s original theory were physiological, safety, love/belonging, self-esteem, and 
self-actualization and are often visually represented as a pyramid (Maslow, 1943). The 
fifth need, self-actualization, was later expanded into four: cognitive, aesthetic, self-
actualization and transcendence. Thus, Maslow’s final hierarchy was divided into two 
domains, the lower or deficient needs and the higher or being needs (D'Souza, & Gurin, 
2016; Maslow, 1973).  
The base need is identified as physiological and refers primarily to hunger or 
thirst. Maslow asserted that when an individual is starving, no other impulse exists but for 
relief. Furthermore, when the drive state is at such a basic level, the human being’s life 
experience is dominated by that need, and one’s perception of the ideal reality is only one 
where there is always enough to eat and drink (1943). Therefore, the task of envisioning 
future goals for self-growth or contributions for the greater good is not likely to occur at 
this level of motivation. Maslow’s motivation theory characterized the drives for survival 
as states that are experienced as deprivation, such as hunger and safety, while the higher 
needs, are experienced as desires for gratification. The intent of Maslow’s theory was to 
describe the development of healthy individuals and presupposes that human 
development must follow a logical and predictable pattern, driven by needs that arise in a 
specific order, from the basest to the most elevated.  
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Guss, Burger, and Dorner (2017) used Maslow’s contrasting concepts of 
deprivation and gratification to explain motivating factors in complex problem solving. 
Complex problem solving may trigger either external or internal motivation depending on 
the individual’s perception of needs. Solving problems of an emergent nature is seen as 
falling within the domain of safety and therefore externally motivated, while the need for 
self-esteem derived from having the knowledge or skills needed to solve a problem falls 
within a higher-level domain and is internally motivated (Guss, Burger & Dorner, 2017). 
This work sheds light on the ways in which different individuals may operate from a 
different locus of motivation in similar situations as a function of their current level of 
personal development.  
While Maslow’s theory was intended to explain the course of healthy human 
development, the behavior of those addicted to a substance and subsequently seeking 
treatment can also be understood in the context of the hierarchy of needs (Maslow, 1943). 
It is well-demonstrated in scientific studies that repeated exposure to an addictive 
substance results in changes in the architecture of the brain (Volkow, Koob, & McLellan, 
2016; Volkow & Morales, 2015). At the onset of drug use, the experience is intensely 
euphoric and triggers the dopaminergic systems to signal a cascade of chemical messages 
motivating the drug user to repeat the behavior. The brain perceives the pleasure 
associated with drug use as equal to pleasures experienced in other life sustaining-
activities such as eating and procreation (Volkow, Koob, & McLellan, 2016; Volkow & 
Morales, 2015). Therefore, the brain’s reward system initially interprets the use of the 
substance use as a life-sustaining activity. As such, the continued drug seeking behavior 
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is motivated by a perceived physiological need, represented at the lowest level of 
Maslow’s pyramid.  
As tolerance to opioids increases along with the occurrence of negative 
consequences such as withdrawal symptoms, legal issues, and rejection by family, the 
substance user’s motivation changes (Rourke, Howard, & Martire, 2015; Volkow, Koob, 
& McLellan, 2016). What began as motivation to repeat a pleasurable activity, changes to 
avoidance of pain perceived as a threat to ongoing survival, which is a motivating drive 
for safety at the second level of the pyramid (Maslow, 1943; Koob, & McLellan, 2016). 
This is the point at which most addicts are motivated to seek treatment. 
The application of Maslow’s theory in the treatment setting has been 
demonstrated in studies of motivation through incentive programs. In a quantitative 
study, Jones et al. (2016) demonstrated that incentives are effective motivators for those 
who present for treatment with the most basic needs unmet, while rewards are more 
useful for those who present at higher levels. Best et al. (2008) found that attending to the 
primal need of the addicted client to be medically stable, free from pain, and in a secure 
environment supportive of abstinence, is essential before the higher needs of resolving 
relationship issues and exploring long-term life goals can be addressed. Moreover, as 
proposed in Maslow’s theory, first order needs must be addressed before higher order 
needs when providing treatment. It can be argued that even the 12 Steps of Alcoholics 
Anonymous reflect a hierarchy of needs, as they begin with surrender to physical 
addiction and progress through ever higher levels of conversion, culminating in a 
spiritual awakening (Alcoholics Anonymous, 1953). 
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Jones, Weintraub and Zia (2016) used Maslow’s hierarchy to test the hypothesis 
that individuals in the healthcare setting will respond differently to incentives versus 
rewards, based on their level of personal growth. Findings revealed rewards received for 
the achievement of initial treatment goals assist in the transition to the development of 
higher-level goals. As this upward movement through treatment continues, there is a 
point at which incentives become the optimal form of motivation. These findings may be 
used to design individualized treatment programs based on an ongoing assessment of 
patient progress. 
DeLucia, Bergman, Formoso, & Weinberg (2015) incorporated Maslow’s concept 
of psychosocial development and motivation to demonstrate the role of psychological 
well-being in ongoing recovery from substance-use disorders (SUD). In a qualitative 
study, 21 men and women with at least 10 years of recovery from SUD were asked to 
describe the experience of recovery, in terms of their personal development, their 
treatment experience and ongoing involvement in recovery. Participants identified the 
attainment of meaningful goals such as finding a purpose in life and increasing their level 
of self-understanding and self-acceptance as key contributors to long-term abstinence and 
continued motivation to remain active in their recovery programs. The findings explored 
the implications for initiating treatment interventions designed to foster psychological 
well-being as opposed to the conventional focus of drug education and abstinence 
(DeLucia et al., 2015).  
Exploring human behavior in the presence of conflicting motivations, Rigg and 
Ibañez (2010) applied Maslow’s theory to gain insight into non-medical prescription drug 
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use. The goal of the research was to inform effective strategies for resolving the drug 
users’ competing motivations for drug use and abstinence through the design of treatment 
and prevention programs that are motivation-specific. Using a mixed methods approach, 
researchers analyzed data from the South Florida Health Survey of prescription drugs 
(SAMHSA, 2006) and survey responses from prescription drug users. Participants varied 
with respect to demographics as well as current level of use, from active users to those 
involved in treatment or methadone programs. Thirty in-depth personal interviews were 
also conducted to obtain qualitative data. 
Quantitative data demonstrated that the majority of drug users are motivated by a 
desire to “get high” (76.3%) or to cope with anxiety or stress (63.5%).  However, 
qualitative analysis revealed that while these users originally seek euphoria, their 
motivation devolves into an avoidance of the pain caused by withdrawal, as tolerance 
prevents the experience of euphoria once produced by the drug. These findings support 
the premise that drug use is driven by needs for survival and physical comfort, which 
appear at the lower tiers of Maslow’s hierarchy (Maslow, 1943). The implications for 
prevention and intervention designs point to the need to target the more salient 
motivations for drug abuse, rather than those that are commonly addressed, yet less 
important, such as peer pressure. 
Gray (2002) conducted a mixed methods study to assess treatment outcomes in 
The Brooklyn Program, a pilot program initiated by the US department of Probations and 
implemented in the Eastern District of Probations in New York City. Based on Maslow’s 
(1970) assumption that individuals are motivated by an innate drive towards self-
29 
 
fulfillment, the program focuses on personal development and skill-building rather than 
meeting abstinence goals. A variety of techniques encompassed in the discipline of 
Neuro-Linguistic Programming (NLP) are employed to assist clients in recalling and 
anchoring resource states. The Brooklyn program reported an 80% program completion 
rate, with 55% of those who completed treatment maintaining continuous abstinence for 
the three months following treatment. This does not represent a statistically significant 
rate; however, it does compete with outcomes of costlier and more time-consuming 
programs. A more promising outcome was evident in the qualitative data, which revealed 
marked changes in the participants’ attitudes. Graduates of the program report enhanced 
self-esteem, a sense of direction, and motivation to pursue positive life goals (Gray, 
2002).  
Ujhelyi et al. (2016) applied the principles of positive psychology to treatment 
and prevention in the addictions field. The study reflected the views of several pioneers 
in the field of positive psychology such as Rogers (1951), Seligman (1972), and Maslow 
(1943). Based on the concept of self-actualization and working from the premise that 
human beings are driven to satisfy higher as well as lower needs, scales of well-being, 
hope, and resilience were employed to identify predictors of these qualities in those with 
SUD and co-occurring psychiatric diagnoses. The aim of the study was to highlight the 
contribution that positive psychology can make in the treatment of addictions. Data were 
analyzed using a stepwise logistic regression to assess relative contributions of a number 
of predictor variables on the reported levels of hope, well-being, and resilience. Findings 
suggest that high resilience and greater satisfaction of life as predictors of higher levels of 
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hopefulness which, in turn, were positively correlated with resilience.  The odds ratio of 
1:19 indicated that respondents who reported higher hopefulness were a great deal more 
likely to report high levels of resilience. The odds ratio of 1:18 predicted that respondents 
who reported higher resilience were a great deal more likely to report high levels of well-
being compared to the other predictors. These variables were selected due to previous 
studies citing positive mental states and resilience as protective factors against substance 
abuse (Ujhelyi et al., 2016).  
Maslow’s theory provides a basis for understanding the drive states that are 
present from the onset of chemical dependency, through the motivation to seek treatment, 
and onto higher levels of recovery. The neuroplastic changes in the brain associated with 
SUD override the ability of the individual to make rational decisions regarding drug use 
(Volkow & Morales, 2015). When this occurs, the addict functions from the survival 
level, as the pain of withdrawal creates a crisis. When continued use of the drug no longer 
offers relief even from the pain of withdrawal, the motivation to seek help follows. As the 
addict progresses in recovery and the brain is restored to normal functioning through 
abstinence, there is a desire to continue on the trajectory of self-fulfillment. This 
progression from addiction through lasting recovery aligns with the strata of Maslow’s 
hierarchy (Maslow, 1943). The research question will provide a vehicle through which 
the addicts may describe their inner experience of addiction and drug seeking behavior. It 
is hoped these narratives will serve to replace commonly held preconceptions of 




Deci and Ryan’s self-determination theory (1985) is a self-described 
“macrotheory of human motivation” (p.1) that grew from their studies of external factors 
acting on intrinsic motivation. Originating in the 1970s, the complete theory was 
published 10 years later. Its appearance in the professional literature at that time is said to 
have sparked numerous studies applying the theory to various fields, mostly in the area of 
education and sports psychology (Deci & Ryan, 1985). The theory addresses a wide 
range of issues such as goal attainment, psychological needs, personality development, 
and cultural factors, and was intended to be applied in a variety of life situations (Deci & 
Ryan, 2008).  
One aspect of self-determination theory that sets it apart from previous 
motivational theories is the distinctions made between types of motivation rather than 
identifying general needs that motivate behavior. This theory asserts that motivation is 
divided into two categories, autonomous and controlled, and the locus and quality of 
motivation is positively correlated to desired outcomes such as development of well-
being. Autonomous motivation is defined as intrinsic and related to the ideals and values 
of the individual’s identity. Controlled motivation is regulated externally and driven by a 
fear of punishment.  
Deci and Ryan asserted that individuals motivated by external factors tend to be 
approval-seeking and feel pressured to meet others’ expectations (Deci & Ryan, 2008). 
However, while such motivation may produce compliance, compliance based on external 
coercion is introjected motivation, which does not translate to acceptance of others’ goals 
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as one’s own. Conversely, self-regulation and the integration of intended goals with the 
individual’s sense of self, results in acceptance and self-determination (Deci et al., 1994). 
In later studies, Deci and Ryan further examined the impact of excessive external control 
on psychological and physiological well-being. Their findings revealed that excessive 
coercion and pressure to conform may actually have a deleterious effect on well-being 
and disrupt the inherent human tendency to move toward self-actualization. This 
interference in personal growth may significantly reduce motivation, contributing to 
psychopathology and emotional distress (Deci & Ryan, 2000). 
As self-determination theory continued to garner the respect of the scientific 
community, its application in healthcare settings grew.  This is due in part to studies of 
the last decade demonstrating positive outcomes for patients who perceive their 
caregivers as supportive of their autonomy (Vansteenkiste & Sheldon, 2006). Self-
determination theory is borne out in the experiences of many addicts who enter treatment, 
as they are typically motivated either by intrinsic factors, external pressure, or a 
combination of both (Wild, Yuan, Rush, & Urbanoski, 2016). Intrinsic factors may 
include a desire to improve quality of life or live up to one’s potential, while external 
pressures are typically exerted by legal issues or threats from family members (Wild et 
al., 2016). This distinction is important as research has shown that intrinsic motivation, or 
a combination of intrinsic and external, is highly correlated with continued engagement 
in treatment and positive outcomes following discharge, while external pressure alone is 
not (Wild, Cunningham & Ryan, 2006). 
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Self-determination theory is especially appropriate when exploring possible 
motivating factors for today’s opioid users seeking treatment. The new demographic of 
opioid user is most likely to experience only external motivation. This is due to the highly 
addictive properties of opioids, which are enhanced by the synaptic plasticity of the still-
developing adolescent brain (Andersen, 2016). The young person who is drug-involved 
rapidly becomes chemically dependent. Once fully dependent on the substance, a great 
deal of time is spent in acquiring and recovering from each episode of drug use, time that 
is ordinarily spent in completing tasks associated with typical adolescent development 
(American Psychiatric Association, 2013).  
The tasks of adolescence include the development of a concept of personal 
identity, empathy skills, and an awareness of the value of personal relationships as well 
as internalizing a sense of morality (Kohlberg & Hersh, 1977). Young opioid users 
develop dependency before they have the opportunity to develop goals or personal 
integrity. Such qualities are those that allow an individual to acquire the internal 
motivation for recovery from addiction that is described in self-determination theory 
(Deci & Ryan, 2008). Substance use in adolescence interferes with all aspects of normal 
personality development (Slater, 2003). As addictive use interferes with personal 
development; it limits the potential of the individual to develop those very characteristics 
that foster internal motivation for personal growth. During the sensitive periods of 
learning in adolescence when salience of the environment is heightened, the normal 
course of development is eclipsed by the intense stimulation provided by mood-altering 
chemicals, directing the users’ energy and attention towards the drug of choice and away 
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from personal growth (Andersen, 2016). This stunting of development differs from the 
addiction process associated with less reinforcing drugs and is similarly not the 
experience of those individuals who begin using drugs when they are older, and the brain 
is fully developed. Therefore, it is possible that developmental delays due to the impact 
of drugs on the brain need to be considered in attempts to foster internal motivation in 
young patients. 
Self-determination theory has been used to explain the influence of social 
interactions on motivation. Deci and Ryan (2008) described motivation as a continuum, 
ranging from those actions that are solely initiated through self-determination, to those 
that are the result of external pressure alone. Many combinations of both fall in the range 
between these two extremes. Intrinsic motivation can evolve from external pressure if 
such pressure is perceived to support personal autonomy rather than complete control 
over the individual (Deci & Ryan, 2008). External pressure that is based solely on 
coercion and attempts to control typically results in introjected motivation, which is 
compliance based on fear or guilt rather than intrinsic factors (Deci & Ryan, 2008).  
Based on Deci and Ryan’s (1985) theoretical framework, a quantitative study of 
the role of social pressure and coercion in client engagement in outpatient settings was 
conducted by Wild, Cunningham and Ryan (2006). The intent of the study was to 
investigate the utility of self-determination theory in understanding the relationships 
between social pressure, treatment motivation, and engagement. Three hundred 
individuals seeking treatment for SUD consented to participate in the study. Participants 
were asked to complete a Treatment Entry Questionnaire (TEQ) assessing reasons for 
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seeking treatment. The two measures of social network pressure were identified as (1) 
referrals through legal mandates, and (2) referrals from employers or social services. 
Results of the study revealed a positive correlation between the two measures of social 
network pressure and both external and introjected motivation. Conversely, identified 
internal motivation for treatment was positively correlated with problem severity, (2) 
inversely related to external coercion, and (3) highest in clients who were self-referred for 
treatment. The research concluded that legal or social pressure to seek treatment did not 
predict internal motivation for treatment, nor positive treatment outcomes, while self-
referral predicted greater interest in treatment, higher retention rates and greater 
commitment to achieving treatment goals (Wild et al., 2016).  
Wild, Yuan, Rush and Urbanski (2016) conducted a similar quantitative study of 
client-engagement levels in court-mandated treatment. Based on self-determination 
theory, the study hypothesized levels of client engagement would be moderated by the 
factors motivating them to seek treatment. Upon admission, a group of 325 males were 
asked to identify the source and rate the level of perceived coercion for seeking treatment 
for SUD. A logistic regression model was used to predict the rate of treatment retention 
with levels of engagement. The results demonstrated that clients who were legally 
mandated to treatment had significantly lower treatment retention rates than those 
without legal mandates. 
Cornelius, Earnshaw, Menino, Bogart and Levy (2016) used self-determination 
theory as the framework to explore SUD treatment engagement motivation in 
adolescents. In a qualitative study, adolescent patients and their caregivers were 
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interviewed regarding treatment experiences. Thematic analysis was employed to code 
transcripts, resulting in the identification of three categories of motivation: (1) 
identified/integrated motivation, (2) introjected motivation, and (3) extrinsic motivation. 
Intrinsically motivated narratives were characterized as external pressure by loved ones 
perceived as supportive of patient autonomy. Extrinsically motivated narratives described 
treatment decisions that were exclusively motivated by external coercion with no support 
of client autonomy and no evidence of intrinsic motivation. The mixed/transitional 
narratives demonstrated motivation initiated by external coercion but transitioned into 
internal motivation. This transition came about when the client was provided non-
judgmental support by family members who gradually relinquished involvement in 
treatment decisions as the client demonstrated honest acceptance of their illness and the 
need for help. Patients who were initially or eventually able to experience intrinsic 
motivation reported they were able to do so through sense of relatedness they 
experienced with their caregivers and family member.  
As individuals remain largely dependent on their parents throughout adolescence, 
the process of individuation at this stage takes place within the family system (Zupančič 
et al., 2014). This accounts for the successful leverage of external coercion from parents 
in motivating adolescents to participate in treatment. Young adults continue the process 
of individuation outside of the family system through the development of independent 
living skills. During this time, the formation of meaningful connections with peers and 
romantic partners replaces dependence on parents for emotional support (Zupančič et al., 
2014). This may explain why young adults respond differently to treatment coercion. A 
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quantitative study of the role of social pressure on treatment motivation revealed a 
negative relationship between treatment motivation and external coercive pressure 
(Goodman, Peterson-Badali, & Henderson, 2015). The study suggests external pressure 
from parents may be viewed as an attempt to thwart emotional independence. The 
concluding discussion called for further investigation into how emerging adults 
differentiate between the sources and types of external pressures that are coercive, and 
those that are supportive and motivating (Goodman et al., 2015).  
The demonstrated cognitive and behavioral differences between adolescents and 
young adults underscores the need to investigate their drug-use experiences separately 
(Goodman et al., 2015; Zupančič et al., 2014). The issue of motivation for treatment and 
recovery in adolescents has been adequately explored through a variety of methods, but 
the same issue in young adults has not (Goodman et al., 2015). This study intends to fill a 
gap in the literature by exploring motivation for treatment and recovery in emerging 
adults, the developmental period preceded by adolescence. This study further intends to 
deepen this exploration through its specific focus on opioid use disorders.  
Cornelius et al. (2016) concluded that intrinsic motivation in the classic sense 
may never be present in addicts seeking SUD treatment as the experience is rarely 
pleasurable. They further cautioned against categorizing all motivation into only intrinsic 
vs. extrinsic, as addicts perceive certain external pressure, such as family concern, as 
supportive rather than coercive. Therefore, effective approaches to increasing patient 
motivation may involve fostering relatedness between clients, clinicians, and caregivers, 
as clients who felt their personal recovery goals were respected and supported 
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experienced increased perceptions of self-competence and achieved higher levels of 
engagement in treatment (Cornelius et al., 2016). 
Interestingly, the client may still experience pressure, even in circumstances 
where there is no evidence of external coercion involved in the client’s decision to seek 
treatment. Opsal, Kristensen, Vederhus and Clausen (2016) conducted a quantitative 
study of patients who were voluntarily admitted (VA) and involuntarily admitted (IA) to 
treatment for substance-use disorder. Patients were asked to complete the Perceived 
Coercion Questionnaire (PCQ), which was developed specifically for patients engaged in 
treatment for substance-use disorders (SUD). The PCQ contains items that appear as 
statements, which the client rates for personal applicability on a 5- point scale. The 
statements are divided into six sets of subscales, five of which measure external pressure. 
The sixth, Self, measures internal pressure that is perceived by the patient as coercion. 
This subscale describes internally motivating factors such as perceived personal 
powerlessness over addiction or shame over drug use and related behaviors (Klag, Creed, 
& O'Callaghan, 2006).  
Analysis of patients’ scores on the PCQ revealed no significant differences in the 
scores between the IA and VA patients. This indicates that even though clinicians may 
regard external sources such as legal, financial, or family issues to be the primary sources 
of coercion, the patient may feel equally coerced by their internal sense of desperation 
and shame. These data point to the possibility that many patients seeking admission to 
SUD programs experience equally high levels of perceived coercion to seek treatment 
regardless of circumstance. The study concluded that in order to enhance motivation and 
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treatment outcomes by increasing intrinsic motivation as predicted by self-determination 
theory, attention must be paid to identifying and ameliorating the source of perceived of 
coercion (Opsal et al., 2016). 
Self-determination theory was an appropriate foundation for this study as it 
provided information relevant to the ways in which impetus to change is impacted by the 
pressure from internal and external sources. Of particular importance in the field of 
addictions treatment is the understanding gained from this theory that even internal 
pressure does not always translate into intrinsic motivation (Wild et al., 2016). Those 
with SUD often internalize the disapproving messages of their family and general social 
support system and are driven to satisfy the needs of others over their own. Such 
motivation typically results in surface compliance, rather than the internal growth that is 
associated with positive treatment outcomes (Wolfe, Kay-Lambkin, Bowman, & Childs, 
2013). This study relates to existing theory on self-determination with its examination of 
the context wherein young substance users view their disorder and their personal process 
of becoming motivated to seek treatment. In this way, the research questions were 
designed to generate discourse that provided enlightenment with regard to the addicts’ 
inner cognitive and emotional processes as they moved through the stages of their illness. 
This understanding of how those with SUD perceive their disorder and personal treatment 
needs may be used to inform the design of treatment methods that encourage internal 
motivation rather than surface compliance (Wild, 2015).  
In summary, a variety of both quantitative and qualitative studies have been 
employed to demonstrate the usefulness of these theories in understanding possible 
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motivation for seeking treatment, prolonged retention, and positive treatment outcomes.  
In a broad sense, Maslow explains basic human needs, which initially are met entirely by 
the drug of choice, only to reverse course and leave the addict suffering in a constant 
state of deprivation. Self-determination theory provides a rationale for moving away from 
the past approach of coercing addicts into treatment, settling merely for compliance with 
program rules, instead fostering a sense of self-competence and an internal motivation for 
recovery. Both theories are examined further in the remaining chapters as they were used 
to analyze and interpret the data.  
Literature Review Related to Key Concepts 
Demographics and Personality Traits of Millennials 
The demographic that was the focus of this study, young opioid addicts between 
the ages of 20 and 25, are a subset of their generation, the Millennials. A review of the 
attributes that set this generation apart from its predecessors has been provided to 
facilitate an understanding of that subset. Millennials currently comprise the largest group 
of Americans, approximately 75 million, or one quarter of the population (McDonald, 
2015). The world in which they have come of age is significantly different from that of 
past generations (McLeigh & Melton, 2015). Millennials grew up in a period of 
American history characterized by unprecedented acts of domestic and foreign terrorism 
on American soil, carried out in cities, schools, places of worship and public social 
gatherings. They have had far greater access to media and information technology than 
previous generations, allowing them to witness repeated broadcasts of violence and 
economic upheaval.  
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The majority of millennials were raised in households earning a middle-class 
income or higher and were heavily influenced by cultural trends such as single parent 
homes, increased access to technology and women in the workplace (Ng & Johnson, 
2015). More millennials attended college and earned degrees than past generations. This 
includes young women, who received their degrees and entered the job market in greater 
numbers than those before them. Their levels of education, and the parenting styles of 
those who raised them has contributed to their tendency to be more assertive, have high 
levels of self-expectation, and to question the status quo. 
Using large sample sizes (175,000 per year), Gallup polls provide one of the 
largest data bases of lifestyle choices for Millennials and previous generations (Gallup, 
2016). Analysis of these data reveals that Millennials prefer a lifestyle that differs greatly 
from previous generations. With regard to relationships, Millennials have the lowest rate 
of marriage in same-age comparisons with GenX and Boomers (41%, 84%, and 90% 
respectively). More millennials live in multiple adult settings as opposed to two adult 
households when compared to their predecessors. Seventy-seven percent of millennials 
who have never been married live in communal settings shared with two or more adults. 
Sixty-eight percent of millennials disclose marriage is not prerequisite for raising 
children. Indeed, more than 50% of millennials over the age of 34 who have never 
married have children as opposed to 30% or less from previous generations. Finally, 
millennials are the most ethnically diverse generation in American history and are twice 
as likely as GenX or Boomers to identify as LBGT (Gallup, 2016).  
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Much of the information on the personality attributes of Millennials has been 
gleaned from workplace studies, as Millennials represent the future of the American 
workforce. Observations and studies of Millennials at work have resulted in unflattering 
characterizations of them including, lazy, defensive, disrespectful, easily distracted, 
needy, indifferent, arrogant, abrasive, self-absorbed and entitled (Lancaster & Stillman, 
2010). More scientific approaches to measuring personality traits indicate higher levels of 
neuroticism, narcissism, self-confidence and self-assuredness in Millennials when 
compared to older workers (Lyons & Kuron, 2014). Perhaps their upbringing by a 
generation of parents who provided reward based on effort rather than merit contributed 
to what was described by Ronald Paul Hill (2002) as the “ability-performance nexus” (p. 
64). Millennials demonstrate an inability to relate performance to their abilities and tend 
to have high levels of self-esteem that is not based on actual levels of self-competence. 
Forty-one percent of Millennials expect to be shown appreciation for their contributions 
in the workplace on a monthly basis which exceeds the expectations for recognition of 
past generations at the same age (Stewart et al., 2017). Finally, they have high 
expectations of success that are unmatched by their ability level and unrealistic 
expectations of advancement, expecting promotions within 15 months of obtaining their 
first position, and yearly salary increases of up to 3% (Ng & Johnson, 2015). 
The information above, when applied to those millennials with SUDs , offers 
some insight into the challenges of motivating them to seek treatment. Their high 
expectations of success are rarely met in the treatment setting as relapse is the hallmark 
of opioid use (Hilton & Pilkonis, 2015). Furthermore, comparing themselves to the 
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typical Millennial without a SUD is an unfair comparison that only reinforces their sense 
of shame and social isolation from their peers. Young addicts entering treatment typically 
present with a variety of legal problems and social, educational, and financial deficits, 
which often seem insurmountable (D’Agostino et al., 2017).  Comparing themselves to 
their non-addicted peers who have successfully graduated from college and secured well-
paid positions can create an overwhelming feeling of failure, which is stressful and 
undermines recovery (Lusk & Veale, 2018). 
Substance Abuse History, Spirituality, and Connectedness 
Individuals who have a history of substance abuse often experience their 
addiction as a form of relationship (Larkin et al., 2006). This fundamental perception in 
addicts of the drug as more than a medication is an important distinction in the way they 
regard abstinence-based treatment. The consideration of drug use from the perspective of 
the addict is a useful context from which to understand motivation for treatment. Unlike 
clinicians, individuals with SUD regard mood-altering substances within the context of 
their reinforcing properties, rather than solely agents of harm. The individual personality 
of the individual and the needs that any given substance fills for that individual, provides 
important clues as to what is needed to increase treatment engagement (Blonigen, Timko, 
Jacob, & Moos, 2015; Hilton & Pilkonis, 2015). A look at the needs met in ancient 
cultures through drug can provide insight into humankind’s earliest positive experiences 
with mood-altering chemicals which in turn may be extrapolated to explain the function 
of drug use in today’s addict.  
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The relationship between human beings and substances has an enduring and well-
documented history. The oldest evidence of the use of the opium poppy in ancient 
cultures was discovered in the ruins of a Stone Age settlement submerged by rising water 
in La Marmotta, Italy. Archeologists believe the site was habited by a Neolithic farming 
community approximately 7,700 years ago. Preserved under the lime of the lake which 
now covers the region were many well-preserved specimens of poppy in a religious cult 
room, linking this oldest specimen to ritual use of the poppy by humans (Merlin, 2003). 
Botanical evidence of opium poppy has also been unearthed in various sites throughout 
Europe and Asia as far back as the Neolithic age (Merlin, 2003). It is believed that 
Neanderthal civilizations used mood-altering substances for medicinal effects and use in 
cult rituals. Such use is believed to have been instrumental in the development of one of 
civilization’s earliest forms of spirituality, shamanism (Inaba & Cohen, 2014).  
The psychoactive properties of various plants known as entheogens, served to 
stimulate visionary experiences in shamans (Jünior et al., 2015). Shamans believed these 
ecstatic states allowed them direct intercession with the spirit world on the behalf of the 
community with regard to illness and climate factors affecting food supply and safety 
(Winkleman, 2105). Therefore, the earliest role of substance use in civilization was to 
provide healing, energy, pain relief, and a connection to the divine – all positive and life-
sustaining functions. These positive functions of substance use are still experienced 
today, not just with respect to medical treatment, but in a spiritual sense as well. This has 
been supported by recent research prompted by a resurgence of interest in the role of 
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psychedelics for the treatment of addiction and certain psychiatric illnesses (MAPS, 
2018; Thomas et al., 2013). 
Studies of the use of ayahuasca, an entheogenic preparation used by indigenous 
tribes of the Amazon basin (Inaba & Cohen, 2014) have demonstrated a relationship 
between the use of this drug and positive changes in attitudes that support abstinence. 
These changes include increased spirituality and optimism, with no evidence of 
psychopathology or neurotoxicity related to the use of this drug (Buoso et al., 2015). A 
study was conducted on the experiences of six tourists from various locations who 
traveled to Iquitos to participate in the ayahuasca ritual. During the month-long retreat, 
micro-ethnographic field study methods were used to collect qualitative data on the 
participants’ experiences and responses to the ritual. All six participants reported 
psychological, social and physical benefits, such as serenity, increased self-awareness, 
and intended improvement in behavior towards others due to a sense of relatedness to 
society as a whole (Prayag, Mura, Hall, & Fontaine, 2015). 
In their investigation of the psychedelic drug experiences of the global dance-drug 
culture, Joe-Laider, Hunt and Moloney (2014) collected narratives of contemporary youth 
to capture the meaning they ascribe to the hallucinations experienced in various settings. 
Their intent was to investigate the role of such drugs in fostering a sense of community 
and shared spiritual experience as a motivation for use. Two groups of participants were 
interviewed from distinctly different demographics. Yet, they all shared an interest in 
frequent attendance at local dance clubs, where they routinely consumed hallucinogens 
such as LSD, Ketamine, or Ecstasy to enhance their experience. Common themes arising 
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from the accounts given by both groups of participants of their intoxication included 
heightening of the senses, increased self-esteem, confidence and happiness, a sense of 
community or connection to those sharing the experience, and a feeling of safety and 
trust which allowed them to lower their defenses (Joe-Laider et al., 2014). Many reported 
that such experiences had a life-changing impact which persisted long after the effects of 
the drug had dissipated, allowing them to be more open, social and spiritual than they had 
been in the past. The researchers concluded that the experience transcended mere 
intoxication and resulted in an enhanced sense of expansion, spirituality, and connection 
to others (Joe-Laider et al., 2014). 
Legislation as Remedy 
The failure to consider these positive effects of substance use may be at the root 
of the many failed attempts to address drug addiction through legislation. As America 
transitioned from the 19th to the 20th century, a growing awareness of the many societal 
problems inherent in habitual drug and alcohol use developed (Sacco, 2014). The 
industrialization of America and England saw a rise in the consumption of alcohol along 
with increased awareness of its negative impact on the family system. Alcohol 
consumption had risen to its highest level in nearly 50 years accompanied by a 
corresponding rise in admissions for treatment of alcoholic psychosis and death rates due 
to cirrhosis (Blocker, 2006; Duke & Gross, 2014). During the same general time period 
the use of opiates and cocaine, available through the unregulated manufacture and sale of 
patent medications, had also become problematic (Kolodny et al., 2015; Sacco, 2014).  
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The response to these problems was as series of legislative actions designed to 
restrict the supply of alcohol and drugs available to Americans while imposing penalties 
for their use. This initiative began in 1901 during Theodore Roosevelt’s term and 
continued into the 21st century. Three of the most well-known and impactful pieces of 
legislation were the Harrison Act (1914), the 18th Amendment or prohibition (1920) and 
the Comprehensive Substance Abuse Act of 1970 (Duke & Gross, 2014). All of these 
laws instituted sweeping changes in federal regulations regarding the manufacture, 
distribution, and use of alcohol and other drugs, yet none of them can be attributed with 
eradicating or even significantly reducing the problem they were intended to address 
(Duke & Gross, 2014). History has shown us that such approaches typically result in the 
same outcomes, (a) an increase in illegal sources of trade and the development of new 
substances that are outside the scope of the law and (b) the incarceration of those already 
addicted (Herzberg et al., 2016).  
These clearly observable outcomes from over a century of such interventions have 
been supported by research. Studies show that cocaine addicts will continue to use 
despite punishment, which is believed to be due to impairments in goal-directed control 
(Ersche et al., 2016; Stern, 2016). Addicts who enter treatment due to legal pressure do 
not experience positive treatment outcomes. Mandatory addiction treatment, considered 
by many to be a violation of human rights, had been a common practice in many Asian 
countries for decades, accounting for the forced treatment of more than 400,000 
individuals. This approach has had so little effect on reducing drug use that there has 
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been a recent move towards voluntary treatment and harm-reduction models in those 
locations (Lunze et al., 2016). 
Moreover, studies of the impact of legal coercion for treatment have shown that 
legal pressure to enter treatment is negatively correlated with treatment readiness, and 
legally mandated treatment is not a significant predictor of engagement in treatment 
(Rourke et al., 2015; Urbanoski, 2010). An equally distressing outcome of these failed 
attempts to reduce substance abuse through legislation was its reinforcing effect on the 
stigma already associated with drug use. One of the outcomes of the first wave of drug 
enforcement laws in the early 20th century was to focus public attention on opiate 
addiction in a way that engendered fear and repulsion regarding the use of such 
substances. The unfortunate individuals who were unable to overcome their drug 
dependency and continued to access opiates and cocaine through illegal channels became 
criminals and outcasts of society. The term “junkies” was coined in this era to describe 
these people who were considered hopelessly incapable of rehabilitation (Herzberg et al., 
2016). Unfortunately, these negative perceptions persist in contemporary society, adding 
to the self-condemnation typically experienced by those with SUDs  (Webb, & Toussaint, 
2018). 
The Medicalization of Substance Use Disorders 
The stigma of alcoholism was finally challenged in the mid twentieth century 
through the efforts of Bill Wilson. Wilson was an unemployed stockbroker who had been 
unsuccessful in maintaining abstinence despite repeated hospitalizations. After having a 
life changing spiritual experience while under the influence of belladonna, a hallucinogen 
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sometimes administered to alcoholics at that time, he was inspired to establish Alcoholics 
Anonymous (AA, 2018). The support group was based on the principles of the Oxford 
Group, an organization of Christian men seeking to improve their spiritual condition. 
Wilson was among the first to use the term “disease” in reference to alcoholism, although 
the principles or “steps” suggested as a path to recovery were mostly spiritual in nature 
(Hartmann & Millea, 1996). 
As membership in AA grew considerably, the group experienced a significant 
boost to their credibility through the work of E.M. Jellinek, a biostatistician from 
Stanford. Jellinek conducted a study into alcoholism using a handful of personally 
selected AA members who submitted self-completed questionnaires regarding their 
experiences as both active alcoholics and while in recovery. This research, which is now 
considered unscientific and flawed, garnered so much attention for its detailed account of 
the progression of alcoholism that it was used by a branch of lobbyists from AA to 
convince members of American Medical Association (AMA) to officially endorse the 
disease concept of alcoholism (Falcone, 2003). This group of lobbyists organized under 
the name of the Committee for Education on Alcoholism (CEA), then joined forces with 
the AMA and other legislators to compel the federal government to accept the AMA’s 
position and officially recognize alcoholism as a primary disease rather than a form of 
mental illness. When this had been accomplished, the field of alcoholism treatment 
earned the right to establish its own national institute, the National Council on 
Alcoholism (NCA).  
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The considerable influence of the NCA combined with the support of the AMA 
led to the acceptance of the AA model of abstinence and powerlessness. Pressure from 
the NCA benefitted alcoholics by making treatment available on a nationwide scale. Such 
treatment however was rigidly modeled after the principles of AA and disallowed any 
approaches other than strict adherence to the 12-Steps of AA and complete abstinence 
from all mood-altering substances. This persisted despite research that was being 
conducted during that period demonstrating the feasibility of controlled use as an option 
in the treatment of alcoholism (Bien, Miller, & Tonigan, 1993). This was primarily due to 
the influence of the NCA and AMA on the federal government (Bien, Miller, & Tonigan, 
1993; Falcone, 2003; Sacco, 2014).  
Fortunately, the advent of managed care compelled treatment providers to 
institute the development of training and credentialing for addiction professionals as well 
as the institution of research-based treatment approaches, allowing the introduction of 
contemporary modalities and integrative therapies (Kunz & Wiegand, 2016). These 
approaches included medically assisted treatments such as opioid agonist and antagonist 
therapies, which have proven successful in reducing overdose deaths and relapse rates 
(Weiss & Roa, 2017).  
Addiction Etiology and the Diagnostic and Statistical Manual of Mental Disorders 
As the long-running debate over the etiology of addiction took place over the past 
century, the discourse was joined by social scientists and those involved in neuroscience 
research. The former opposed a purely genetic/biological model of addiction, as this 
disallows what is believed to be the credible biocultural and ecological contributors to 
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SUDs . The latter brought to the discussion several decades of research devoted to 
identifying the neuro-circuitry involved in SUD through the use of advanced 
neuroimaging technology. The biological model has been publicly endorsed by NIDA, 
and thus, government funding of research has been primarily directed towards this model 
(Courtwright, 2010).  
The struggle to develop a consensus on the cause and manifestation of addiction 
was reflected in the many editions of the Diagnostic and Statistical Manual of Mental 
Disorders (DSM). The first edition of the DSM was published through a cooperative 
effort between the Veterans’ Administration and the American Psychiatric Association 
following the end of World War II to address the psychiatric causalities of the war 
(Nathan, Conrad & Skinstad, 2016). The panel of 28 physicians developed the system of 
naming and establishing diagnostic criteria for each disorder by drawing on their clinical 
experience rather than research findings. The manual was titled the Diagnostic and 
Statistical Manual of Mental Disorders (DSM), and was the first of what has been a series 
of five, to-date. In the first edition alcohol and drug intoxication were included under 
acute and chronic brain syndromes. Five personality disorders were identified in the 
original addition of the DSM. The fourth in this category was sociopathic personality 
disorder (SPD). SPD included four subcategories, sexual deviation, antisocial reaction, 
dyssocial reaction, and addiction. The first three of these four diagnoses were 
characterized as conditions that were not responsive to punishment or treatment and/or 
conflicted with the mores of society held (APA 1952). This categorization of alcoholism 
and addiction, which also appeared in the DSM-II, was a reflection of the psychodynamic 
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theories that were widely accepted at the time. It was not until the DSM-III was published 
28 years later that addiction and alcoholism were removed from this category (APA, 
1980; Nathan et al., 2016). This was due to a growing body of research into the biological 
and genetic contributions to addictive disease that began in the latter part of the 20th 
century (Garriott & Raikhel, 2015).  
Treatment Effectiveness  
The various political, financial, and public agendas described in the preceding 
sections that have historically driven investigation into the nature of SUD, have 
influenced clinical practice (Livingston, Fei & Fanelli, 2017; Marinelli-Casey, Domier & 
Rawson, 2002; Stein et al., 2015). Reimbursement by most health insurance companies 
calls for accountability through documented use of research-based practices (Livingston, 
Fei & Fanelli, 2017). Therefore, a great deal of study has been devoted to treatment 
modalities and their effectiveness in order to ensure these approaches find their way into 
practice (Marinelli-Casey, Domier & Rawson, 2002). In addition to research funded by 
universities and corporate interests, the federal government is responsible for a large 
body of research and publication of statistical data regarding substance use through 
agencies falling under the auspices of the DHS, such as the NIDA. 
The ongoing debate between fields of psychotherapy and neuroscience over the 
credibility of the disease concept of addiction has generated research into the effect of the 
addict’s perception of the nature of their illness with regard to treatment outcomes. In a 
quantitative study, Wiens and Walker (2015) explored the impact of certain beliefs on 
their recovery held by alcoholics/addicts regarding the origin of their substance disorder. 
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The primary purpose of the study was to measure the effect of the alcoholic/addict’s 
belief regarding the root cause of SUDs  on their sense of personal control and feelings of 
shame and stigma regarding their addiction. 
Ninety-one participants were separated into three groups and provided reading 
material which supported acceptance of (a) the disease model, (b) the psychosocial 
model, or (c) neutral reading material. This manipulation was intended to simulate the 
manner in which clients are indoctrinated into such beliefs while in the treatment setting.  
Following this first phase of the experiment, the participants were asked to complete ten 
separate scales designed to measure levels of agency, stigma, belief in the disease model, 
belief in the psychosocial model, shame/guilt, approach/avoidance, locus of control, and 
controlled drinking self-efficacy. The participants’ responses were analyzed to determine 
the effects of the individual’s beliefs on personal management of their addiction (Wiens 
& Walker, 2015). No significant differences were found between the treatment groups 
with regard to stigma, shame, and coping styles. Those in the psychosocial condition 
however, had a significantly stronger internal locus of control and stronger perceptions of 
self-efficacy than those who accepted the disease model. Weins and Walker (2015) 
suggested accepting the biogenetic model of addiction may erode clients’ motivation to 
recover due to feelings of learned helplessness. 
Kvaale, Haslam, and Gottdiener (2013) conducted a meta-analysis to explore the 
effect of holding a biomedical view of psychological problems on the stigmatizing impact 
of a psychiatric diagnosis. The researchers concluded that while biogenetic models 
reduce blame directed towards the affected individual by others, they also increase 
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stereotypical perceptions of such persons as dangerous or uncontrollable. Pessimism 
often develops among the client and family members, due to the mistaken belief that self-
will and personal recovery efforts cannot significantly impact an illness of biogenetic 
origin (Kvaale, Haslam, & Gottdiener, 2013). 
Weinberg (2013) argued for adopting a post-humanist approach with regard to the 
issue of addiction and self-governed behavior. This position is based on the failure of the 
neuroscientific community to provide explanations for the many “holes” in their brain 
disease paradigm. This includes an operational definition for loss-of-control regarding 
drug use, or an explanation for why addicts will relapse to active use long after recovery 
from the acute withdrawal phase. Furthermore, there appears to be no explanation for 
identical patterns of craving and compulsive procurement behaviors with substances that 
are not physiologically addictive even in the case of behaviors that are self-destructive 
but do not involve substances, such a gambling or sexual addiction (Weinberg, 2013).  
Despite the adoption of the atheoretical classification system used in the DSM, 
the mental health field continues to advance initiatives for developing cross-diagnostic 
models of substance use and other psychiatric disorders. The Research Domain Criteria 
Initiative (RDoC) was developed by the National Institute of Mental Health (NIMH) for 
such a purpose (Kozak & Cuthbert, 2016). This strategy has not stimulated much 
research specific to SUD as yet (Robinson & Adinoff, 2016), however, clinicians have 
adopted the practice of integrating psychodynamic therapies with the biogenetic model in 
the field of addiction treatment (Lilienfeld, 2014).  
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The debate between proponents of medically assisted treatment (MAT) and 
conventional psychotherapists over the advisability of using therapy as an adjunct to 
agonist treatment has generated research as well. Proponents of the psychodynamic 
approach to substance use treatment assert that agonist medications alone are not 
sufficient to support long-term, quality recovery. Research demonstrates the response to 
treatment approaches that include cognitive behavioral therapy (CBT) as an adjunct to 
physician management (PM) in treatment for opioid use disorder have been mixed. 
Moore et al. (2016) demonstrated improved abstinence rates for patients who receive 
combined CBT and PM treatment. The benefit of incorporating behavioral therapies with 
opioid agonist therapy was measured in prescription opioid (PO) and heroin (H) users. 
Following 40 weeks of treatment, the PO group showed a significant difference in 
negative urine screenings over the H group, which may be explained by baseline 
differences between groups. PO users tend to present with chronic pain and mental health 
issues and shorter histories of opioid use, which may result in favorable responses to the 
pain-relieving and anxiolytic properties of opioid agonists (Nielsen et al., 2015).  
However, a randomized controlled trial which was conducted to explore the 
effectiveness of four behavioral treatment interventions when combined with medical 
management (MM) of their opioid addiction yielded no significant results. This indicated 
a lack of evidence to support the benefit of incorporating behavioral interventions with 
MM (Ling et al., 2012). However, an admitted limitation of the study was that the 
treatment length did not reflect the longer treatment periods associated with positive 
outcomes in similar studies, which may account for the results. Similar results were 
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demonstrated by Fiellin et al. (2013) in a 24-week randomized trial involving 141 
patients with opioid use disorder in an outpatient program. There was no significant 
difference in self-reported reduction in frequency of use. Results indicate no significant 
benefit from the addition of CBT therapy to PM.  
Overall, despite the large body of research prompted by the opioid epidemic, data 
demonstrating the long-term effectiveness of any specific therapeutic modalities in the 
treatment of young adults with SUDs  have been limited (Matson et al., 2014). There is, 
however, a significant body of evidence demonstrating the general failure of treatment 
programs to engage young adults in treatment. In a meta-analysis of 122 studies of 
treatment drop-out risk factors, Bronson et al. (2013) identified younger age as the only 
consistently demonstrated risk factor. The Treatment Episode Data Set of 2015 
(SAMHSA, 2015) reported a 45% outpatient drop-out rate in clients aged 21-34, as 
opposed to less than 5% and 11% in adolescents and older adults, respectively. Vo et al. 
(2016) cited numerous explanations for less than optimum treatment outcomes, including 
developmental susceptibility, psychiatric co-morbidity, and lack of engagement Griffin 
and Botvin (2010) suggested that disengagement from the family system, which is 
common in young adults, eliminates much of the interpersonal motivation experienced by 
both younger and older populations of substance users.   
Isolated reports of improved outcomes in the treatment of young opioid addicts 
through medically assisted treatments, such as agonist and antagonist therapies, are 
represented in the literature. An outcome study of community-based relapse prevention 
programs for young adults reported 3- and 6-month retention rates of approximately 60% 
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and 40% respectively, almost equal to those of older adult clients (Vo et al., 2016). 
However, the preponderance of data indicates positive treatment outcomes in emerging 
adults are rare. Schuman-Olivier et al. (2014); found statistically significant differences 
in treatment retention (17% versus 45% at 12 months), duration of abstinence, and 
relapse rates in such programs when comparing emerging adults to older patients. Finally, 
a number of studies have reported positive correlations between increased age and 
treatment retention in agonist treatment programs, which is a predictor of long-term 
abstinence and reductions in overdose fatalities (Clausen, Anchersen, & Waal, 2008; 
McHugh et al., 2013).  
Harm Reduction Models 
While the debate over the nature of addiction and the most efficacious treatment 
approaches goes on, the emergent nature of the epidemic of opioid abuse has led some to 
abandon academic discussion in favor of taking action to save lives. Kolodony et al. 
(2015) presented evidence of the effectiveness of contemporary programs established by 
public health authorities in ameliorating the devastating impact of the current opioid 
crisis. The public health response to soaring rates of opioid relapse and deaths due to 
overdose has resulted in the adoption of heretofore unpopular approaches to reducing 
drug use. These include harm-reduction programs and medically assisted treatments.  
Harm reduction approaches include needle exchange programs, which have been 
shown to reduce the incidence of infections such as Hepatitis C and HIV resulting from 
shared needles (Page et al., 2013). Furthermore, IV drug users are five times more likely 
to seek treatment for addiction when they access the auxiliary services available to them 
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through a community-based syringe service program (CDC, 2017). Access to Naloxone 
has been instrumental in reducing overdose fatalities by providing a means of reversing 
life-threatening respiratory depression (Doe-Simkins et al., 2015; Wheeler, Jones, Gilbert 
& Davidson, 2015). Medically assisted treatments such as buprenorphine, a partial opiate 
agonist, have been successful in reducing relapse and overdose rates (Bentzley et al., 
2015).  
Conclusion 
A large body of research has been directed towards the etiology and treatment of 
SUD, yet to-date there is little consensus among professionals regarding the causes of 
addiction and which treatment approaches are the most effective. The federal 
government’s attempts to address the issue with legislation has been ineffective. The 
addiction treatment community has been entrenched in archaic modalities instituted in the 
mid-19th century that reflect the efforts of those with political influence more than best-
practices driven by research (Falcone, 2003; Sacco, 2014). The enormity of the current 
epidemic of opioid use tends to eclipse historical accounts of American’s problematic 
relationship with drugs, when in fact it is one of three such surges that took place in the 
last two centuries.  
The ineffectiveness of past legislative and therapeutic measures to reduce the 
severity of the current tide of opioid use disorder has led to the acceptance of strategies 
that were once considered unacceptable. This is due to a sense of desperation as mortality 
rates from opioid overdoses continue to climb, lowering the life expectancy of Americans 
for the past 2 years, an occurrence unheard of since the flu pandemic of 1918. These 
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measures are largely directed towards harm reduction, which has proven to be more 
effective in reducing death rates from overdose as well as the spread of life-threatening 
infectious diseases such as HIV and Hepatitis C. Harm reduction programs such as 
syringe exchange programs (SEP), overdose prevention, and opioid agonist therapies 
have already been initiated by public health authorities in most of the United States. Still 
others, such as law enforcement assisted diversion (LEAD), supervised consumption, and 
the legalization of cannabis are either in place in some states or poised for introduction to 
state legislative systems in others. Due to the demonstrated effectiveness of these 
innovative programs, the federal government has shown support through funding as well 
as legislative measures designed to reduce resistance to their implementation on the state 
level. The impediments to successfully addressing the current epidemic present a 
formidable task for policymakers. Substantial progress in this area is unlikely without the 
resolution of long-standing dissension within and among those in public health, 
treatment, research and criminal justice systems on the fundamental issues of best-
practices in treatment and the operational definition of SUD.  
Finally, the demographic of the new face of opioid addict presents many 
challenges with regard to motivating them to seek treatment and commit to a program of 
recovery. Their sense of entitlement, unrealistic expectations of success, unwillingness to 
submit to the judgment of others leaves them unprepared for the reality of treatment and 
the trials of early recovery. Their failure to meet the goals of their non-using peers further 
isolates them from possible support systems. And the early onset and rapid development 
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of dependency on opioids prevents the development of positive relationships and interests 
that can fill the void left by the cessation of drug use.  
Human motivation theory tells us that human beings are motivated toward 
experiences that sustain life and support spiritual evolution in a predictable and 
meaningful order. Self-determination theory demonstrates the need for intrinsic 
motivation as a necessary ingredient in personal growth and development. Both theories 
have been applied in studies of the causes and treatment of SUD. Yet the body of 
literature lacks an investigation into how these concepts may be applied in the study of a 
new generation of opioid addicts. This study addressed the gap in the literature and 
extended knowledge of this subset of the Millennial generation, the largest group of 
individuals alive today, who differ greatly from past generations with regard to their 
personal attributes and lifestyle choices. Their well-documented departure from the norm 
of previous generations warrants a fresh perspective on the issue of SUDs, which this 
study explored through an investigation of their lived experiences as a new generation of 
opioid addicts.   
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Chapter 3: Research Method 
Introduction  
My intent for this study was to explore the lived experiences of motivation to seek 
treatment and recovery in young adults with opioid use disorder. The study was designed 
to address the gap that exists in qualitative literature regarding a new generation of opioid 
users and what motivates them to seek treatment and recovery. Research indicates that 
only 11% of young adults with SUD seek and receive treatment. (Adams et al., 2014). 
When compared to adult populations, young people typically respond poorly to treatment 
(Adams et al., 2014). In 2015 alone, death rates from opioid overdoses reached 35,000 
with the largest number of deaths occurring in the 25 to 44-year-old age group (HHS, 
2017). These statistics indicate a possible failure to motivate and engage this vulnerable 
population in much needed treatment. Insights into the lived experiences of these young 
addicts might inform new approaches that stimulate motivation and treatment 
engagement in young addicts.  
Most studies of individuals with opioid use disorder consist of cohort studies and 
surveys of older populations who are not representative of the young adult population. 
Recent research into motivation for treatment and recovery has offered some insight into 
motivational processes in alcoholics and older adults but not in young adults with opioid 
use disorder. In a quantitative study of motivation in adults with alcohol use disorder, 549 
individuals were assessed to ascertain the relationship between severity of alcohol 
problems and motivation for treatment and behavior change. Results revealed higher rates 
of help-seeking were positively associated with higher alcohol problem severity, but 
62 
 
readiness to change was not. While the study did not include data on the specific age 
range of the participants, the discussion section noted that higher motivation for change 
was reported by older adults and those with partners, but data supporting this conclusion 
were not included (Freyer et al., 2005).  
Kelly and Green (2014) conducted a quantitative longitudinal study of young 
adult men (aged 21-34) who had successfully completed residential treatment for SUD. 
The study revealed that high internal motivation for abstinence was a better predictor of 
long-term abstinence than high levels of self-efficacy. The research concluded that 
confidence in one’s ability to maintain abstinence is not a protective measure against 
relapse if internal motivation for recovery from SUD is not in evidence. However, this 
study did not contribute to an understanding of what leads to high levels of internal 
motivation for abstinence in young adults as this construct was not explored.  
Sinha et al. (2003) investigated readiness to change and treatment outcomes in 
young adults referred by probation for outpatient SUD treatment. Quantitative analysis of 
scores from the Stages of Change Readiness and Treatment Eagerness Scale 
(SOCRATES) revealed significant differences between younger and older adults with 
regard to levels of motivation and readiness to change. The study suggested that young 
age is a predictor of poor treatment outcomes and postulated that young adults fail to 
perceive their substance use as problematic. However, the study further noted significant 
histories of incarceration during adolescence in the young adult participants, suggesting a 
higher likelihood of co-occurring psychopathology, which does not represent the target 
group of my study.  
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Thus, while some research has been directed towards understanding factors 
involved in treatment-seeking behaviors and commitment to recovery, qualitative studies 
that specifically explore these issues in young adult opioid addicts are not represented in 
the literature.  
This chapter describes the procedures for data collection and analysis. The 
rationale for using narrative inquiry is discussed. The recruitment procedures and 
development of the interview questions are also described. Ethical issues associated with 
this type of study are addressed as well as how I established the trustworthiness of the 
findings.   
Research Design and Rationale 
Research Questions 
The following  research questions guided this qualitative inquiry:  
RQ1: What do narratives of young opioid addicts reveal about their 
motivation to enter treatment? 
RQ2: What do narratives of young opioid addicts reveal about their 
motivation for recovery? 
Central Phenomenon of Interest  
The phenomenon of interest was motivation to seek treatment for opioid use 
disorder. I examined motivation from within the framework of two theories of human 
motivation: Maslow’s theory of human motivation (1943) and Deci and Ryan’s self-
determination theory (2008). Maslow stated that all human motivation is driven by needs 
that build from the most basic, such as survival, to higher needs of belonging and self-
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actualization (1943). Self-determination theory asserts that the locus of motivation may 
be external or internal, which determines to a large extent the individual’s commitment to 
goal achievement (2008). Both theories offer a frame of reference for understanding the 
drives that motivate addicts’ decision-making and behavior patterns within the context of 
their disorder. These include initial drug-seeking behavior (gratification), continued drug 
use and withdrawal sickness (deprivation), and intrinsic as well as external motivations 
for seeking treatment (Deci & Ryan, 2008; Maslow, 1943). 
Rationale for Use of Narrative Inquiry Design 
Narrative research uses the stories told by individuals about their experiences as a 
source of knowledge. According to Reissman (2008), a narrative approach generates 
dialogue and clarification. It invites the audience to share in the lived experience of the 
participant from their emotional perspective. This richness offers a depth of analysis and 
a chronological vantage point unique to narrative method (Reissman, 2008).  
In this respect, a narrative approach was appropriate for the exploration of SUD, 
which is not an event, but a process that can begin at any point in time and unfold over 
the course of months and years. Other approaches were considered, but they were not 
well-suited to the focus of the study. A grounded theory approach was not chosen, as, 
according to Patton (2015), it is meant to “build theory rather than test theory” (p.110), 
and the purpose of this study was not to test or build upon theories regarding motivation. 
I did not select ethnography, as the focus of this study was not limited to the experiences 
of a particular race, religion, or ethnic group nor was it intended to generalize across 
populations. Interpretative phenomenological analysis can be used to explore the lived 
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experience of individuals, but phenomenologists explore the present moment, rather than 
what occurs over time. What was crucial to this study was to learn about the individual’s 
experience of the entire process of the disorder from onset and progression through 
motivation, treatment, and recovery, rather than at any single point in time. 
Role of the Researcher 
Riessman (2008) described the narrative researcher as a facilitator who uses the 
interview process to elicit detailed, personal accounts of the participant’s experiences. In 
this role, the interviewer moves from the position of listener to that of “active participant” 
(Riessman, 2008, p. 58). Mishler (1986) envisioned narrative interviewing as a 
collaborative event in which both the researcher and the interviewee impart meaning to 
the experiences of the participant.  
Regarding my role in the design and development of the study, I conducted face-
to-face interviews unassisted, using open-ended questions designed to generate the 
participants’ narratives. I had the interview questions reviewed by content and 
methodology experts for validity and consistency with the study’s intended focus. 
Feedback from these experts served to validate the sufficiency of the interview questions 
to answer the research questions. I also specified the criteria for participant selection as 
well as the strategies I employed to recruit participants. Finally, having secured 
authorization to proceed from the Walden University Institutional Review Board (IRB), I 
carried-out the collection and analysis of data and took the necessary steps to safely store 
data and disseminate the study’s findings. 
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Ethical Issues and Biases 
There were no professional issues that might have influenced the study with 
regard to conflict of interest or power differentials, as I did not know the sample of 
participants prior to beginning the study, and I did not have a referral relationship with 
local treatment providers that would have created a business incentive for their 
cooperation in recruiting participants. The participants were of the age of consent and 
therefore did not meet the IRB criteria for protected populations (HHS, 2016). However, 
I worked at an addiction treatment facility where young adults with opioid use disorder 
received treatment, and I developed some opinions and beliefs about the disorder. 
Therefore, I bracketed my beliefs and reactions by recording them before and 
immediately following the data collection process in a reflexive journal (see Josselson, 
2013). Finally, those who have a history of treatment in the facility where I was 
previously employed were excluded from participation. 
Methodology 
Participation Selection 
Target group. The target group consisted of individuals between the ages of 22 
and 37 (Millennials) who, at the time of the study, were participating in treatment for 
opioid use disorder. 
Sampling strategy. A sample consistent with the theoretical orientation of 
narrative inquiry is described as consisting of individuals for whom the study would have 
personal meaning (Riessman, 2008). The sample is selected purposively and can be a 
convenience sample in that recruitment may begin with personal contacts. Therefore, I 
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used a convenience sample comprising SUD clients participating in local treatment 
programs (Miles et al., 2013; Tindall, Smith, Flower & Larkin, 2009). As the sample size 
required by narrative inquiry is typically small, I expected to have access to an acceptable 
number of participants through this method alone. If necessary, I planned to employ 
snowball sampling, which is referral by participants (Smith & Osborn, 2004). 
Participant Criteria  
Narrative inquiry focuses on individuals’ experiences of the topic of study over 
time, and therefore the participants should have direct personal experience of the topic of 
study (Larkin & Thompson, 2011). For this reason, only individuals who were engaged in 
treatment for opioid use disorder and who met the following criteria were considered for 
participation in the study. These were individuals who (a) are between the ages of 22 and 
37, (b) meet the DSM-V for opioid use disorder (severe), and (c) have had at least two 
prior treatment experiences in the course of their illness (not including the current 
admission). Prior treatments may have included detox, but detox alone will not qualify as 
a treatment experience. Additionally, while it is not uncommon for SUD to co-occur with 
a psychiatric illness, those with co-occurring disorders were not considered because the 
complex nature of their illness sets them apart in experience from those with a primary 
diagnosis of SUD alone (Inaba & Cohen, 2014).  
Sample Size and Rationale  
Guest, Bunce, and Johnson (2006) established that data saturation with a 
homogeneous sample occurs at around 6 participants, and thematic saturation occurs at 
around 12 participants. Small sample sizes are often typical in narrative inquiry due the 
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detailed analysis inherent in this approach (Smith, 2004). Therefore, I planned to recruit 6 
to 12 individuals for this study.  
Procedures for Recruitment 
As I was employed as a clinical supervisor in an outpatient SUD program at the 
time the study was conducted, I had developed a roster of contacts with clinicians who 
worked in local treatment centers. I contacted the directors of these programs and 
requested permission to address their clinical staff regarding my study and my need for 
participants. This was followed by a brief presentation describing the nature of the study 
and the criteria for participation when the cooperating programs requested one. Initial 
recruitment occurred through a flyer containing the selection criteria and my contact 
information. These were posted in the community area of the sober housing facility 
associated with each treatment program. Clinicians were asked to make their client 
population aware of the flyers. I planned to recruit additional participants, if needed, 
through snowball sampling, as this strategy is known to support inductive analysis (Miles 
et al., 2013). I screened all potential participants in person to confirm their eligibility for 
the study. At the time of the screening, individuals who met the criteria and wished to 
participate were provided a consent form and an overview of the purpose and procedures 
of the study (Smith & Osborne, 2004). The overview included information regarding the 
nature of the questions they would be asked and an explanation of their rights to 
confidentiality. In the event someone overlooked the exclusionary criteria and presented 
for screening, an explanation of the ethical and medical reasons for excluding those who 
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had a co-occurring diagnosis or who were pregnant would have been provided to avoid 
stigmatizing such individuals. 
Instrumentation  
The use of interview guides is not common practice in narrative inquiry (NI) as 
the intent of this approach is to allow the participant to share without the controlling 
influence of the researcher. Jovchelovitch and Bauer (2000) suggest this process of 
storytelling arises from a self-generating schema, which follows a tacitly understood 
format consisting of three distinct characteristics. The story, then, will (a) include enough 
detail to render the narrative plausible for the listener, (b) be recounted from the fixed 
viewpoint of the speaker, and finally, (c) follow a temporal sequence that includes a 
beginning, middle, and conclusion. This is not to say that narrative inquiry (NI) is devoid 
of structure, but instead the structure is imposed on the researcher rather than the 
participant. Ultimately, the goal of the interview is to allow the participant to relate their 
story naturally and spontaneously without attempts to lead or guide them towards desired 
topics or material (Jovchelovitch & Bauer, 2000).  
Once the participant was effectively prompted to share his/her story, I engaged in 
the process of observation and active listening. I communicated my attention and interest 
in the narrative non-verbally by nodding and maintaining open body language (Joselson, 
2013). I allowed the participant to continue without interruption and only inserted 
occasional questions for the purpose of clarification. While listening, I sustained 
awareness of the tone and cadence of their delivery. Facial expression, eye movements 
and posture, were be noted, as these non-verbal cues can communicate a great deal 
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regarding the affective content of the narrative and the participant’s internal process of 
recounting their story (Patton, 2015).   
Interview Guide  
As narrative interviewing is more about listening than talking, I prepared open-
ended interview questions with probes rather than a lengthy interview guide. The probes 
were used to encourage the participant to elaborate on a given topic and therefore 
changed with each narrative as needed. The interview questions that follow include 
examples of such probes:  
1. I’d like you to share with me what is was like for you when you first started to 
use mood-altering substances. What got you started? 
a. Can you tell me about what it was like early on? What was a typical day 
like? 
b. Tell me about the people you spent time with. What would you 
typically do with your friends? 
c. Tell me about how you took care of yourself (i.e. regular meals; place 
to stay; something to do) 
d. How did your substance use change after your early experience –  
i. How did you spend your time? What was a typical day like? 
ii. How did your relationships with family and friends change? 




iv. Tell me about what you noticed about yourself as your 
substance use increased- what was different? 
v. How do you take care of yourself as you were using more? 
How did you support yourself? Your drug use? 
2. Let’s move on to the time of your first admission.   
a. What were your reasons for entering treatment the first time?  
i. What was the biggest consequence of your drug that influenced your 
decision to seek treatment?  
ii. Was there another important consequence or event that influenced 
your decision to seek treatment? 
iii. What did that mean to you? 
iv. What had the least impact on this decision? the greatest? 
b. How did you find your first treatment program?  
i. What kind of help did you receive? From whom? Did you need to ask 
for help?  
c. Tell me about your first admission experience. What was that like? 
i. What was the physical pain of withdrawal like? What emotions were 
you feeling? 
d. Tell me about your reaction to treatment recommendations/rules in your 
first program.  
i. What made sense to you?  
ii. What did you refuse to follow? Why? 
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3. Now that I’ve learned about what you experienced before treatment, can you 
share something about what it’s been like for you during treatment and those 
times in-between treatments? 
a. What most attracts you to treatment? What holds you back? 
i. What aspect(s) of treatment feel helpful? 
ii. What stands out the most? Why? 
iii. What is another helpful part? 
iv. What feels useless? Why? 
b. Tell me about your relationships with your primary therapists.  
i. What was most memorable/affected you most?  
c. Tell me about your relationships with your peers.  
i. What was most memorable/affected you the most? 
d. What were your feelings about staying clean before your first treatment? 
This treatment?  
i. How did you define recovery then? Now?  
ii. How does abstinence fit into your recovery goals? 
e. Tell me about your relapse episodes. How have your relapses changed?  
i. in severity? in duration? in consequence? how soon after discharge?  
f. Why do you keep returning to treatment after relapsing? 
g. What most attracts you to treatment after a relapse? What holds you back?  
h. What do you have at stake this time is you don’t complete treatment?  
i. If you don’t stay clean?  
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ii. What do you know you will lose?  
iii. How has that changed over time? 
Procedures for Data Collection and Debriefing  
I conducted the interview sessions in a setting that promoted a sense of participant 
comfort and ease. The participant were engaged in outpatient treatment and housed in 
sober-living residences. With permission, I conducted the interviews in one of the 
administrative offices of these houses. Open-ended interviews typically require a long 
segment of uninterrupted time; therefore, I allotted 60 to 90 minutes time for each 
participant (Smith & Osborn, 2007). All interviews were recorded for later transcription 
and analysis. Participants were advised that the interviews were designed to be completed 
in one session; and that a summary of their transcript would be provided so they could 
review and provide feedback on accuracy and make additions and deletions within 2 
weeks of the interview (Colaizzi, 1978; Schwandt, Lincoln, & Guba, 2007). Immediately 
following the interview, I continued the process of noting my perceptions, emotional 
responses, impressions and interpretations in my reflexive journal, which was taken into 
account during data analysis.   
At the end of the interview, I thanked each participant for their honesty and the 
personal time they devoted in the interest of completing this study. Their contribution 
was acknowledged as key to this work as well as to future interventions that may build on 
findings from this study. Participants were given the opportunity to ask any remaining 
questions and provide additional comments that may have arisen but were not voiced 
during the interview. During the interview, I was alert to any signs that the participant 
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was experiencing any physical or psychological discomfort, such as excessive remorse, 
re-activated cravings for the drug of choice, or the resurfacing of suppressed memories of 
trauma, in which case I planned to notify the participant’s primary therapist for follow-up 
in the treatment setting. 
Additional treatment costs that may have been incurred by the client for this 
service, or acute emotional reactions that may have arisen that represented an immediate 
threat to the participant’s physical and emotional well-being, such as suicidal ideation or 
dissociation, would have been referred immediately to the local psychiatric mobile 
emergency unit (PMEU) for no cost assessment and treatment. A list of such resources 
was compiled and provided prior to the interview.  As a licensed professional, I was 
qualified to assess the need for emergency services and provide crisis intervention 
counseling until the PMEU arrives if needed. 
Data Analysis Plan 
The data was analyzed using the four-step categorical-content process described 
by Lieblich, Tuval-Mashiach, and Zilber (1998). The four steps I used to analyze the data 
included: 
1. Selection of the Subtext: Here all relevant sections of the text that address the 
RQs were marked to form a new file. This is the area that will be studied.   
2. Definition of the Content Categories: Categories provided the means for 
classifying pertinent information.  They were comprised of words, sentences, 
and groups of sentences. Most often they were principal sentences. The names 
of the categories originated with theory and at times emerged directly from the 
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data or a combination of the two. The categories were identified by name and 
defined. A circular procedure of comparing the categories with the data while 
re-reading the subtext occurred until the final categories and their definitions 
emerged. This back and forth process allowed me to determine which 
categories were initially used for the next step. 
3. Sorting the Material into Categories: At this stage, the words (including 
utterances), sentences, and groups of sentences were sorted into the categories 
from step 2. 
4. Drawing Conclusions from the Results: Here the contents from each category 
were used to separately and then together create a picture of the overall 
findings – the onset and progression	of	opioid	use	disorder	through	
motivation	for	treatment	and/or	recovery.	The	information	from	each	
category	was	grouped	and	ordered	by frequency to illustrate a sequence of 
how formative experiences shaped future decisions. 
The ATLAS.ti program was used to assist in the process of analysis and graphic 
representation of data software program (ATLAS.ti, 1999; Beck, 1993). ATLAS.ti is a 
software program designed for use in qualitative and mixed-methods analysis, which has 
the capability of identifying and calculating percentages of agreement among multiple 
coders. An audit trail diagram, which is a recommended method of demonstrating 
trustworthiness through a detailed representation of the data analysis procedures, was 
created using this platform (Patton, 2002). Additionally, the software’s 
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visualization function was used to organize the data and create visual representations for 
data presentation (ATLAS.ti, 1999). 
Issues of Trustworthiness 
Credibility 
Member checking. Credibility, i.e., confidence in the truth of the findings, 
corresponds to internal validity in quantitative research. Lincoln and Guba (1986) have 
identified member checking as one of the most critical techniques in establishing 
credibility for qualitative studies. Member checking, or respondent validation, can occur 
during or after the data have been collected (Kornbluh, 2015). After data was collected, 
participants were given a 1- to 2-page summary of key findings to review for accuracy. In 
the case of direct quotes that were included in the body of the text, the participant was 
asked to screen statements that would compromise their right to confidentiality under 
federal law (Confidentiality of Substance Use Disorder Patient Records, 2017). 
Triangulation. Triangulation involves corroboration from three different sources 
to support the trustworthiness of the analysis (Miles et al., 2014). One value in 
triangulation is that it exposes inconsistencies in the data, which offers the opportunity 
for deeper analysis of abstract concepts or a reconsideration of the phenomenon of 
interest (Patton, 2015). To accomplish this in my study, I used site triangulation by 
interviewing participants from three different treatment programs that were located in 
different geographical locations. This enabled me to compare collateral details (i.e., 
regarding treatment program components and local drug culture) from the narratives of 
the individuals in each group against those of the others. I also incorporated data 
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triangulation into the study by comparing the documentation from previous treatments 
with that of the current treatment providers (when it was available) and the participants’ 
narratives. This allowed me to compare specific details shared in the narratives against 
clinical documents for accuracy and consistency (Shenton, 2004). 
Validity. Validity in quantitative research is achieved by minimizing bias through 
rigorous controls and maintaining professional distance from the subject (Patton. 2015). 
The reverse is true in qualitative analysis, where the validity of findings is increased 
through prolonged contact with participants (Lincoln & Guba, 1985). Therefore, in NI, 
neutrality is expected to be reflected in the data rather than researcher. Credibility in 
qualitative data is subject-oriented and not derived through a priori interpretation by the 
researcher (Guba, 1981). I achieved prolonged contact with my participants through face-
to-face, unstructured interviews. The interview schedule was designed to minimize time 
constraints that may have put pressure on the participants to respond quickly.  
Transferability. Transferability is not always guaranteed in qualitative research 
due to the uniqueness of the data, which is often collected in naturalistic settings and 
consists of accounts of subjective experience. Thus, Guba (1981) asserted that 
transferability is the concern of the researcher who wishes to apply qualitative findings to 
their choice of population or setting, and the only responsibility of the original researcher 
is to provide enough detail to allow for comparison. Therefore, I provided this level of 
detail in my study at a depth and breadth sufficient for the reader to determine if the 
findings would apply in their choice of setting. Detailed descriptions of the study’s design 
and analysis of data will facilitate replication of the study in other settings. It is not 
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necessarily the intent of qualitative research to produce data that generalize; however, 
repeated replication of the study with alternative groups may produce results applicable 
to other populations (Pietkiewicz & Smith, 2014). 
Dependability and Confirmability 
Audit trails. Lincoln and Guba (1986) identified audit trails as a means of 
establishing both dependability and confirmability. The audit trail provides the 
information necessary for objective parties to ascertain, through an audit inquiry, that the 
findings of the study are indeed grounded in the data (Bowen, 2008). Drawing from 
Halpern’s (1986) six categories suggested for a thorough audit trail, I provided detailed 
information about the design and implementation of the study and interview protocol, as 
well as raw and processed data. Additionally, an audit trail diagram provides a useful 
representation of the data analysis procedures, which I created using the ATLAS.ti 
software program (ATLAS.ti, 1999; Beck, 1993). 
Reflexivity. Shenton (2004) has raised the issue of objectivity with regard to 
confirmability in qualitative research. Objectivity is often established by qualitative 
researchers through a process known as bracketing, whereby preexisting experience, 
knowledge, or assumptions are noted and set aside at the onset of the interview process. 
Chan, Fung and Chien (2013) questioned the ability of any individual to be completely 
objective and aware of the personal factors that might impact objectivity. To that end, 
they recommend the process of bracketing should occur in advance of the actual data 
collection and through the analysis with the practice of reflexivity. Finlay (2002) asserts 
that reflection should begin with the conception of the research project when identifying 
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a topic of interest and the personal connection that topic holds for the researcher. This 
continues through the effort to maintain awareness of the assumptions and expectations 
brought into the interpretive process of data analysis, as validity is often judged by the 
researcher’s ability to explain how these interpretations were reached (Mauthner & 
Doucet, 2003). I began this process by documenting my expectations, beliefs, and 
personal experiences with SUD in a reflexive journal (Josselson, 2013). In this way, I 
entered into the process of data collection prepared with a higher level of awareness of 
my reactions to participants’ stories (Josselson, 2013). These personal reactions and 
impressions were noted in my journal directly following the interview, and this 
information was considered during data analysis.   
In addition to my engagement in the process of reflexive journaling, I entered into 
this study having had the benefit of clinical supervision, which was a requirement of my 
position. This allowed me to continually examine my feelings, reactions, and beliefs 
about SUD and/or any specific client. I believe this practice deepened my self-awareness 
as well as strengthened my powers of reflexivity and thereby enhanced my objectivity 
with regard to this study. 
Ethical Procedures 
Upon approval of the IRB (approval number: 02-28-19-0159633), I conducted the 
study. All participants were invited to participate via an invitation from clinicians at 
local, state-licensed treatment facilities. Initial contact with me was completely voluntary, 
and no direct solicitation by me or intrusion of privacy occurred. I provided each 
potential participant two forms prior to the interview, allowing time for completion and 
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clarifying questions. The consent form included information about any possible risks 
associated with participation, as well as the procedures I planned to take to ensure 
participants’ confidentiality. The form clearly explained that all participants were entitled 
to withdraw from the study at any time during the interview and prior to dissemination of 
findings. As their emotional well-being was also paramount, I informed participants that 
while the interview process was not intended to be upsetting in any way, any issues that 
might arise would be addressed immediately. If the issue did not present an immediate 
risk to the participant’s psychological or physical well-being, it would be referred to their 
primary therapist to be addressed as a treatment issue. The release of information form 
(Appendix B) allowed access to their treatment records. This form clearly defined the 
participant’s rights to confidentiality under federal law (Confidentiality of Substance Use 
Disorder Patient Records, 42 C.F.R., pt. 2, 2017) and outlined limits to my access of their 
records as well as the date upon which the release would automatically expire.  
I kept the participants’ identities confidential using alphanumeric identification 
codes. Any other identifiers, such as treatment program names or locations were replaced 
with generic labels. Those who participated in the study were asked to provide written 
permission to have their interview recorded. As the confidentiality of those in treatment 
for SUD is protected under federal law, I took extra measures to ensure that any details of 
the participants’ experiences in active addiction and treatment that might reveal their 
identity would not be included in the transcripts 
Hard copies of data were kept in a locked file, and digital data was stored on an 
external hard-drive, which I removed after each session and placed in the same locked 
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file. During the transcription process all processing took place on one laptop that was 
password protected and not physically accessible to any individual other than me. 
Following the completion of the study and dissemination of the findings, I returned the 
data to locked in the file, where it will continue to be stored for a period of five years, 
after which it will be destroyed. 
Summary 
In Chapter 3, I explained the rationale for my choice of narrative inquiry to 
explore the experiences of young people diagnosed with SUD. Issues such as ethical 
concerns were addressed, and the specific methodology was outlined. Plans for 
recruitment were discussed as well as the ways in which I would develop my 
instrumentation and account for its validity. Finally, the data collection and analysis 
procedures were provided, along with the processes I used to inform and debrief 
participants at the opening and closing of the interviews. Chapter 4 describes the results 





Chapter 4 - Results 
Introduction 
The purpose of this study was to explore the experiences of young opioid users 
and their perceptions regarding addiction, treatment, and recovery. The intent was to 
understand the role of the young addicts’ experience in their readiness to seek help 
through treatment. Maslow’s theory of human motivation (1943) and Deci and Ryan’s 
self-determination theory (1985) guided the interpretation of these experiences. This 
study focused on the participants’ emotional and cognitive processes activated during two 
key stages: (a) their process of becoming internally motivated for treatment, and (b) the 
onset of internal motivation to recover. 
This chapter describes the procedures used in conducting this study, beginning 
with a description of the setting, the general demographic profile of the participant pool, 
and a brief description of each participant. The data collection and analysis process is 
presented in detail, along with graphic displays of data and supporting excerpts from the 
transcripts. Any necessary deviations from the recruitment strategy are explained and any 
unexpected circumstances are described. Finally, issues related to trustworthiness are 
reestablished and the findings discussed in response to each research question. A 
summary and introduction to Chapter 5 will close Chapter 4.  
Setting 
The study was conducted in the counties of Monmouth and Ocean in New Jersey 
and in Philadelphia, Pennsylvania. The interviews took place in sober living quarters 
where clients live while they are participating in treatment. The sober living facilities 
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featured common areas and offices that allowed me to conduct the interviews privately 
without intruding on the participants’ personal living quarters. White noise machines 
were placed at the door of each interview room as a cautionary measure to guard against 
violation of the participants’ legal rights to confidentiality. There were no conditions in 
evidence at the time of data collection such as changes in personnel or funding that would 
have impacted data collection or interpretation. 
Demographics 
The population of interest for this study comprised men and women between the 
ages of 21 and 37 who had a primary diagnosis of opioid use disorder, severe (see 
American Psychiatric Association, 2013). Six of the eight participants were recruited 
using a flyer indicating the selection criteria and my contact information. These were 
posted in the community area of the sober housing facilities that had agreed to serve as 
community partners. The last two participants were obtained through snowball sampling, 
which occurred when one participant provided information regarding the study and my 
contact information to friends who were residing in sober residences in Florida.   
Changes to the Initial Recruitment Strategy.  
The initial recruitment strategy involved a face-to-face presentation of the study 
to clinicians following initial contact by e-mail or telephone with the clinical directors. 
This did not occur due to lack of availability of the clinicians during program hours. 
Therefore, flyers were provided to the directors who forwarded them to the sober living 
supervisors. When the response to the flyers alone was insufficient to meet the required 
sample size, I requested permission to address the communities in person, and this was 
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permitted in one location. I visited that location and met with the clients who were 
provided a brief overview and allowed time to voice their questions and concerns. This 
approach was well-received, resulting in the acquisition of four participants. 
Additionally, due to distance, the two participants located in Florida were screened and 
interviewed by telephone.  
It should also be mentioned that one of the community partners was experiencing 
a low census at the time I requested they post the recruitment flyer and closed shortly 
thereafter. This reduced my number of available recruitment locations by one. At this 
point, I explained the process of snowball sampling to the existing participants, resulting 
in the referral of the last two participants. An alphanumeric code based on interview 
sequence and location was assigned to each participant to protect their confidentiality. 
Brief Summaries of Participants 
P1N is a single, Caucasian, self-identified heterosexual male, age 21+. At the time 
of data collection, he was living in a men’s sober house in the area described with a 
primary diagnosis of opioid use disorder, severe, and a history of eight previous treatment 
experiences. At the time of the interview, he was involved in a medically assisted 
treatment program and had maintained program compliance for approximately 9 months 
at the time of data collection.  
P2P is a single, Caucasian, self-identified heterosexual male, age 21+. At the time 
of data collection, he was living in a men’s sober house in the area described with a 
primary diagnosis of opioid use disorder, severe, and a history of two previous treatment 
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experiences. At the time of data collection, he was involved in an outpatient program and 
had maintained abstinence for 90 days.  
P3P is a single, Caucasian, self-identified heterosexual female, age 21+. At the 
time of data collection, she was living in a women’s sober house in the area described 
with a primary diagnosis of opioid use disorder, severe, and a history of three previous 
treatment experiences.  At the time of data collection, she was attending an outpatient 
program and had maintained abstinence for approximately 45 days.  
P4P is a single, African American, self-identified heterosexual male, age 21+. At 
the time of data collection, he was living in a men’s sober house in the area described 
with a primary diagnosis of opioid use disorder, severe, and a history of five previous 
treatment experiences. At the time of data collection, he was involved in an outpatient 
SUD disorder program and had maintained abstinence for approximately 90 days.  
P5N is a divorced, Caucasian, self-identified lesbian female, age 21+. At the time 
of data collection, she was living in a coed sober house in the area described with a 
primary diagnosis of opioid use disorder, severe, and a history of two previous treatment 
experiences. At the time of data collection, she was attending an outpatient SUD program 
and had maintained abstinence for 30 days.  
P6P is a single, Caucasian, self-identified heterosexual female, age 21+. At the 
time of data collection, she was living in a women’s sober house in the area described 
with a primary diagnosis of opioid use disorder, severe, and a history of two previous 
treatment experiences.  At the time of data collection, she was attending an outpatient 
SUD program and had maintained abstinence for 6 months.  
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P7F is a single, Caucasian, self-identified heterosexual male, age 21+. At the time 
of data collection, he was living in coed sober housing in the area described with a 
primary diagnosis of opioid use disorder, severe, and a history of six previous treatment 
experiences. At the time of data collection, he was involved in outpatient counseling and 
had maintained abstinence for 1 year.  
P8F is a single, Caucasian, self-identified heterosexual female, age 21+. At the 
time of data collection, she was living in coed sober housing in the area described with a 
primary diagnosis of opioid use disorder, severe, and a history of five previous treatment 
experiences.  At the time of data collection, she was attending an outpatient SUD 
program and had maintained abstinence for approximately 9 months.  
Data Collection 
Data were collected in face-to-face interviews conducted solely by me, using an 
interview guide that I created for the study. Each interview took place at the participant’s 
sober living residence. The interviews took place in a private office with a white noise 
generator placed outside the door to provide an additional measure of privacy. The 
interviews were recorded on a digital recorder in a single session on separate visits to the 
residences, which took place over the course of 3 weeks. The interview times ranged 
from 45 to 90 minutes. Two of the interviews took place in a coed sober residence in 
Monmouth County, New Jersey. One was conducted in a woman’s sober residence in 
Philadelphia, Pennsylvania, and three in a male residence in that same geographic 
location. The two interviews of Florida residents were conducted by telephone. I 
transcribed the digital recordings verbatim into individual Word documents and 
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proofread against the original recording for accuracy. All identifying data were redacted 
to protect the participants’ legal rights to confidentiality (Confidentiality of Substance 
Use Disorder Patient Records, 42 C.F.R., 2017) and saved under the participants’ ID 
code. The resulting documents were uploaded into ATLAS.ti (1999) for coding and the 
creation of graphic representations of the findings. 
I converted the interviews to rough text drafts through dictation of the digital 
recordings into Google Docs using the voice typing tool. I exported the rough drafts into 
MS Word and saved them on my laptop, which is password protected. When I had 
converted all the interviews to text in this manner, I downloaded the digital files in 
Google Docs into an external drive and deleted the originals. I proofread each Word 
document while listening to the original audio files. I corrected errors caused by 
distortion in the dictation process, resulting in a verbatim transcript of each interview. 
Before proceeding further with the data analysis, I transferred the digital recorder to a 
locked file cabinet for safe-keeping, and I converted the Word documents into pdf files. 
I reviewed the pdf files for the purpose of identifying and redacting any names of 
individuals, treatment centers, and/or locations that might in some way compromise the 
anonymity of the participant. I saved the redacted document and printed two copies of 
each transcript, one for the purpose of member checking, the other for the first round of 
coding. I stored the participants’ copies in a locked file until they were distributed. 
During the period of data analysis, I also all notes and hard copies of transcripts in the 
locked file when I was not actively engaged in that process. 
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Variations in Data Collection  
Due to the distance between my location and the State of Florida, the screening 
session and interviews for the last two participants were conducted by telephone using 
Google Voice. This software allows recording of telephone conversations only through 
incoming calls and with advance vocal permission of the caller. Therefore, after the 
initial screening was completed, the participants were provided confirmation of their 
appointment and the telephone number for the Google Voice account by email and given 
instructions on how to place the call. With regard to the interviews conducted by 
telephone, no important or striking differences in the quality of interviews was noted. 
Data Analysis 
Coding Process 
Data analysis was accomplished using manual coding and ATLAS.ti software, a 
computer aided qualitative data analysis system (CAQDAS).  As I read the transcribed 
interviews, my interpretations and intuitive reaction with respect to the relationship of the 
narratives to the phenomenon of interest were noted in the margin of the documents. 
First-cycle codes were created that were derived from these initial impressions, using a 
descriptive coding process, and entered into the software code manager (Saldaña, 2014). 
The data were condensed through the extraction of relevant phrases, which were saved as 
quotations and linked to the codes. Pattern coding was used in second-cycle coding to 
identify more refined constructs within the data and were linked to the first-cycle process 
codes (Miles et al., 2014). This continued until I reached a point of saturation, whereby 
no additional concepts could be identified. The result was 13 codes and 71 sub-codes. I 
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created networks linking sub-codes to the first-cycle codes, which now served as code 
group names. ATLAS.ti allows the user to view code networks as concept maps and 
manipulate the display elements as a tool in conceptualizing relationships among codes. 
In doing so, I became aware of redundant codes, which I merged with others or 
eliminated. Codes that appeared to have been assigned in error were reassigned to more 
appropriate code groups. An example of a code network visual display appears as 
Appendix C: Perceived Benefits Network Tree.   
For example, the category of progression was changed to symptoms of SUD. Its 
13 sub-codes were condensed into 10 by combining illegal activity to support use and 
overdose into one code, which was renamed dangerous use. Emotional numbing and 
drug-seeking behavior were deleted because codes representing the same concepts 
already existed in other categories.  
Categories 
The final code list consisted of 10 code categories: external treatment motivators, 
family issues related to SUD, internal treatment motivators, perceived benefits of 
substance use, perceptions/misconceptions re: SUD, recovery support, relapse, symptoms 
of SUD, substance use history and treatment history. The sub-codes were reduced to 57 
and linked to the main code categories to create 10 code networks. Definitions of the 
codes and sub-codes, which were derived from the content of the narratives and current 
knowledge regarding SUD and illicit substances, were entered in the comments section of 
each code and sub-code. The final code list was output as an Excel spreadsheet and 
converted into an MS Word table (Appendix A). 
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When relationships between the code networks and the data were displayed 
visually in the network manager, patterns became evident, which were used to interpret 
the data with regard to the research questions and theoretical foundations of the study. 
For example, several of the codes appearing under the headings internal motivators and 
perceived benefits of drug use represent survival needs and deprivation states identified in 
Maslow’s theory of human motivation (1943). The symptoms of substance use disorder 
category includes conditions that lead to intrinsic motivation as described by Deci and 
Ryan (1985). A graphic representation of a simple code network and a code network with 
linked quotations from this study appear as Appendix C: Perceived Benefits Code Tree, 
and Appendix D: Internal Motivation Code Tree with Linked Quotations. 
Evidence of Trustworthiness 
Credibility 
Member checking. According to Guba (1981) neutrality in narrative interviewing 
should be reflected in the data, which is subject-oriented and not derived from the 
researcher’s interpretation. Credibility was established through respondent validation. At 
the conclusion of each interview, I debriefed the process with the participant by asking if 
they were comfortable that the questions they were asked and the amount of time they 
were given to relate their story was sufficient to accurately describe their experiences as a 
substance user. I also reflected on my understanding of their stories as they related to 
their process of motivation for recovery and treatment and asked for confirmation that 
they had been heard and understood. I explained that they would be provided a brief 
written summary of my findings along with a copy of a verbatim transcription of their 
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interview and that they were welcome to provide feedback on the accuracy of the 
documents with regard to content and interpretation.  
The transcriptions and summaries were provided to each participant within two 
weeks of each interview by encrypted email or delivered in-person. Three of the six 
participants who received emails responded with positive feedback and no revisions 
while the remaining three failed to respond. The two individuals who were provided their 
documents in-person reviewed them in my presence; they confirmed that the findings 
accurately reflected the intent of their narrative.  
Triangulation. Triangulation was used to support trustworthiness of data (Miles 
et al., 2014) and provide for a deeper analysis of the phenomenon of motivation (Patton, 
2015). This was accomplished in two ways, by interviewing participants from three or 
more sites in varying geographical locations and by reviewing documentation from 
previous treatment events to ensure accuracy and consistency with details recounted in 
the participants’ narratives. Comparing narratives from diverse geographical locations 
allowed me to compare details in the individual narratives against those of the same 
group regarding treatment program approaches and regional drug culture norms. Clinical 
records from current and previous treatments were made available with the respondents’ 
signed permission for the purpose of confirming the accuracy of the participants’ self-
report with regard to treatment duration, locations, and primary diagnoses.   
Validity. Lincoln and Guba (1985) advise that validity in qualitative research is 
achieved through prolonged contact with participants. My contact with the participants 
took place over several days and in various ways. I visited the treatment centers 
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following the initial recruitment outreach to meet potential participants, explain the 
nature of my study, answer any questions and allow them a chance to meet me in a non-
threatening and informal setting. I then spent time with interested parties in face-to-face 
screening sessions, during which I provided and explained the consent form and release 
of information. Those who resided in Florida were emailed these documents and 
interviewed by telephone. Each participant had the opportunity to discuss the forms and 
the format and general content of the interview until they confirmed that they were 
comfortable enough to proceed. The interview sessions were lengthy, lasting up to 2 
hours depending on the participant’s history. Each respondent was allowed as much time 
as they needed to share their story and were then debriefed to ensure that they were not in 
distress. The debriefing session also served to confirm that the interview questions were 
understandable and had allowed them to provide the information they felt was essential to 
their story. 
Transferability  
Transferability is enhanced when researcher clearly identifies the boundaries of 
the study (Shenton, 2004). This study explored the lived experiences of a group of 
individuals with substance use disorder (SUD) who fell within a narrow age range and 
who were participating in specific treatment settings. The study took place in one urban 
and two suburban locations in the Northeast within a 50-mile radius of each other and in 
a suburban setting in northern Florida. The Northeast differs from other regions of the 
U.S. in that it has a much higher incidence of heroin use. According to data from the 
National Survey on Drug Use and Health, the rate of heroin use by those over 12 years of 
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age in New Jersey and Pennsylvania exceeds the national average by 35% and 22%, 
respectively. States in the Southwest, such as New Mexico and Texas, fall below the 
average by over 50% (SAMHSA, 2017).  Recent research also demonstrates there are 
significant differences in opioid-related mortality rates based on demographics such as 
geographic location and socioeconomic status (Monnat, 2019). Ultimately, the 
transferability of results should be appreciated in the context of a study’s scope and 
delimitations, with the encouragement for subsequent studies to explore similar questions 
in different contexts.  
Dependability and Confirmability 
An audit trail was recorded in ATLAS.ti software program (ATLAS.ti, 1999; 
Beck, 1993) consisting of transcripts, codes, memos, code networks and network groups. 
The audit trail is available for visual display in the menu on the user interface screen of 
the research project, where each step in the process of data collection, coding, and 
analysis can be easily accessed and reviewed in detail. 
Digital audio recordings of each interview were included in the audit trail. The 
same interview instrument was used in all interviews, and all participants were debriefed 
following the interview session using the same protocol. Verbatim quotations were 
collected using the software interface and incorporated into the data analysis. A reflexive 
journal was maintained, which contained notes regarding my reactions throughout the 
interview and analysis process to guard against bias. My impressions and reactions were 
recorded and linked to data and codes using the software memo feature. My clinical 
supervisor was available to confidentially discuss and resolve issues arising from 
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counter-transference, which may have compromised my objectivity during the process of 
data collection and analysis. 
Results 
Research Questions 
RQ1: What do narratives of young opioid addicts reveal about their motivation to 
enter treatment? 
RQ2: What do narratives of young opioid addicts reveal about their motivation for 
recovery? 
While studying the relationships between the code networks and quotations, 
themes emerged with regard to the motivation processes of the respondents. Motivation 
for treatment is the beginning and recovery is the destination that is reached at the end of 
a long and arduous journey. Each substance user’s story was unique yet shared threads of 
common experience with the other respondents. These common experiences formed the 
themes upon which my interpretations were based. A graphic of the motivational 
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Research Question 1 
Theme 1: Substances as remedies. The first question was intended to elicit the 
circumstances of participants’ initial experience with a mood-altering substance and their 
emotional response. They all shared that they were in early adolescence, in the presence 
of friends or family, and found the experience to be positive. A common theme among 
the respondents was that the drug provided an immediate solution to their problems. They 
described the effect in the same way one might describe a romantic encounter, “I loved 
that stuff, I definitely fell in love” (P2P). They also related a sense of relief from painful 
emotions. One respondent explained “…it made me feel good to take away pain, and it 
was like, it's all right you know” (P1N). When asked for more detail, they described 
painful experiences or perceived flaws in themselves that were ameliorated by the 
substance. Some experienced relief from low self-esteem: 
P3P: Inside my head was always just very torturous to myself. I never liked what I 
looked like. I never liked what I sounded like. I didn’t like anything about me.  
P2P: I was, kind of like a fat kid, I didn’t mature fast. So, like, my self-esteem was 
damaged from a young age. The way I see it is, it was, like, a miracle drug. It took 
me outside of myself. I was able to laugh, and not care what anyone thought of my 
laugh.  
They also reported feeling less fear and insecurity, and relief of pain from childhood 
trauma or grief and loss issues: 
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P6P: I had this crippling fear and insecurity just knowing that [all the students in 
the school were wealthy, but not her]. So, the alcohol helped take away some of 
that fear, or at least hide it. 
P8F: It made me feel good. It made me feel excited, it made me feel, I don’t know 
if powerful is the right word? But it made me feel like, not this scared little girl that 
I was. And it made me wanna keep doing it. 
P5N: Yeah, well my grandfather had sexually abused me when I was a kid. But the 
alcohol, like made all that pain just go away.  
Some experienced an overall sense of well-being from the euphoric sensations of 
the substance, surpassing other activities they once enjoyed with the added benefit of 
blocking all unpleasant emotions: 
P1N: I liked it better than sex. I liked it better than you know you know, scoring a 
touchdown. Better than watching a movie, or whatever. It just made me feel, just 
unbeatable, impeccable, impregnable, I was flawless. I was the best, you know? 
Top of the world. It took away emotional pain. That's what I liked about it. Yeah, I 
didn't like to, I never liked to feel, you know? I didn't like any emotions. I didn’t 
like to feel humiliation. I didn't like to feel anxious or depressed. You know I felt 
like if I could feel like this all the time it would be awesome, you know? 
P6P: I didn’t know I was missing something until I did it. And then I was like, this 
is what has been missing my whole life. This is the thing that is going to make me 
whole. Cause I just never felt whole. And by doing that, I was like a whole person. 
And then I was “I need to do this every day to feel like a normal person”.  I guess 
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it just made me feel normal, or what my sense of what other people felt like who I 
saw as normal, you know?  
Theme 2: Tolerance—“Chasing the high.” I next asked about their ongoing 
experiences with substance use and the theme of tolerance emerged. Tolerance occurs as 
the brain adapts to the use of mood-altering chemicals, raising the effective dose of the 
drug. Addicts need to compensate for this by increasing the quantity and frequency of 
their substance intake. In the culture of substance abuse, this is known as chasing-the-
high. Two of the participants described it in the following manner:  
P1N: I never felt that same high like I did the first time. I'd say I was just using, just 
to maintain, you know? It's not like the first time I used it. I would always try to get 
to that, but I never could…it didn't take that much, much, longer until I was to the 
point where I was just doing it to feel normal you know? 
P5N:  I was just so addicted, yes. I just wanted more… it was just like it was really 
a good feeling at first, and then like I chased that feeling, and I wanted that feeling 
again, and I never found that feeling again, even like relapsing. I never found that 
feeling again (sigh). 
When I asked them to share about the impact of tolerance on their drug use, the 
language of their narrative shifted from pleasure-seeking and relief to pain and survival: 
P2P: But yeah, it was like definitely heroin was like survival. And that was how I 
was going to work, that was how I was going to wake up, eat, sleep. No at that time 
I felt like it was survival. It was almost like a survival instinct. 
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P7F: I knew that like I loved getting high and I loved doing dope, I still felt pain. 
Like it didn't, it wasn't making everything okay anymore. I was having to do more, 
and like I never had enough. 
They described becoming involved in dangerous use such as supporting their habit 
through illegal activity and overdosing from inconsistent schedules and dosages of drug 
use: 
P7F: I started to take his checkbook, and he never knew about the checks, and that 
went on for like six or seven months where I was able to forge a couple of checks 
and I was able to make it, you know? I would look at people that were going to the 
ATM and think about robbing them. 
P4P: Got drunk, met up with old friends. And they were doing a bag, and I did a 
quarter of a bag. Next thing I wake up, shirtless, in the ER, he carried me up 3 
flights of stairs, limp, and drove me to the hospital. He said if he didn't drive me 
and waited for the ambulance, I'd be dead. 
I asked them about the physical toll of tolerance, and they talked about 
withdrawal, or as they refer to it “dope-sickness:” 
P7F: And then I have, I need to get $30 every single day or I’ll start withdrawing. 
So, I needed three pills a day, so I didn't withdraw. But it doesn't work out that way. 
I'm normally dope sick for 2 days, and then I’d figure out a way how to make the 
hundred dollars, and then I’d do all the pills in one day. And then I'm sick for two 
days, and then keep doing that cycle.  
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P6P: I remember vividly the first time I withdrew; I went away with my mom to 
XYZ* Beach, and I brought some stuff with me, but not enough. I had no idea what 
I was in for. And I left the beach house, at like 4:00 a.m., because I was in such bad 
shape. 
P4P: I’m dope sick more than I'm high. It’s like, you gotta buy, I had to buy so 
much a week, cuz once you do it, you gotta keep doing... and I didn't realize what 
I was getting myself into until after I was like, there.  
Theme 3: External motivation and resistance. Dangerous use typically results 
in external motivation to enter treatment due to legal problems or family pressure. 
Resistance is often the reaction of the substance users when pressured to seek treatment 
before they are ready. Resistance may be expressed overtly by refusing treatment. 
However, in situations such as coercion from the legal system, treatment refusal is 
inadvisable, and resistance may not be overt. In these cases, the individual may engage in 
passive aggressive behavior once they are admitted, or exhibit compliance, while 
harboring the intention to return to drug use immediately upon discharge. Resistance 
reveals a lack of readiness for recovery and denial of the seriousness of the addict’s 
condition (Hachtel, Vogel, T& Huber, 2019). It is a vain attempt to exert control, when in 
fact, the substance user is rapidly losing control of his or her substance use and behavior 
in general (Gorski, 2009).  
When asked about the circumstances that brought about their first admission, 
several of the participants recalled agreeing to treatment because of legal issues or 
following an overdose: 
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P7F: No this was court-ordered. So, in order for me to go back to school, I had to 
complete a diversionary program. So that was my first introduction into a program. 
I did two programs, um, one was like an intensive outpatient program that I had to 
go to, and one was a one-on-one therapy program.  
P1N: Okay, I got arrested…the first time. And my mom's like “You should go into 
rehab before court date comes up, you know? It'll look good if you get into an IOP.” 
P5N: I had my first overdose and I woke up in the hospital and my mom was 
standing over my hospital bed crying and that was when I guess they realized that 
enough had to be enough and they tried to get me to go into treatment and I refused 
to go into treatment and I told them I would do an outpatient program and I did the 
outpatient program.  
All of the respondents agreed that they were not committed to recovery or willing 
to comply with most treatment recommendations when they were coerced into treatment. 
For example, when asked if she complied with any of the requirements of her first 
treatment, one participant replied [long pause] “I don’t think so. I have to be honest” 
(P6P). The responses of the other participants were similar: 
P6P: I took that as an opportunity [to detox], but without really knowing what I was 
signing up for. I was strongly motivated to withdraw from heroin, but not to do 
recovery. I was like “all right, I’ll get off the drugs” but I had no real reason to be 
abstinent, I remember the big thing was my 21st birthday was that September, and 
I was like, there’s nothing you people can tell me that will get me to sign up for not 
drinking on my 21st birthday. 
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P1N: All right, yeah, my mind still was on, when the justice system is off my back, 
I will go back to using, you know? I did my 30 days there and just pretty much said 
whatever they wanted to hear, you know, and I completed. The first day I was out, 
I was taking pills… 
P8F: I think it was partially me not wanting to get better, and so I would just fuck 
around and it was like a place to be. And then eventually, in one of them I realized 
that I could leave. Once I knew that I could AMA [leave against medical advice] 
from a place it was impossible to keep me. 
One participant who entered treatment following an overdose admitted she understood 
the value of treatment, but she still rejected it because she was not personally ready, 
P5N: Like I knew there was a better way. I knew that I had to want the better way. 
And I just, I just knew that I didn't want the better way yet. 
Theme 4: The cycle of relapse. I next asked about what happened after 
completing a treatment without being fulling committed. Without exception, they shared 
that they would achieve a limited period of abstinence followed by relapse. The cycle of 
detox/abstinence/relapse was repeated many times, adding to their sense of powerlessness 
and hopelessness. One participant described his relapse process: 
P7F: I had tried to quit 10 – 20 times, wholeheartedly. And I would tell myself, 
like, “After tonight I’m going to stop buying this.” And I would quit for 3 weeks, 
and I would do it again. And I would try all these different ways, and a month would 
go by and I’d be doin’ it again, and I just couldn’t believe it. here’s no way you’re 
gonna quit pills. I couldn’t, I couldn’t go three days without ‘em, two days without 
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‘em.  I felt so hopelessly addicted…there was no way I was getting off of pills, 
because I’d physically need ‘em. So, I started to realize that I had fucked, I had 
totally fucked my life up. 
Subtheme: Behavioral relapse and toxic relationships. I asked participants if 
they were consciously aware prior to using again that they were at risk to relapse. Two of 
the respondents were able to identify behavioral changes that, in hindsight, were 
predictive of relapse, 
P5N: And I completely lost my mind and I started acting-out on character defects. 
I got mad, I got resentful. I was like running my mouth all the time not doing what 
I was supposed to be doing and I was just on that relapse road. 
P8F: Yes! Yes! And also, shortly before I relapsed, I'd started stealing from like 
CVS and Walgreens again, which was a behavior from the past that was a sign that 
I was headed in the wrong direction. 
Several participants identified “toxic relationships” as the first stage of their relapse 
process. Some reflected on the way they had allowed relationships to continue, knowing 
they were unhealthy and contributed to their drug use: 
P3P: I just drank cuz I just want him to think I was perfect so I just I didn't do 
anything else. He was drinking too, just drinking. I was miserable. I hated him, but 
I couldn't leave him because I just didn't want him to be with anybody else, and I 
knew he would. 
P8F: And I was dating this guy who had just gotten out of jail and I had known him 
and been in love with him since I was 16. He was like one of the first people I ever 
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slept with and he got out of jail, and we started dating. And he was relapsing and 
was getting high, and I decided that I was going to get high too. 
P2P: I mean there's a big thing for like me, the struggle is female affection… every 
time I get out of treatment, when I have access to my phone the first thing I'm off 
to a female and chances are one of you is going to relapse and if not both of you. 
P6P: I met a guy in I.O.P., and I started using with him. I remember my 21st 
birthday. I was already using by then. I was drinking, and that led to drugs again. I 
was already full-blown at that point.  
Theme 5: Internal motivation—“Hitting a bottom.” “Hitting a bottom” (W., 
Bill, 1953, p.24) is a term used by recovering alcoholics and addicts to describe that stage 
in their illness where they are living in a state of deprivation and suffering that can no 
longer be relieved by alcohol or drugs, a state so low that there is nowhere left to go but 
up. When asked to relate what had finally transpired to end their cycle of relapse and 
motivate them to willingly seek treatment, the participants described their hitting their 
bottom:   
P2P: I didn't, I didn’t care at the time, I was just like so, so beat up on myself. I was 
starving, I was hungry, I was thirsty. I didn't think I was going to make it out of 
this. I was like all right this has got to be my bottom. I was like, I don't see me going 
any further down. 
P1N: It finally got to the point; you know. I remember I told my mom I was so tired 
of sleeping on the ground. I just wanted to sleep in a bed. And she asked someone 
she knew from AA to come and talk to me. He walked in and he saw the pills on 
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the table and he's like ‘How about you just do what you got to do, and then I’ll drive 
you over to over to the hospital.’ I was like, ‘You know what? That sounds like a 
good idea. I don't even know why I just wasted my whole twenties doing this. I 
can't take this anymore.’ 
P7F: And I remember the lady who was the drug counselor who was there said um, 
“Are you withdrawing” and I started crying as soon as she said withdrawing. I broke 
down crying. 
P8F: And they did all of these things to help me, and I kept using, and that got me 
to a place spiritually where I was just like really broken and willing. And I just 
woke up four months later still using, sick, and decided to get help. I came back 
completely beaten, and that was it. I got a sponsor that day. 
Subtheme: Hopelessness. Their descriptions of the cognitive and affective 
content of their experiences revealed several sub themes, such as feeling that despite 
being ready for help, they were beyond help: 
P7F: To me staying clean long term was like wearing all white and saying you're 
not going to get a crumb of dirt on it. I knew it might last a little bit, but I had tried 
so many times that I just knew it was impossible… there were times when we were 
using drugs in the beginning and he would say things like ‘I'm going to be a drug 
addict for the rest of my life,’ and I would look at him and be like ‘Well you're 
crazy, I'm gonna to get clean one day.’ Then I’d try to get clean and realize that it 
was impossible. And then I'd have to accept that it was impossible. 
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P8P: I felt defeated. Some of the times I was forced to, but you know a lot of the 
times I would just decide to go to treatment, but it just never helped. It never helped. 
P2P: And um, I was like there's no way I can get sober, I was like I don't know what 
sober is. 
Subtheme: Cognitive dissonance. When asked to share about their self-concept at 
this point in their story, they related sensing a contrast between their perceived potential 
and who they had become as a result of their addiction, which they believed contributed 
to their internal motivation as well: 
P7F: I believe deep down every addict, if you're a real drug addict with the disease 
of addiction, you do not want to use drugs. I don't think that you can want to do 
drugs and be an addict. I think that's what makes you an addict? It’s that you don't 
want to do the things that you're doing, and that there's one side of you that wants 
to do it, and one side of you that knows that this is not something you want to do, 
and we battle those two things. 
P4P: It was glimpses of who I knew I could be, but I was afraid to be that person. 
I was not supposed to fail in any way. Like it was expected for me to always succeed 
on a high trajectory at all times, and it kind of got to me later on in life. I had like 
that moment like, bro, you’re 30 years old. That 30-year-old moment. If anyone’s 
30 they know what I mean. You know what I mean? And in my sick mind, you’re 
30 and you’re doin’ the wrong thing… 
P6P: Yes, and at that point I was probably watching some of my friends starting to 
graduate from college, like here I was, completely flunked out of college at this 
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point. Cause like I went to Rutgers when I flunked out of West Virginia, and I 
completely screwed that up. You know, like I had nothing to my name, I had no 
car, no cell phone, nowhere to live, like I had nothing. 
P8F: Yeah, yeah, exactly! Like part of me knew that this wasn't the life that I was 
supposed to be living, but then the other part of me couldn’t see myself living any 
other way. 
Subtheme: Remorse. I asked them if the impact of their drug use on their 
relationships with family and close friends contributed in any way to their bottom. They 
answered by sharing the deep remorse they felt for the pain their addiction brought to 
their loved ones:  
P2P: [L]ike my family was with me and they were crying. My mom has gray hair, 
like I never noticed it, like she has gray hair now and everything. My Dad's getting 
old and I'm gonna be dead before they are the way I'm going. My brother was like 
‘I don't want to lose my only brother.’  And that sparked the fire in my head to like 
to want to get clean. 
P1N: I got to the point where I was thinking like I can't go on like this, you know? 
It started really bothering me. I was hurting the people around me…I can't be selfish 
and just think like I'm hurting myself because I'm really hurting a lot of my loved 
ones, you know? It really tore me apart. 
Research Question 2 
To learn more about their motivation for recovery, I first asked the participants to 
share their personal understanding of recovery.  
108 
 
Theme 1: Misconceptions regarding recovery. The participants’ responses 
revealed how little they had previously known about recovery leading up to and even 
beyond their initial treatment. They shared that prior to their first admission, they had no 
concept of recovery. They believed abstinence was the only alternative to drug use and 
that was intolerable” 
P7F: For my whole life I always thought that it was drugs or abstinence, and 
abstinence made me feel suicidal. 
P3P: Sobriety is hard for me. Like that irritable, discontented, uncomfortable 
[feeling], like that is like paralyzing. 
Several of them had been unaware that abstinence was even a necessary requirement for 
recovery, 
P6P: I really thought at that point that the drugs were out of my system and I was 
like good. I don’t need to listen now, like my problem is not deeper than just 
needing to take care of the physical side of things, you know what I mean? 
R: Are you saying you believed you could just detox from heroin, and then resume 
the recreational use of other drugs, including alcohol, without any problem? 
P6P: Yeah, yeah, my life would be fine. Everything would go back to the way it 
was. 
When asked what they learned about recovery from treatment professionals, or in school-
based prevention programs, they responded:  
P6P: I don’t remember anyone even talking to me about drugs…period, nobody 
had discussed the disease of addiction. 
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P7F: Not a single doctor said, ‘You're going to be okay.’ Nobody came up to me 
and said ‘Oh, it's okay, you're just an addict.’ I had not even heard the word addict 
out loud. In the whole 7 days of detox nobody said, ‘you're an addict.’ 
They recalled friends that used drugs and never developed an addiction, “My 
friend did heroin and dropped it the next day, just never was a problem for him, he was 
able to do any type of drug drink whatever and then be fine and I’d be blown out of the 
water” (P2P), but they had had no prolonged, meaningful encounters with recovering 
addicts. When asked if, in their previous treatments, they had ever achieved the 
therapeutic goal of building a support network of recovering role models in their 
supervised attendance of AA or NA they responded: 
P3P: I just had no interest in it. 
P2P: I’d get a phone list and I’d toss it in the trash or toss it on my shelf. 
P8F: I wasn't like doing anything for my recovery. I wasn't, I would only go to 
meetings to get my meeting sheet signed, and I was like talking to lots of boys... I 
wasn't really in recovery, so I didn't really pick a fellowship. I didn't have a sponsor 
or anything like that. I would just go to whatever meeting was closest, and like I 
might leave early. 
Theme 2: Treatment and recovery readiness. I next explored the ways in which 
their treatment experiences may have informed their understanding of recovery and 
recovery goals. When I asked if they could identify a relationship between treatment and 
their motivation to recover a common theme emerged. All participants asserted that they 
were not motivated to recover as a result of any specific modality or intervention, but 
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rather because they had reached a state of readiness that had little to do with treatment. 
One participant shared that even though he had completed what he felt was an ideal 
program, his motivation to recover was largely due to his attitude at that point in time:  
P4P: I was introduced to a program called the XYZ* Program which changed my 
life and [it] changed my life because they gave me structure. They gave me a true 
understanding of the 12 steps. 
R: If you had been offered a program like the XYZ* Program years ago, would you 
have gone? 
P4P: Absolutely not. 
According to the respondents, they sought treatment largely because of option 
reduction, as they no longer experienced any benefit from substance use and had no other 
coping skills, “I just like didn't want to do it anymore. I was like I hate it; I hate every 
time I get high now. I cry every time I get high now” (P3P). But once they were admitted, 
they had no idea of how to move on from addiction or what they could hope to expect. 
They simply wanted to feel better and they were willing to work towards that goal: 
P6P: I just wanted to wake up every morning and feel okay, you know what I mean? 
And I didn’t even know what that meant, because I never really felt that. But I just 
wanted to wake up and feel okay, and not have to get high to get out of bed, and 
not have to get high to feel like a human being. I just wanted to be able to wake up 
and feel like a human being. Because I knew people like that existed, I just didn’t 
know how they did it.  
R: Did you believe it was possible for you? 
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P6P: I didn’t know if it was possible, but I wanted to try. 
The participants shared a common misconception in their earlier treatment 
experiences, which stemmed from a lack of knowledge about their illness. In the 
aftermath of many failed treatment attempts and relapse episodes, they realized that no 
amount of treatment could reverse the progression of their addiction and restore their 
euphoric response to substances. When they fully understood that continued drug use 
would only prolong their emotional and physical pain, they were ready to maintain 
abstinence from all mood-altering chemicals.  At this point they became receptive to the 
recommendations they had once ignored. This was one participant’s response when asked 
why she finally felt motivated to recover and follow treatment recommendations after her 
last relapse: 
P5N: I think it was different because I wanted it and I was more like, what’s the 
word, I was more susceptible? 
R: Receptive?  
P5N: Yeah, I was more receptive to what was going on and how to help myself. 
Like before I was just taking the bits and pieces in, like I was taking suggestions 
here and there but like I when I went to XYZ* if somebody told me to stand on my 
head in the corner I would have stood on my head in a corner. 
I asked them to share what they had done differently in their most recent 
treatment and how it motivated them to recover despite the hopelessness they had 
experienced during their bottom. Some were helped by reading 12-step program 
materials, “It instilled in me the importance of literature” (P8F). “And then when I started 
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to read the NA literature, that's when I started to see, holy shit, this is the one thing that's 
going to save me” (P7F). 
All built sober social support networks by attending their church or 12-step meetings, 
P1N: Yeah, yeah, I'm doing it the right way, that's the thing. I have my people. I'm 
really connected with the church. I'm going, I'm going to church. Me and my mom. 
We go to this church every week, and I have really, really, great people. They're 
just great kids, a great church you know? Good people I can talk to all the time, you 
know?  
P6P: In the beginning when I was struggling, I reached out to girls in the program 
for help and they helped me in those couple of months that I was in Florida. So, it 
was like I stopped using, I went to treatment, I went to meetings, and I kept doing 
that, and that was it. 
P7F: I started going to NA meetings, and I met people that are like 19 and 20. I’m 
like ‘Wow, I can’t believe I thought I'd never get clean. I can get clean.’ 
Theme 3: Connection and hope. I asked how they avoided relapse and 
maintained motivation to achieve their recovery goals during the initial, most difficult 
period of early recovery. They shared how becoming connected to a community of 
people who had achieved quality of life without using drugs had attracted and inspired 
them, 
P3: I see other people that are in recovery with 25 years or whatever, and they're 
happy and they have freedom. Like they're, they have freedom from their brain. 
Like from the way that their mind used to think.  
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P5N: I started to go to meetings, like it was a requirement to go to at least three 
meetings a week while I was in there, so I got introduced to the 12-step program. I 
saw it differently. I saw that I could live differently. 
P7F: And then they would start talking, and I couldn't help it feel close to these 
people. These people think the same way that I think.  They struggle with the same 
things that I struggled with. I knew they wanted to be there and were happy, and 
were serious drug addicts, and had found something to make them feel like they 
don't need drugs anymore and were now totally obsessed with this new high of 
living life that wasn't that wasn’t abstinence. 
Ultimately, they found role models for recovery and a connection to others that the filled 
the void left by their addiction. As one young man poignantly explained: 
P7F: I can feel the connection; I can feel what I call the magic of empathy. I felt 
more comfortable in a crack house than I did at school at 14 years old. There was 
something drawing me to these people my whole life. I just didn't know that there 
was a whole other subculture of the same people that were bettering themselves and 




Figure 2. A model of recovery motivation for young opioid users.  
Summary 
This study examined the experience of becoming motivated to seek treatment and 
recovery for “Millennials” diagnosed with opioid use disorder (OUD), a diagnostic 
subcategory of substance use disorder (SUD).  Eight individuals residing in recovery 
houses in urban and suburban areas in the northeastern United States and Florida were 
interviewed. The participants were asked to relate their story of substance use from its 
onset through their current state of abstinence and recovery.  
The first research question explored their process of becoming motivated for 
treatment and comprised the larger part of their stories. The narratives began with their 
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first experience of drug use, which they all described as having an immediate and 
profoundly positive effect with statements such as, “Right away I knew that this was it 
for me, I loved that stuff” (P1N), and “It's just the best feeling I ever felt. I wanted to feel 
like that all the time you know” (P7F). Substances that were used later in their stories had 
a similar effect. It is important to note that the reactions they described spoke of more 
than simple intoxication. When asked why the experience was so positive they shared a 
need or a perceived deficit that was filled or remedied by the drug such as, “It made me 
feel like, not this scared little girl that I was” (P8F),”‘It was, like, a miracle drug, it gave 
me the ability to talk to people” (P6P), “It just made all my pain go away, my emotional 
pain” (P1N), and “I guess it just made me feel normal” (P6P). 
The immediate relief of these pre-existing conditions underscores the powerful 
reinforcing effect of the drug and its impact on the developing brain’s reward pathways. 
Resulting changes in the dopaminergic pathways compel the individual to continue to 
seek out the drug in order to repeat the experience (Volkow & Morales, 2015). However, 
continued use of mood-altering substances inevitably leads to tolerance, a reduced effect 
due to a resetting of the hedonic set-point in the brain (Volkow & Morales, 2015). When 
asked about this stage in their drug use, they responded “I got a tolerance very, very, fast” 
(P1N), and “I needed them [oxycodone pills] every single day, so I tried to do as many as 
I could” (P7F). Such comments were present in every narrative.   
Ultimately, the drug user becomes caught in a downward spiral of seeking to 
repeat the original euphoric experience and in failing to so do, engages in an escalation in 
the amount and frequency of drug use. In the vernacular of the drug culture this is known 
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as “chasing-the-high.” I asked them to describe how this impacted their response to the 
drug and they shared, “I never felt that same high like I did the first time, I'd say I was 
just using to maintain,” (P1N), and “I was to the point where I was just doing it to feel 
normal” (P3P). 
When questioned regarding how they made sense of their increased tolerance, loss 
of control, and physical discomfort they generally responded that they had no 
understanding of what was taking place, “I had no idea what I was in for” (P6P). They 
also denied having been educated about substance abuse, “I don’t remember anyone even 
talking to me about drugs…period” (P6P) and had no understanding of physical 
dependence and withdrawal, stating, “People would say ‘Oh I’m withdrawing’ and I 
wouldn’t even understand what they were talking about” (P7F), or “At this time, I'm 
thinking I have like the flu” (P4P). 
The participants were asked to recall any negative consequences they experienced 
during this stage. They recounted arrests and overdoses, resulting in external pressure to 
enter treatment from the legal system or family members who recognized the seriousness 
of their drug use and tried to intervene. When asked if these consequences had any 
impact on their awareness of the progression and gravity of their disorder, they admitted 
being mostly in denial, responding to those who tried to help them, “Oh you guys are so 
stupid, you don’t even know what you’re doing, there’s nothing wrong with this” (P8F), 
and “I don't have a drug problem, I don’t know what you’re talking about” (P5N). 
Despite the participants’ resistance, legal and family coercion led to their first 
treatment. When asked about the circumstances that brought about their first admission, 
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several of the participants related a situation where they agreed to treatment because of 
legal issues or an overdose, “This was court-ordered. I got arrested and my mom's like ‘ 
It'll look good if you get into an IOP’ ”(P1N), and “I had my first overdose and they tried 
to get me to go into treatment” (P5N). 
When asked about their state-of-mind regarding treatment at that stage of their 
illness, they generally admitted they were (a) not prepared for what they were about to 
experience, (b) not committed to recovery, (c) had no intention of maintaining complete 
abstinence from all mood altering chemicals, and/or (d) were not convinced they needed 
treatment despite evidence of dependency and loss of control. For example, when one 
participant was asked why she entered treatment if she intended to continue drinking 
alcohol upon discharge she responded, 
“I was strongly motivated to withdraw from heroin, but I had no real reason to be 
abstinent” (P6P). 
In discussing their response to treatment that resulted from coercion, all of the 
participants reported they were noncompliant with treatment and discharge 
recommendations following coerced treatments. Their attitudes regarding the treatment 
experience itself varied, and in some cases were positive, even though they had no 
intention of complying with discharge recommendations: “It was a real nice place. I liked 
that place. But I just did my 30 days and said whatever they wanted to hear. The first day 
I was out, I was taking pills” (P1N). 
Regardless of their attitude towards treatment, ultimately the result was the same. 
When asked about the outcome of coerced treatment events, all participants reported 
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relapsing and experiencing a reactivation of the cycle of drug use and withdrawal until 
they arrived at their “bottom,” a place where they surrendered to the reality that they 
could no longer expect to feel any pleasure or relief from using drugs, “I was like all right 
this is got to be my bottom. I was like, I don't see me going any further down” (P2P). 
This was a critical point in their story where they reported a shift in motivation 
from external to internal. All agreed that this “bottom” is different for each substance 
user and that willingness cannot be forced or expedited by external pressure. One young 
woman explained, “I couldn't be forced to get the help that anybody wanted me to have. 
You can’t force that. Everybody's bottom is different” (P5N). Her statement underscored 
a common theme throughout the narratives: it is an individual’s readiness to accept help 
rather than any specific treatment modality or intervention that is the key to experiencing 
a positive outcome.   
The second research question dealt with motivation for recovery. When asked 
about how they became motivated to recover, the participants’ agreed that they began the 
process of recovery as soon as they let go of the belief that they could return to their 
earlier level of drug use and acquired an attitude of openness towards the suggestions 
offered in treatment, “If somebody told me to stand on my head in the corner I would 
have stood on my head in a corner” (P5N). From that point on, they reported being 
prepared to do whatever was necessary to move past the pain and struggling of active 
drug use. Therefore, their motivation process for recovery was less about being motivated 
to recover and more about realizing what was meant by recovery, that recovery was more 
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than abstinence and that it could replace the role that drugs had played in their life but 
without the negative consequences.  
The respondents’ stories revealed a process that consisted of three stages. The 
first involved developing an understanding of recovery by witnessing it in others, “I got 
introduced to the 12-step program, I saw it differently. I saw that I could live differently” 
(P5N).  The second was realizing it was possible for them to recover, because those in 
recovery were simply addicts like themselves who had found a way to live a quality of 
life without drugs. As one participant explained: 
(P7F): The majority of the people I met in the 12-step program that I went to were 
serious drug addicts, had found something to make them feel like they don't need 
drugs anymore and were now totally obsessed with this new high of living life 
that wasn't abstinence. 
These first two stages led to the third and final stage, which was being willing to 
adopt lifestyle changes that support recovery so they could achieve that same quality of 
life they witnessed in others: 
(P7F): I’m like wow, I can’t believe I thought I'd never get clean. I can get clean. 
I'm going to do whatever these people tell me to do, and I hope to God that I'm 99 
years old still going to meetings. 
Role models for recovery were found in AA and NA meetings, in their faith 
communities, “And I see other people that are in recovery with 25 years or whatever, and 
they're happy and they have freedom” (P3P). Once engaged in the process of seeing 
recovery modeled by others like themselves and becoming hopeful that they could 
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recover, their motivation for recovery was channeled into positive behavioral change, 
“The way I do it is I just pray to God every day, and like so far I've been doing things that 
I never done before, I got a commitment; I chair a meeting in May. January, February, 
March, April, May, that’s something I’d never do. I actually got a home group.” 
Interestingly, these individuals who existed for years as compulsive pleasure-seekers 
unable to delay gratification, acquired the strength to maintain abstinence throughout the 
painful and arduous process of acute and post-acute withdrawal for a future goal they 
now believed was achievable. In the words of one young woman who had recently 
celebrated 45 days of continuous “clean time,” “I just kept telling myself like, don't leave 
before the miracle happens” (P3P). 
Transition 
Chapter 5 will present interpretations of the results guided by the theoretical 
framework that informs the study. Limitations and strengths of the study will be 
discussed, and recommendations for future research suggested. The study’s potential for 
effecting social change will be presented at the close of the chapter. 
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Chapter 5: Discussion, Conclusions, and Recommendations 
The purpose of this narrative study was to explore the lived experiences of 
Millennials with a diagnosis of opioid use disorder in order to learn what motivates them 
to seek treatment and recovery. Eight recovering individuals between the ages of 21-37 
living in the eastern United States shared their personal journey from the onset of drug 
use through recovery. This study addressed a gap in the literature with respect to 
motivation for treatment and recovery in a demographic that differs greatly from previous 
generations of opioid addicts (Fleury et al., 2016; Kelly et al., 2014). Additionally, the 
study extended the knowledge of intrinsic and external motivation and behavioral health 
outcomes and affirmed previous findings that intrinsic motivation is predictive of 
engagement in treatment and positive treatment outcomes in this specific sample.  
Summary of Key Findings 
Participants agreed that their motivation for treatment was generated by their 
personal experiences of pain and hopelessness, and that readiness to accept help could not 
be forced. While each individual shared a motivation process that was unique, there were 
commonalities among the narratives of all participants, which included isolation from 
loved ones, shame, deprivation, and physical suffering. During the progression of their 
illness, they were coerced into treatment repeatedly as a result of legal issues or family 
pressure. All reported relapsing to substance use immediately or shortly after discharge. 
Participants reported noncompliance during coerced treatment, sharing that they allowed 
themselves to be admitted to programs with full knowledge that they had no intention of 
maintaining abstinence after completing treatment.  
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When they were intrinsically motivated for treatment as a result of what they 
described as their bottom, they integrated the goal of recovery and readily complied with 
treatment recommendations.  While it is clear that the external circumstances which lead 
to “hitting a bottom” were different for each participant, the one experience they did 
share is key to understanding their process of developing intrinsic motivation. That 
common experience was the realization that they could no longer find relief from their 
pain through the use of mood-altering chemicals. This left them with few options other 
than to accept the help they had resisted in active addiction. As a result of this new level 
of awareness, they became willing to maintain abstinence despite the discomfort of 
withdrawal and postacute withdrawal for a future goal of living a satisfying and 
manageable life without drugs. They shared that their interactions and relationships with 
others in recovery contributed greatly to their motivation for recovery by providing hope, 
support, and role modeling. Seeing that others were able to recover instilled confidence 
that they could as well. At the time of their interviews, all participants had maintained 
continuous abstinence for at least 3 months and were still actively and voluntarily 
involved in treatment programs.  
Interpretation of the Findings 
RQ1: What do narratives of young opioid addicts reveal about their motivation to 
enter treatment? 
Factors contributing to the development of motivation for treatment were 
explored by eliciting narratives of the history of their substance use from onset through 
current treatment. All participants shared that the initial euphoria associated with their 
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drug of choice diminished over time due to tolerance; tolerance is a neuroadaptive 
response to repeated exposure of the brain’s reward circuits to mood altering chemicals 
and is characteristic of physical dependency (Koob & Schulkin, 2018). Participants 
attempts to offset tolerance through dosage increase contributed to dangerous drug use 
and behavioral changes, which in turn led to negative consequences and related external 
pressures to enter treatment. All participants shared a history of at least one coerced 
treatment resulting from legal issues, hospitalizations for overdose, and/or family 
pressure. All initial coerced treatments resulted in a lack of engagement followed by 
relapse to substance use shortly after discharge. Similar findings were presented in 
previous research, which demonstrated an association between lack of internal motivation 
and low levels of engagement in treatment with reduced rates of retention (Brorson et al., 
2013).  
Internal treatment motivation was reported by all participants as occurring at a 
point when they found themselves in a state of emotional and/or physiological pain that 
could no longer be relieved by drug use. The development of internal pressure to seek 
help after “hitting rock bottom” was noted by Opsal et al. (2016, p.7). The average 
number of years that the participants spent in active drug use from age of onset to their 
current state of abstinence was 14.5 years. Therefore, the progression process that 
brought them to their bottom was a lengthy one in relative terms, as they had doubled in 
age by the time they became motivated to seek help. This aligns with previous studies, 
which found young substance users were less likely to enter treatment as a result of 
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coercion and more likely to identify internal motivation for seeking treatment as they 
aged (Goodman et al., 2015). 
Becoming internally motivated for treatment was described by participants as a 
single event that occurred at the lowest point in their addiction. However, when further 
exploring their narratives, it became evident that their motivational processes were 
actually a combination of internal and external events that occurred separately and in 
concert over the course of their disorder. Ultimately, the participants began to respond to 
mounting external crises with feelings of shame and desperation to the extent that they 
internalized the idea of their drug use as harmful. Thus, these emotions, while not 
intrinsically motivating, represented a shift from external to internal motivation, signaling 
the onset of integration (i.e., intrinsic motivation for recovery). Integration, in self-
determination theory, is the point at which an individual becomes aware of how an 
activity aligns with their internal value system and thus becomes intrinsically motivated 
to pursue it.  In the case of the participants, it became necessary to first experience a shift 
in their internal value system or, in some, a return to what they once believed to activate 
that motivation.  Similar examples of external motivation that transitioned to internal 
motivation in the course of treatment were reported by Cornelius et al. (2016). In a study 
of adolescent treatment engagement, clients’ motivation transitioned from external to 
intrinsic when they experienced support and feelings of relatedness with their caregivers 
and significant others. Conversely, the participants in my study developed intrinsic 
motivation in the isolation of their addiction, not through the support of others. When 
they reached a point-of-no-return and wholeheartedly accepted treatment, they became 
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open to the support they had rejected in the past. This was the point at which they 
experienced relatedness and connection to their caregivers and others in recovery and, in 
turn, became internally motivated to recover.  
RQ2: What do narratives of young opioid addicts reveal about their motivation 
for recovery?  
Participants’ motivation for recovery began to surface when they had successfully 
completed the detox phase of treatment. At that point they had sufficiently stabilized to 
participate in program components that were previously rejected or ignored.  All 
participants agreed they benefitted most from therapeutic and educational material they 
perceived as personally relevant. This response was similarly observed by Cornelius et al. 
(2016) in a study that demonstrated a positive relationship between clinicians’ support of 
clients’ personal recovery goals and client engagement in treatment.   
When asked to elaborate on the nature of the treatment components that enhanced 
their motivation for recovery, they identified individualized treatment plans and group 
sessions that were geared toward the issues that first compelled them to use substances as 
a coping mechanism such as social phobia, peer pressure, and unresolved grief. Such 
groups included refusal skills, which allows the client to practice assertive action in the 
face of peer pressure, education sessions on the neurobiology of SUD, and skill rehearsal 
for managing anger and social phobia. This supports the recommendations of Blonigen et 
al. (2015) who suggested that individualized treatment plans designed to address the 
specific needs that compelled the client to use drugs initially may result in increased 
recovery motivation. Participants were then asked to rank the characteristics they found 
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most appealing in clinicians; they identified warmth, mutual respect, and compassion 
above clinical expertise, professional credentials, or depth of knowledge. Their responses 
were comparable to those reported in a study by Wolfe et al. (2013) who found strong 
therapeutic bonds between clients and clinicians were predictive of higher levels of 
internal motivation. 
Treatment programs typically incorporate attendance at 12-step meetings into 
their therapeutic schedule and encourage clients to engage with others in recovery as a 
means of establishing and maintaining a network of social support. Participants who 
adhered to this recommendation experienced benefits from engaging with recovering 
addicts in stable recovery who engendered in them feelings of self-acceptance while 
serving as role models for positive behavioral change. Participants shared that they 
gained hope from these role models that a satisfying life in recovery was possible for 
them as well. This not only energized their belief that they could recover but inspired 
them to set immediate and long-term personal goals for their life of recovery. Such 
benefits were reported by Delucia et al. (2015) who found increased levels of positive 
self-regard and establishing and achieving meaningful goals were predictors of sustained 
recovery motivation and continued abstinence.  
Finally, participants shared that establishing relationships with others in recovery 
satisfied a need for connection and belonging, which in turn sustained their commitment 
to their program of recovery and ongoing abstinence. This association was demonstrated 
in a study by Litt, Kadden, Kabela-Cormier, and Petry (2009) who found that recovering 
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adults who develop social support networks as a result of treatment recommendations 
were more likely to maintain abstinence and involvement in therapeutic activities.  
Moreover, while Millennials differ from other addicts with regard to 
demographics, the latter stages of their motivational process for treatment and recovery 
are not entirely unique. The internal and emotional nature of the experiences that 
motivate them and their responses to those experiences are very similar to addicts in 
general. However, the external factors that lead them to the point of treatment readiness 
are quite different. One disparity is the comparatively long period of time it may take for 
them to seek help, which is, to a certain degree, a function of their level of development 
and their youth. With regard to the latter, in youth the discomfort experienced through 
repeated use of drugs and withdrawal is not compounded by the physical effects of aging, 
which allows the young addict to endure for a longer period of time.  
With regard to developmental issues, it is appropriate for emerging adults to reject 
ties to their family in favor of peer relationships. In the case of young substance users, 
these peers are fellow addicts, which supports, rather than discourages continued 
substance use. Additionally, in most instances, the developmental delays related to 
sustained substance abuse interfere with moving past the stage of strong identification 
with peer groups to the formation of committed romantic relationships and family-
building. Addiction further interferes with goal setting and attainment in the areas of 
education, career and stable employment. Therefore, unlike adults with substance use 
disorder who may have much to lose as a result of continued drug use, such as marriage, 
custody of their children, employment and material possessions, young people have 
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relatively little to lose. Furthermore, they eventually come to see themselves as so 
delayed in the achievement of such goals compared to their non-using peers that they 
often give up hope of moving beyond their current predicament. Therefore, unlike adults, 
the loss of what has been gained through hard work or the promise of a bright future – 
common sources of internal motivation for adults – do nothing to promote intrinsic 
motivation for treatment and recovery in young people with substance use disorder.  
Theoretical Frameworks 
Maslow’s theory of human motivation explains that the behavior of human beings 
is motivated by drive states that evolve from basic needs for self-actualization as each 
state is achieved. For the participants in this study, motivation for treatment came about 
as the result of a significant amount of emotional, psychological, and physical pain 
experienced over the course of months or years before they were ready to seek help; the 
internal and external consequences they experienced differed among individuals. Their 
histories varied with regard to their number of previous treatment admissions, the length 
of time they were in active addiction, the circumstances that caused their pain, and their 
level of tolerance for these negative experiences, but the nature of the process was the 
same in all cases. The participants described their progression as a transition from a state 
of profound pleasure and relief of all physical and emotional pain to a state of ongoing 
suffering and deprivation. This was similarly reported by Rigg and Ibañez (2010) in their 
mixed methods study of non-medical opioid users in Southern Florida, which revealed 
initial motivation for drug use is pleasure seeking but ultimately devolves into avoidance 
of pain from withdrawal. 
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All of the participants’ stories began with an initial intoxication experience that 
produced a level of euphoria unsurpassed by previous pleasurable experiences. In the 
words of P1N “I liked it better than sex. I liked it better than scoring a touchdown. Better 
than watching a movie, or whatever. It just made me feel, just unbeatable, impeccable, 
impregnable, I was flawless.” Intensely pleasurable experiences, such as opioid 
intoxication, are associated with other life-sustaining activities such as nourishment and 
procreation by the brain’s reward system, thus activating drug-seeking behavior (Volkow, 
Koob, & McLellan, 2016; Volkow & Morales, 2015). Drug-seeking behavior is therefore 
motivated by physiological and safety needs, which are found at the base of Maslow’s 
pyramid of needs. The compulsion to seek drugs is driven by the dopaminergic system, 
and increasing tolerance ensures that the drive is never fully satisfied. Tolerance occurs 
when an individual no longer experiences the same effect from the drug and must 
increase the dose, which signals the onset of progression. Progression is a clinical term 
used to describe the painful cycle of reduced drug effectiveness, withdrawal symptoms, 
cravings and loss of control that characterizes opioid addiction (Inaba & Cohen, 2014).  
One young man described his progression in this way: 
P1N: Yeah, it’s like, it slowly progressed. It’s like the progression, you know? I 
remember making a chart about this in one of the rehabs, you know? You’d see the 
progression, you know? The arrests, you know? Financial problems, family 
problems, it just slowly progressed… 
Engaging in tedious, demeaning, or dangerous activities to pay for drugs is a clear 
indication of the desperation experienced by the addict during progression as obtaining 
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drugs becomes a necessity rather than a pleasure. P2P described his heroin use in this 
manner “[A]t that time I felt like it was survival. It was almost like a survival instinct.” 
This participant’s description of his addiction reflects what Maslow (1945) characterized 
as a survival drive state motivated by deprivation as opposed to higher order needs, 
which are motivated by gratification. 
Several participants related the ways in which they financed their drug habit to 
avoid withdrawal sickness. P1N described his efforts to earn money by “scrapping,” 
collecting scrap metal from discarded appliances: 
I broke them down and I separated the aluminum and the copper because it was a 
lot more money if it’s separated. If you bring it all together at once it's like $0.03 a 
pound but if I separate the copper from the aluminum, the aluminum’s 50 cents a 
pound, the copper is $3 a pound. I had all the tools to do it I did HVAC for a while, 
so I had all the tools. I just broke it down in piles in my mom’s garage. It was like 
piles and piles of copper here, piles and piles of aluminum there. 
In a study of opposing drives, Guss et al. (2017) posited that behavior perceived 
as necessary for one’s survival is externally motivated as it falls within Maslow’s lower 
domain of safety. Treatment can be perceived as a place of safety by addicts, which may 
explain why individuals at times may initially appear motivated for treatment even when 
coerced. However, such motivation is typically accompanied by ambivalence toward 
recovery and usually results in relapse shortly after discharge. The participants’ 
motivation did not survive beyond the initial stabilization stage of detox when treatment 
was coerced or driven solely by relief of withdrawal.  As P6P explained:  
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I really thought at that point that the drugs were out of my system and I was like 
good. I don’t need to listen now, like my problem is not deeper than just needing to 
take care of the physical side of things, you know what I mean? Like I didn’t think 
it went deeper than that. 
Motivation did not emerge in a fixed sequence for any of the participants, but rather 
developed unevenly over the course of their illness. Participants related that even in their 
lowest moments, such as following an overdose, they experienced what are sometimes 
referred to by recovering addicts as “moments of clarity.” These may have been minor or 
profound realizations that there is, as P5P described “…a better way” even though, as she 
further stated “I just I knew that I had to want the better way. And I just knew that I didn't 
want the better way yet.” Such insights, though not sufficient to motivate behavioral 
change at the time they occurred, were recounted by several participants as significant 
contributors to their overall motivation process.  
One participant characterized these realizations in this manner: “[L]ike a seed 
being planted. And like that seed was planted while I was in there [outpatient treatment]” 
(P5P). This substantiates Rourke’s (2015) concept of motivation as dynamic and 
therefore subject to increases during treatment found in their study of legal mandates and 
perceived coercion. Findings revealed that even in the case of coerced treatment driven 
by external motivation, intrinsic motivation can develop through peer support and 
increased self-efficacy.  
In relating their experiences of hitting-a-bottom, the participants identified 
negative consequences beyond the physical pain of withdrawal such as loneliness and a 
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sense of regret about their status in life. These feelings contributed to their moments of 
clarity, which eventually accumulated to an extent whereby intrinsic motivation for 
treatment developed. This transition was driven by higher level needs such as 
love/belonging or self-esteem. A similar effect was reported by Guss et al. (2017) in their 
study of motivation in opposing drives such as deprivation versus gratification. Their 
findings revealed that external motivation is involved in resolving crises that threaten 
physical safety, while behaviors that satisfy the need for self-esteem are internally 
motivated. An example of integrated motivation to achieve higher needs was expressed 
by P7F in sharing his desire to reach his personal potential:  
Like I knew, I knew that if I was able to stay clean, that I could accomplish 
anything. Like I knew that I was smart, I knew that I was a hard worker, I knew 
that I would get in shape. 
It is important to note that the recovery process takes time. Following 
detoxification, post-acute withdrawal syndrome (PAWS) can continue to affect brain 
function for as long as 18 months (Gorski, 2009; Marlatt et al., 1988). PAWS negatively 
impacts memory, concentration, sleep, physical coordination and emotional stability 
(Gorski, 2009; Marlatt et al., 1988). As one participant explained, “At 3 months I wasn't 
going to do a packet. I wasn't working on my attitude; I wasn't going to think about… 
three months… it took me three months to just wake up” (P7F). 
Once the participants begin to think rationally, their motivation shifted from 
addressing physiological and safety needs to the higher needs identified by Maslow 
(1943). This is the point at which the participants began to experience motivation for 
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recovery.  When they willingly reached out to others who had achieved long-term 
recovery, they began to believe recovery was possible for them as well. As P7F 
explained: 
Age was not really a thing, but the fact that I saw a couple younger people made it 
made it feel like it was possible, you know. But what motivated me, was the 
connection with other people, that they had the thing that I had. And once I knew 
that these other people were doing it, it was like ‘I can get clean.’ 
Connecting with others in the treatment community and support groups, fulfilled their 
need for belonging and love. The recognition that they were “lovable” positively 
impacted their self-esteem. P5N experienced this when she realized her family still loved 
her despite her addiction: 
I had that moment of clarity where like when my girlfriend came through the door 
and she was like ‘listen your family's worried about you.” To know that somebody 
actually cared that much, and I actually cared that I cared? Like it all has to do with 
me. Like it all has to do with the feelings behind it.   
Participants shared that in hearing the stories of other addicts with sustained recovery, 
they began to see that they too could establish and achieve goals. After graduating to the 
outpatient level of care, P2P entered a vocational program to prepare for the carpenters 
union exam:  
Well, every other time I never invested my life. This time I went and took the 
Carpenters Union test I passed, um. I’m currently working on my test to get in the 
Carpenters Union in Philadelphia. So that is halfway done cuz you can only do 7.5 
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hours a day on it and it’s a 10-hour course. I bang out 5 hours a day. My brother’s 
been wanting me to get in the union for three years now. My brother’s been wanting 
me to get in the union for three years now. [Before I stopped using drugs] I knew I 
would never be able to live up to it, never. 
Self-Determination Theory  
Self-determination theory presents a humanistic view of motivation defined as 
that which energizes the individual’s efforts to reach potential (Deci & Flaste, 1995). The 
theory presupposes that healthy human beings are naturally inclined towards achieving 
personal growth and integrity. In the absence of pathology, human beings interact with 
their environment in a proactive manner, which supports their movement towards self-
actualization. In general, behaviors that are intrinsically motivated are enjoyable and 
rewarding and promote self-perceptions of competence. 
Humanists such as Rogers (1951) and Maslow (1943) viewed intrinsic motivation 
as an inborne trait of all human beings who experience a sense of enjoyment when 
engaged in activities that promote self-fulfillment. Deci and Ryan’s (1985) work was 
focused on understanding how motivation becomes diminished through social controls 
and how it can be reactivated (Deci & Flaste, 1995). Through their research, they 
identified varieties of motivation and their relationship to outcomes, particularly with 
regard to education and health.  
Introjected and integrated motivation. Behavior that is externally motivated by 
outside controls such as legal consequences result in introjected motivation. Introjected 
motivation may promote compliant behaviors but is not associated with positive 
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outcomes or long-term results. Participant P1N provided an example of introverted 
motivation when he shared his feelings about the abstinence requirements of probation, 
“All right, yeah, my mind still was on, when this is all done, when the justice system is 
off my back, I will go back to using, you know?” (P1N). All of the participants shared 
similar examples of compliance driven by introverted motivation when they recounted 
stories of their earlier, coerced, treatment experiences.  
As their illness progressed however, they began to regard their substance use as 
problematic, and became internally motivated for treatment. They understood that what 
they were going to face would be unpleasant; they did not believe there was a positive 
alternative waiting to replace their addiction, because they had never experienced 
recovery. Despite this, they accepted responsibility for their illness and their treatment 
with no expectation of enjoying the experience. This is an example of Deci and Ryan’s 
(1985) integrated motivation.  
Readiness to change self-destructive behavior needs to be accompanied by the 
awareness that to do so involves working through the issues that caused the pain or 
inadequacies that compelled one to use substances in the first place – but without the 
buffering effect of drugs. Undertaking this with a sense of autonomy, because one is 
ready to accept responsibility for change and recovery, is associated with prolonged 
engagement in treatment and maintenance of abstinence (Deci & Flaste, 1995; Ryan, 
Plant & O’Malley, 1995). P5N expressed her intention to work through painful issues of 
childhood sexual trauma in this statement: “I wanted to deal with the feelings for what 
they were, and I was tired like of numbing those negative feelings.” P7F demonstrated his 
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willingness to accept personal responsibility for a relapse, even though it was 
unintentional: 
I started to really like NA and at 60 days clean I drank with my whole family. I 
never thought that I had to stop drinking. And I told my sponsor that I drank, and 
he told me “Oh you relapsed.” And I was like “No, I drank alcohol.” And he's like 
“No, you relapsed.” And I'm like “I'm not an alcoholic, what am I supposed to never 
drink again?” You know what I mean? And my sponsor was like “You either want 
to get clean, or you're gonna go and get high.” And I was like “Well I don't want to 
get high; I want to be clean.” And he was like “You can't do both.” And I'm like 
“I'm not giving up my clean time.” And he looked at me and said, “You already 
did.” And um, I went to a meeting, I got a white key tag [token presented to 
someone at their first NA meeting or upon returning after a relapse.] 
These behaviors are evidence of integrated motivation, which was the variety of 
motivation the participants’ described when discussing self-referral to their last treatment 
program:  
P8F: I just wasn't sure that I could, that I was capable of being in recovery. But I 
was willing to give it a shot. 
P6P: I just wanted to wake up every morning and feel okay, you know what I mean? 
And I didn’t even know what that meant, because I never really felt that. But I just 
wanted to wake up and feel okay, and not have to get high to get out of bed, and 
not have to get high to feel like a human being. I just wanted to be able to wake up 
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and feel like a human being. Because I knew people like that existed, I just didn’t 
know how they did it.  
R: Did you believe it was possible for you? 
P6P: I didn’t know if it was possible, but I wanted to try. 
Competence and intrinsic motivation. Deci and Ryan (2008) asserted that 
although competence is a factor in extrinsic and intrinsic motivation, in the case of 
intrinsically motivated behavior, a sense of competence contributes to the enjoyment of 
any activity in which one is engaged. Participants described their failure to recover, 
despite repeated treatments, in self-critical terms, and some expressed that they had, at 
times, felt hopeless and incapable of recovering. This hopelessness rendered them 
disinclined to seek help and is an example how a perceived lack of competence can 
diminish motivation:   
P8F: Some of the times I was forced to, but you know a lot of the times I would 
just decide to go to treatment, but it just never helped. It never helped.  
P7F: I had tried so many times that I just knew it was impossible. 
P1P: I was like there's no way I can get sober, I was like I don't know what sober 
is, so I don't know what sober is. Yeah, I thought it was like it was pointless… 
However, what they had perceived as treatment failure was not due to a lack of 
competence. It is was a failure to engage in the process because they had not yet 
internalized the goals of treatment (i.e., abstinence and ongoing recovery), as is so often 
the case in coerced treatment (Cornelius et al., 2016). By their own admission, 
participants revealed that they had entered previous treatment programs for many reasons 
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other than to recover, such as detoxing to reduce tolerance, partial remission (i.e., 
abstinence from one/some but not all substances), to minimize the impact of legal issues, 
or to quiet the protests of family members and significant others. When the participants 
presented for treatment as a result of integrated motivated, they were successful in 
accomplishing treatment objectives and found that this sense of competence in turn 
enhanced their enjoyment of therapeutic activities. As one participant explained: 
P7F: Honestly, so, my whole take on it is if there's something you don't like in 
treatment it's just as therapeutic as something you like in treatment, because you 
need to learn how to deal with shit that you don't like, you know? I used to hate arts 
and crafts. I used to think that arts and crafts was the dumbest thing you could do. 
I was like, to me, like I’m a grown-ass man. I’m not doing no noodle necklaces. I'm 
not making drawings of butterflies in my timeline, I'm not going to make a paper 
mâché globe, you know?  And towards, like four months? You couldn't tell me that 
we weren't doing paper mâché globes. I was so excited to be making a paper 
necklace. I was so excited that we were going to draw our feelings on a piece of 
paper. I had bracelets up and down my arms, you know? These were things that I 
didn’t really like, that I learned to enjoy. I learned how to be a kid again. 
A feeling of accomplishment is a reward associated with intrinsically motivated 
behavior (Deci & Flaste, 1995). Treatment is not enjoyable, but meeting abstinence goals 
can foster a sense of accomplishment. The participants expressed pride in accrual of clean 
time, which is celebrated in 12-step meetings with refreshments, guest speakers, and the 
awarding of mementos such as pins, coins, key fobs, and other tokens: 
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P4P: I have 30 days, and for the first time I grabbed my token, I had it before me, 
and I'm, this is like a trophy, I likened it to a trophy. I won trophies as an athlete 
and I'm like okay that's good. Let's work hard and get another trophy.  
As the participants progressed in treatment, building support networks with others in 
recovery and repairing relationships with family members, they began to feel a sense of 
belonging and the re-establishment of connections with others.  
P6P: I remember that one time I relapsed in Florida and I called my mom, and it 
wasn’t like ‘you’re a scumbag’ anymore. It was like ‘I just want you to be okay’ 
and she was supportive and loving, you know? 
R: And that made a big difference? 
P6P: It did. 
P5N: Yeah, being here, I feel like this is my family.  
R: Do you feel connected to people again?  
Yeah, I feel connected and I'm happy again. 
P7F: …it changed the family dynamic to a point where my parents were kind of, 
my mom was encouraging. My sister was, kinda knew what I was going through, 
and were able to be a part of it. 
PF7: I didn't want to feel connected. When I went to those meetings I went there 
out of curiosity. I did not go there and wanting to feel like I was going to be a part 
of this place. And I would look at those people and I would say I have nothing in 
common with them? And then they would start talking, and I couldn't help it feel 
close to these people. These people think the same way that I think.  They struggle 
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with the same things that I struggled with. And then when I started to read the NA 
literature, that's when I start to see holy shit, this is the one thing that's going to save 
me. I knew… 
Limitations of the Study 
Because of a low response to recruitment efforts, the sample was limited to eight. 
This fell within the projected sample size but did not reach the desired total of 12, which 
may have impacted data saturation.  All of the respondents were living in or near two 
major cities on the East Coast and had lived there for most of their lives; their 
experiences and perceptions may be unique to the culture of these specific locations, 
potentially limiting the transferability of the findings. Individuals in early remission from 
SUD may be poor historians due to the cognitive symptoms of post-acute withdrawal 
(Marlatt et al., 1988; Shillington et al., 2012; Simon and VonKorff, 1995). Triangulation 
of site location and comparison of information from past and current treatment records 
was employed to support credibility. However, due to lack of response and/or objections 
by clinicians, access to these records was limited to diagnosis and treatment history dates 
and locations. Access to each participant’s bio-psych-social assessment would have 
provided additional details against which to compare narratives for confirmation of 
accuracy. 
Recommendations 
The results of this study underscore previous findings regarding the positive 
impact of internal motivation on behavior change and the value of autonomous support 
for clients while in treatment for opioid use disorder (OUD) (Cornelius et al., 2016; 
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Wolfe et al., 2013). A large body of research has demonstrated the relationship between 
internal motivation and positive results in healthcare (Deci & Ryan, 2008) as well as the 
futility of attempting to generate internal motivation through coercion (Deci et al., 1994). 
Future research should be directed towards finding ways to foster autonomous support 
and build alliance between clients and clinicians, as these two factors are positively 
correlated to treatment engagement and internal motivation for recovery (Cornelius et al., 
2016; Wolfe et al., 2013). 
A sense of urgency created by rising rates of opioid addiction and related fatalities 
in the past several decades gave rise to a wealth of research. A large portion of this 
research points to the ineffectiveness of conventional treatment approaches in emerging 
adults, the demographic that is most highly represented in recent opioid use statistics 
(Adams et al., 2014). However, when analyzing the course of this disorder in the context 
of the culture and developmental processes of young substance users, the problem 
appears to be one of motivation, not modalities. This perspective is supported by seminal 
research on human motivation (Deci & Ryan, 1995; Maslow, 1945) and recent literature 
as well (Brorson et al., 2013; Rourke et al., 2015; Urbanoski & Wild, 2012).  
Substance use disorders have been classified as independent disorder in the DSM 
since 1980 (Robinson & Adinoff, 2016). This classification is based on evidence of 
observable and consistent neuroplastic changes in the brain. However, it does not 
discount the many other environmental, sociological, psychological, and economic 
contributors to the disorder in the individual who is biologically predisposed to SUD 
(NIDA, 2018). It is this combination of contributing factors, which is unique to each 
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individual, that should inform treatment goals rather than a universal approach (Blonigen 
et al., 2015). The recognition and support of clients’ personal health goals have been 
shown to be the best predictors of prolonged engagement in treatment and adherence to 
treatment recommendations (Deci et al., 1994; Deci, 2008). 
Understanding what motivates young opioid users to seek treatment and commit 
to an ongoing personal recovery program could be used to encourage emerging adults to 
enter treatment despite past treatment failures. The findings of this study revealed that 
while the stages of the recovery process are similar in both populations, the motivational 
process for treatment and recovery does not follow the same course and timeline in 
emerging adults as it does in older populations. Millennials become internally motivated 
by the emotional and physical pain they experience from increased tolerance and 
withdrawal, rather the fear of the loss of relationships, employment and finances, as is 
typical of adults. This is because they have not yet had time to acquire such things due to 
their early onset of drug use and rapid progression to drug dependency. While their 
young age prevents them from acquiring recovery capital, it is also their young age that 
enables them to endure the physical rigors of heavy drug use for much longer periods of 
time than their older counterparts. Additionally, adults often have an existing support 
system that may positively influence their decision to seek treatment, but millennials do 
not. Young substance users do not develop such relationships until after they enter 
treatment and become committed to a lifestyle of abstinence and involvement in a 12-step 
support fellowship. It is at this point that they emotionally connect with others in 
recovery who have travelled the same path and experienced positive outcomes. These 
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individuals serve as positive role-models, giving rise to hope and an internal motivation 
to recover. 
Moreover, unlike adults, the entire process of becoming motivated and 
experiencing the motivational shift can occur over the course of several years and many 
failed treatment experiences, and each relapse poses a high risk of fatality due to 
overdose. Therefore, the goal of future research should be to expand the field’s 
understanding of how to identify and support the client’s transition toward integrated 
motivation. 
Implications 
Positive social change can result from improving the rates of treatment 
engagement and positive outcomes in emerging adults with opioid use disorder. The loss 
of life due to opioid abuse continues to rise, with estimates of over 130 deaths per day 
due to overdose reported by the Centers for Disease Control (2018). The total economic 
burden of opioid abuse in America due to incarceration and healthcare, loss of 
productivity, and treatment is an estimated $78.5 billion per year (CDCP, 2018). 
Research conducted in the past several decades has demonstrated a significant 
relationship between internal motivation and positive outcomes in behavioral health 
programs (Wolf et al., 2013). A large body of research points to the need for new 
approaches in the treatment of opioid addiction, citing the poor response to treatment in 




However, the participants in my study benefitted from conventional treatment 
programs once they were internally motivated to participate and stable enough both 
medically and cognitively to benefit from treatment. Participants further revealed that 
their motivation did not result from any specific treatment approach but occurred over 
time as a result of the progression of their illness and therefore could not have been 
forced or expedited. 
Despite the fact that motivation has been shown to be dynamic in nature and may 
actually change during treatment (Rourke; 2015), there is no guarantee it will improve. 
Indeed, the findings of a large body of research on motivation and behavior change in 
healthcare, including the results from this study, indicate that the motivation process is 
highly individualized and cannot be coerced or hastened (Deci & Flaste, 1995; Deci & 
Ryan, 2008). Therefore, channeling research efforts and funding into finding ways to 
increase motivation may not be the most expedient or efficacious approach to saving 
lives.  
An overriding issue with opioid addiction is the rapid onset of physical 
dependence to the drug and the relationship between dependence, tolerance, and overdose 
deaths.  This is exacerbated by earlier onset of drug use during critical periods of brain 
development (Behrendt et al., 2009; Marel et al., 2019).  Additionally, the risk of death 
increases when relapse occurs after treatment as detox reduces tolerance and raises the 
risk of overdose. Therefore, conventional treatment programs that begin with detox and 
require total abstinence may actually present a risk to those who are not fully committed 
to treatment and recovery and who intend to continue their drug use upon discharge. 
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Since the disorder can be so intractable once activated and the risk of fatalities so great, 
treatment approaches should involve scaffolded / individualized treatment programs that 
meet the client at their current level of readiness rather than attempting to force a 
therapeutic agenda that the client is not ready to accept.  
Prolonged engagement in treatment has long been recognized as effective in 
supporting ongoing abstinence and recovery. This has traditionally been accomplished by 
stepping-down the level of care from the most intensive, such as residential, to the least, 
such as outpatient counseling sessions. Unfortunately, in this model, all levels of care are 
still predicated on total abstinence where failure to comply typically results in dismissal. 
This leaves the addict vulnerable to additional relapse episodes and less likely to re-
engage in treatment (Deci & Ryan, 2000). The results of this study indicate the need for a 
continuum of care that extends to include those who are not yet abstinent (Magill et al., 
2018). 
A more inclusive treatment model would be comprised of harm-reduction 
programs for substance users who are not ready to commit to total abstinence and which 
includes medically assisted treatment (MAT) for those who wish to remain abstinent but 
have been unsuccessful due to intense drug cravings (CDC, 2017; Kolodony et al., 2015). 
In this way, substance users would not be exposed to greater risk due lack of support and 
would be engaged at some level in the treatment system when they do experience internal 
motivation for recovery. Meeting the client “where they’re at” would be a more effective 
method of treatment delivery as research shows that excessive coercion can actually 
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hinder the individual’s natural tendency to seek healing and personal growth (Deci & 
Ryan, 2000).  
Conclusion 
This study extended knowledge of substance abuse addicts’ experience by 
exploring the motivation processes of a specific population, millennials with opioid use 
disorder (OUD). In the past decade, a large body of research was generated in response to 
the opioid crisis in America, and much of what was learned painted a desperate picture of 
young addicts doomed to repeated treatments with little or no hope of remission.  
The participants in this study shared narratives that underscore the singularity of 
each person’s journey from active addiction to sustained abstinence and recovery. 
Perhaps the most significant contribution of this study was to promote the understanding 
that intrinsic motivation occurs within the course of one’s personal life experience and is 
a unique process for each individual. It is unlikely that it can be forced or expedited 
through threats, emotional manipulation, or reward contingencies. However, it is also a 
dynamic process and is influenced by positive interactions with caregivers and family 
members that foster autonomy.  
For these reasons, it is important not to interpret treatment outcomes that do not 
result in long-term abstinence as failures or to assume that initial resistance cannot give 
way to acceptance. Regression and relapse occur at similar rates for substance use 
disorder (SUD) and other chronic illnesses such as asthma or hypertension, yet only in 
the former are they evaluated as treatment failures (NIDA, 2018). This is most likely due 
to society’s continued stigmatization of those afflicted with SUD.  Unfortunately, 
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stigmatization often deters addicts from seeking treatment (Crapanzano et al., 2019). In 
the case of young opioid addicts, anything that discourages rather than engages them in 
treatment can have lethal consequences. There is no conclusive evidence to support the 
assumption that opioid addiction in millennials is intractable and that they are resistant to 
conventional treatment. As stated previously in this study, this is not the first group of 
individuals to be afflicted with opioid addiction in epidemic proportions, but it is the 
youngest, and perhaps that has clouded perceptions. It is possible that millennials are not 
inherently different from other addicts, but simply younger, and thus it is the course, not 
the nature of their illness that should be the focus of future investigation.   
Based on the stories of the young participants in this study, it appears that there is 
not necessarily a need for different treatment approaches for young addicts as much as 
more realistic expectations for how long it may take this new generation of drug users to 
become ready to recover.  In the meantime, supporting them throughout their process of 
becoming ready and ensuring that they survive their active drug use with medically 
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Appendix A: Codes Groups and Codes 
Code Group Code Definition 
EXTERNAL TX 
MOTIVATORS:      
External pressures or 
events that compel 
individual to accept 
treatment.  
Formal interventions Organized event facilitated by a 
licensed counselor with family 
members and other significant 
people in the addict's life with 
the intent of breaking through 
denial and increasing awareness 
of the negative impact of 
substance use on the addict and 
the family system. Interventions 
typically end with an ultimatum 
to enter treatment or lose 
family, job, etc. 
 
Ex: “I stayed out all night. My 
brother calls me says ‘Your 
mom's having a heart 
attack…She wasn't. But like this 
was their way of getting me 
home for an intervention…”  
 
Lack of financial resources Usually experienced in later 
stages of progression of SUD 
when the individual is unable to 
support drug habit and exhausts 
financial resources or help of 
family members who refuse to 
enable addiction. Often leads to 
criminal activity to obtain 
money (i.e.; B&E, forging 
checks, prostitution). 
 
Ex: “You know, like I had 
nothing to my name, I had no 
car, no cell phone, nowhere to 




Legal issues /coercion Legal consequences that often 
occur as substance abuse 
progresses (i.e.; D.U.I, 
possession/distribution charges) 
that may create leverage for 
external treatment motivation. 
 
Ex: “Now I have to do drug 
court, and everyone in school 
knows, and people are labeling 
me as this bad kid.”  
 
“And, when I got arrested that 
was like my breaking point.”  
 
Pressure from family / 
employer 
External pressure exerted by 
family members on individual to 
accept treatment for SUD. May 
be in the form of loving support 
or threats. 
 
Ex: “I had my first overdose and 
I woke up in the hospital and my 
mom was standing over my 
hospital bed crying and that was 
when I guess they realized that 
enough had to be enough and 
they tried to get me to go into 
treatment…”  
FAMILY ISSUES RELATED 
TO SUD:  
Issues present in the family 
of origin that are often 
reported by substance 
users when relating their 
history  
Cultural norms, modeling of 
substance use 
Exposure to members of 
immediate or extended family 
members who drank or used 
other substances excessively  
 
Ex: “And then when I moved in 
with my dad, um, I like really 
had, it was like a free-for-all. I 
could like drink whenever I 
wanted, um and I started 
drinking, like, very regularly, 
um, because, there were no 
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repercussions, because I would 
like drink with him.” 
 
Divorce Divorce or separation of parents 
in childhood or adolescence, 
especially when this involved 
domestic violence, loss of time 
with one parent, ongoing 
hostility between parents. 
 
Ex: “They were getting divorced, 
and then like nobody was 
paying attention to me, so that's 
when I got introduced to 
cocaine.”  
 
“My mom worked so much she 
wasn’t around enough to really 
know what I was doing.” 
 
Enabling, condoning or 
ignoring substance use 
Family engages in protecting 
drug user from negative 
consequences of use (enabling), 
does not forbid use of drugs or 
condones or overlooks the use 
of certain substances despite 
legality or potential harm (i.e.; 
underage drinking, use of MJ).  
 
Ex: “Like alcohol was so 
acceptable in my family, and 
everyone drank, and everyone 




Lack of supervision Lack of family supervision 
during childhood and early 
stages of substance use due to 
issues in the home, (i.e.; marital 
discord, lack of awareness of 
signs of substance use, poor 
parenting skills, serious illness of 
other family member, limited 
time at home due to workload 
of single parent). 
 
Ex: “My mom worked so much 
she wasn’t around enough to 
really know what I was doing.”  
INTERNAL TX 
MOTIVATION 
“hitting bottom”:  
Factors that contribute to a 
substance user’s readiness 
to seek treatment for SUD.  
Cognitive dissonance A point at which the addict 
begins to experience a conflict 
between their behavior as an 
active drug user and their “true 
self.” 
 
Ex: “I was starving, I was hungry, 
I was thirsty. I didn't think I was 
going to make it out of this… I 
was like all right this has got to 
be my bottom. I was like, I don't 
see me going any further 
down.” 
 
Guilt / remorse / shame Painful emotions associated 
with SUD, which often lead to 
motivation for treatment but 
may also be a part of the 
relapse process.  
 
Ex: “I was hurting the people 
around me that part was 
bothering me, you know? It 
really was, it was, it was, just — 
like it got kind of — it tore me 




Homelessness Loss of housing due to SUD 
related behaviors, which were 
unacceptable to family, S/O or 
sober living residence - usually 
resulting in living outdoors or in 
a vehicle (if one was still 
available). 
 
Ex: “I was living on the streets of 
North Carolina for like 2 weeks. 
And I ended up, I was sleeping 
outside the hospitals down 
there, sleeping at the train 
stations, like anywhere I could 
sleep I was sleeping.”  
 
Loneliness / alienation Complete loss of social support, 
either through rejection by 
family and friends due to 
substance use or self-directed 
due to complete involvement in 
substance acquisition and use, 
which can contribute to internal 
treatment motivation. 
 
Ex: “I stopped needing people I 
realized what's the point of 
having people around, you 
know um.”  
 
“I was now like in Florida alone, 
with no one to call, with the 
news that like this person that I 
loved had died…”  
 
Physical / emotional 
exhaustion 
Terms frequently used by those 
with SUD to describe the way 
they feel when they are 
emotionally and physically 
depleted from trying to 
purchase drugs and recovering 





Ex: “It took, it took this long. It 
finally got to the point; you 
know. I remember I told my 
mom I was so tired of sleeping 
on the ground. I just wanted to 
sleep in a bed.”  
 
“…I definitely was tired. I 
remember feeling like so tired 
of what I was doing.”  
 
Recognition of SUD / 
powerlessness 
The point at which the 
substance abuser gains 
awareness that they are 
experiencing withdrawal, have 
lost the ability to control their 
substance use, and/or begin to 
believe that they are incapable 
of maintaining abstinence. 
 
Ex: “I think that uh, in the 
beginning when I started to 
have consequences, I thought I 
could just pump the brakes 
whenever I wanted. But then 
there came a time when I 
realized I had no brakes 
whatsoever, and that I was no 
longer in control, and that this 
was going to be more difficult 




Self-condemnation / lack of 
achievement 
A state self-recrimination the 
substance user experiences 
when he/she sees repeated 
relapse and treatment failures 
as a sign of personal weakness 
or “defect of character.” 
Sometimes the result of 
comparing oneself negatively 
with their friends who did not 
develop SUD, especially with 
regard to their own lack of 
achievement in the areas of 
personal relationships, post-
secondary education, career, 
property ownership. 
 
Ex: “Yes, and at that point I was 
probably watching some of my 
friends starting to graduate 
from college, like here I was, 
completely flunked out of 
college at this point. Cause like I 
went to Rutgers when I flunked 
out of West Virginia, and I 
completely screwed that up. 
You know, like I had nothing to 
my name, I had no car, no cell 
phone, nowhere to live, like I 
had nothing.”  
 
Spiritual experience An experience whereby the 
drug user becomes more aware 
of his or her spiritual nature / 
higher-self and or the existence 
of a “higher power” or God, 
which may accompany a 
willingness to accept treatment 
or a desire to improve their 
situation. 
 
Ex: “I surrendered to God. It was 
the most crazy feeling ever. I’ll 
just never forget. I surrendered, 
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and I worked on things, and I 
stayed. Instead of 30 days I 
stayed 57. I turned my will over 
to not just God, my parents, and 
let them make my decisions. I 
went to a recovery house…”  
 




Experiencing the symptoms of 
withdrawal and realizing they 
are the result of drug 
dependence rather than 
symptoms of flu or other 
malady. 
 
Ex: “And then finally it clicked. I 
was like “Oh my God, it's these 
little blue pills! That's what it's 
causing this. It’s gotta be.” Cuz 
every time I do one, I feel 
better. Every time I don’t do 
one, I'm like wishing I’d be dead, 
you know, it was like bad.”   
 
“All the pawn shops know who I 
am. I've been arrested four or 
five times. I’m dope sick more 
than I'm high.” 
  
PERCEIVED BENEFITS OF 
SUBSTANCE USE:  
Perceived benefits of 
substance use such as peer 
acceptance and/or relief of 
painful affective states 
such as anxiety, 
depression, social phobia.  
Balancing drug effects Using drugs with opposite 
effects, such as stimulants and 
depressants, to offset the 
negative effects of intoxication. 
This can extend the time before 
the user can experience the 
“high” (e.g., using cocaine to 
stay awake/conscious when 
drinking alcohol) or to soften 
the anxiety associated with 
withdrawal (e.g., taking Xanax 




Ex: “No, because then I was just 
using heroin and crack at the 
same time, and like I would 
come up with crack, then I used 
the heroin to come down and 
balance out.” 
 
Financial gains Selling drugs as a means of 
supporting the habit and 
lifestyle of substance use. 
 
Ex: “I started selling weed. It 
was like 60 - 100 lbs. a month 
getting delivered from Cali. It 
was like, ok we’ll make 10 grand 
then we’ll stop. Okay we’ll make 
20 grand and we’ll stop. I made 
so much money in a year and a 
half span, it was out of control.” 
 
“I was able to afford the car and 
insurance I had and my phone 
because I was selling.”  
 
Temporary increase in self-
esteem 
Using drugs to mask feelings of 
low self-esteem and boost 
confidence in social situations. 
 
Ex: “I was, kind of like a fat kid, I 
didn’t mature fast. So, like, my 
self-esteem was damaged from 
a young age. I was never picked 
on or bullied. It was more or less 
like me bullying myself. The way 
I see it is, it was, like, a miracle 









Use of drugs as prescribed for 
medical issues such as pain 
management or affective 
disorders. 
 
Ex: “I had my tonsils out, my 
adenoids out, and I had 
something wrong with my teeth 
that I had to get them exposed, 
and then I got my wisdom teeth 
out when I was 13. So, they give 
you liquid Vicodin for wisdom 
teeth and I, like I was drinking it 
so much my dad poured it down 
the sink.  Cuz he seen that I was 
doing it too much, and I was 13. 






Novelty Use of drugs for experiences 
outside of the user’s normal 
frame of reference. 
 
Ex: “I think of all things I just 
enjoyed that it was something 
we weren't supposed to be 
doing, and it was just deviant 
and exciting, and it was new. 
And I felt like kids that weren't 





Peer acceptance / belonging Experience of acceptance and a 
sense of belonging when 
introduced into culture of drug 
users. 
 
Ex: “I started going in that circle 
of friends and I got like real 
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close with everybody, with 
everybody in there…” 
 
“Then in seventh grade, I was 
really popular at that point, had 
a whole bunch of friends that 
were older than me. I was going 
to college parties, I looked older 
than I was. And I started to 
become a part of the party 
scene and that's what I really 
started to like, the whole 
popularity contest.” 
 
Relief of boredom Use of drugs for amusement in 
lieu of other activities that are 
not drug-centered such as 
sports, hobbies. 
 
Ex: “I just needed something to 
fill my time. A lot of other kids 
were playing sports and I really 
never liked sports.” 
  Status A belief that one is elevated 
above peers because of 
knowledge of/ experience with 
drugs/ dealing drugs…which 
may be real or imagined. 
 
Ex:  “Like it wasn’t um, this 
feeling of being intoxicated. It 
was this feeling of just like 
superiority and nobody was 
doing it. This was like adult, 





MISCONCEPTIONS RE SUD:  
The beliefs that are held by 
the substance abuser that 
contribute to their denial 
and continued use, such as 
misconceptions about 
addictive disease, lack of 
awareness of the signs of 
progression and 
withdrawal, and lack of 
education regarding the 
role of abstinence in 
supporting continued 
recovery.  
Lack of awareness of 
dependence symptoms 
Inability of substance user to 
recognize physical discomfort as 
withdrawal symptoms due to 
lack of knowledge regarding 
chemical dependency. 
 
Ex:  “And then once I started 
withdrawing in 10th grade, 
that’s when I had this whole, 
like my whole world flipped 
upside down when I realized 
‘Holy shit! I got addicted to 
fuckin’ opiates!’ Because people 
would say ‘Oh I’m withdrawing.’ 
I wouldn’t even understand 
what they were talking about.” 
 
Lacks education on SUD Substance user lacks knowledge 
of the causes and manifestation 
of substance use disorder, 
which contributes to denial and 
treatment refusal. 
 
Ex:  “Nobody came up to me 
and said ‘Oh, it's okay, you're 
just an addict.’ I had not even 
heard the word ‘addict’ out 
loud. In the whole 7 days of 
detox nobody said you're an 
addict.” 
 
“I don’t remember anyone even 
talking to me about 
drugs…period.” 
 
“Yeah, that was it, and you 
know, and I really thought at 
that point that the drugs were 
out of my system and I was like 
good. Like I didn’t think it went 




Rejects abstinence as a 
condition of recovery 
Despite willingness to accept 
treatment, substance user is not 
ready to be completely 
abstinent from all mood-altering 
chemicals, a standard treatment 
recommendation. 
 
Ex: “No, no, I never had 
intended to stop…my mind still 
was on, was going on, when this 
is all done when this, when the 
justice system is off my back, I 
will go back to using, you know? 
“ 
 
“I was like ‘all right, I’ll get off 
the drugs’, but I had no real 
reason to be abstinent, you 
know?” 
RECOVERY SUPPORT:  
Those individuals who 
either remain connected 
despite the substance 
user’s addiction or who 
enter their social system 
through treatment or 12-
step involvement that 
provide support for 
ongoing abstinence and 
recovery. 
  
12-Step involvement A common recommendation of 
treatment centers is to attend 
Narcotics Anonymous (NA) or 
Alcoholics Anonymous (AA) 
meetings, and to ask other 
members for their phone 
numbers, obtain a sponsor, join 
a home group, etc. The 
intended result is the 
development of a strong 
network of “sober” social 
support to replace relationships 
with “using” friends. 
 
Ex: “But meetings made sense 
to me. I started really enjoying 
meetings, and I got a sponsor, 





Emotional connection Establishing a connection to 
other people in recovery that is 
deeper than the superficial 
connection with fellow drug 
users that is typical in active 
addiction.  
 
Ex: “…what motivated me, was 
the connection with other 
people, that they had the thing 
that I had. And once I knew that 
these other people were doing 
it, it was like “I can get clean.”  
 
Non-judgmental acceptance An often-reported social 
behavioral norm of 12-step 
members towards meeting 
attendees. 
 
Ex: And then they would start 
talking, and I couldn't help it 
feel close to these people. 
These people think the same 
way that I think.  They struggle 
with the same things that I 
struggled with…and I got a 
white key tag and the woman 
chairing gave me the biggest 
hug, and I started crying, and 
other people started like 
encouraging me, and ever since 
that day to this day I've been 
clean.”  
 
Recovery role models Individuals who have achieved a 
level of recovery that reflects 
internal growth and a quality of 
life that provides hope for newly 
recovering individuals who are 





Ex: “I could tell you without a 
shadow of a doubt that the 
majority of the people I met in 
the 12-step program that I went 
to were there because they 
wanted to be there, and were 
happy, and were serious drug 
addicts, had found something to 
make them feel like they don't 
need drugs anymore and were 
now totally obsessed with this 
new high of living life…” 
RELAPSE:  
Return to active addiction. 
Behavioral relapse Return to behaviors that are 
associated with active addiction 
and that often precede a return 
to drug use, such as illegal 
activities, associating with drug 
users, decrease of or cessation 
in 12-step meeting attendance, 
etc. 
 
Ex: “And I completely lost my 
mind and I started acting-out on 
character defects. I got mad, I 
got resentful. I was like running 
my mouth all the time not doing 
what I was supposed to be 
doing and I was just on that 
relapse road. and I ended up… it 
was over a month or month-
and-a-half that this was going 
on.” 
 
“Yes! Yes! And also, shortly 
before I relapsed I I'd started 
stealing from like CVS and 
Walgreens again, which was a 
behavior from the past that was 





Toxic relationships Relationships, often romantic in 
nature but not always, that are 
a part of one’s relapse process 
due to codependency, pressure 
to use drugs, or abuse that leads 
back to active drug use. 
 
Ex: “I met a boy in treatment, 
and we were like, we wound up 
being together for a while, we 
lived together. And then like the 
relationship was like very toxic. I 
mean it was toxic from the start, 
but I was just like so in love that 
I didn't care how toxic it was.” 
 
“And then I started dating a guy 
that I met in an NA and he was 
like really bad news. And he 
started smoking weed and then 
eventually I decided that I could 
drink with him. And then one 
night we were at the bar and he 
ran into his old coke dealer and 
he didn't have any money, and 
like I bought him everything. 
And he told me that I could 
either buy him coke or that we 
were over. And I decided to just 
buy him coke because I didn't 
want the relationship to be 
over. “  
SYMPTOMS OF SUD:  
A combination of 
physiological, social, and 
psychological 
manifestations associated 
with repeated drug use 
that characterizes addictive 
as opposed to casual use. 
Many of these signs are 
included in the list of the 
Abandonment of other 
interests due to drug use 
The acquisition and use of 
substances become so 
consuming that the drug user 
loses interest in most or all 
other activities that he/she once 
enjoyed. 
 
Ex: “School began to plummet, 
like drastically. I remember I 
was at 2.83 [GPA]. Within a year 
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DSM-IV diagnostic criteria 
for substance use 
disorder.   
selling weed and having parties 
at my house every night of the 
week, it went from like a to 2.83 
to like a 1.6 in a year span.” 
 
“I went to WVU and had 
planned to play softball. I didn’t 
even make it past fall ball.” 
 
Changes in primary support 
network 
A stage in progression of drug 
use when the individual 
gravitates towards those who 
share his/her proclivity for drug 
abuse and disconnects from 
non-using peers. 
 
Ex: “I met this girl at this game 
and started seeing her, and 
that’s like how I started doing 
heroin…she went to a different 
school. When I started seeing 
her, I stopped hanging out with 
my other friends, and I like just 
spent all my time with her and 
her friends.” 
 
“I knew a good amount of 
people down there. But the 
people I went to go live with 
weren’t the right kind of 
people…they were people that 
used.”  
 
“Chasing the High” An expression coined by drug 
users to describe the continued 
use of drug-of-choice despite 
diminished effect due to 
tolerance in the hope of 
achieving the same level of 





Ex: “…it was really a good 
feeling at first, and then like I 
chased that feeling, and I 
wanted that feeling again, and I 
never found that feeling again, 
even like relapsing. I never 
found that feeling again (sigh, 
then laughter).”  
 
Continued use despite 
negative consequences 
Drug use persists despite 
serious issues such as arrests, 
loss of employment, etc.  
 
Ex: “I've been arrested four or 
five times. I’m dope sick more 
than I'm high. I've been smoking 
crack for three years. I've been 
kicked out of school 4 or 5 
times.” 
 
“And, when I got arrested that 
was like my breaking point I was 
like, I can't. Cuz I'm on the run 
from the military technically 
right now, I'm AWOL. I just got 
arrested, it's not a good look. It 
was like, I don't, I don't have a 
phone. I sold it. Car’s 
impounded. I already owe 2 
months back payments back-
pay on the car, so it's going to 
get repo’ed at the same time. 
Um, I was like, my life, I’m 
done.”  
 
Cravings Strong physical urges to use 
drugs experienced during 
withdrawal and post-acute 
withdrawal. 
 
Ex: “Yeah, I don't know, it took 
the cravings away, it really 
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helped you know. Really helped, 
but then at the 9 months point 
to a year I feel like it wasn't 
working anymore.  Something 
about it wasn't helping, you 
know? It wasn't helping. 
Yeah, yeah. I started to get 
cravings again. and you know… 
it would just come and go drive 
me crazy.“  
 
Dangerous use Use of substances in a way that 
poses great risk (i.e.; driving 
while intoxicated, mixing drugs, 
using unidentified substance 
from unknown dealer, sharing 
needles, etc.) and/ or engaging 
in illegal and risky behavior to 
obtain drugs with little 
awareness or concern for the 
possible consequences.  
 
Ex: “Once I started mixing the 
two, my tolerance, like I didn't 
realize where my tolerance 
really was with that, and then I 
had my first overdose and I 
woke up in the hospital and my 
mom was standing over my 
hospital bed crying…”  
 
Defensiveness Anger and protest of user who is 
still in a state of denial regarding 
their SUD when confronted by 
others regarding their use. 
 
Ex: “Yeah, but I rejected it I did 
everything I could I ran, he 
chased, I didn't run, I walked, 
and he kept following me, and I 
was like dude, fuck yourself, I'm 
not going to treatment, like I 




“And it was like that for 
everybody who confronted me 
about having a problem. I was 
like I don't know what you're 
talkin’ about I don't have a 
problem and it was just like I 
wasn't ready for it. Like I didn't 
want the help.”  
 
Increasing tolerance/  
substance dependence 
resulting in increased 
quantity and frequency of 
drug use. 
Adaptation of the brain 
resulting from continued 
exposure to psychoactive 
substances, which results in the 
need for larger doses to achieve 
effect. One of the symptoms of 
progression. 
 
Ex: “I still felt pain. Like it didn't, 
it wasn't making everything 
okay anymore. And like I wasn't 
like; I was having to do more…” 
 
“Like my tolerance was insane. 
When I think about it now, I was 
probably, there were days when 
I was probably doing a hundred 
mg. of painkillers — not a 
hundred, a thousand mg. of 
painkillers, you know?”  
 
Preoccupation with drug use Spending an inordinate amount 
of time fantasizing about 
substance use and/or planning 
to use. 
 
Ex: “And then I started to really 
crave crack, and really obsess 
about crack. And all I could think 
about was crack.”  
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SUBSTANCE USE HISTORY:  
History and details of 
substance use, including 
substances used.  
Alcohol A mood altering chemical. 
 
Ex: “…the first drug I did was 
alcohol.”  
 
Circumstances of first use The details surrounding the 
onset of substance use, such as 
age, location, social setting, etc. 
 
Ex: “I was with my family. It was 
around second grade, so it was 
like a family party and I just got 
into the alcohol and started 
drinking, and no one really took 
it serious. They just thought it 
was kind of funny, but that's my 
first recollection doing it”.  
 
Cocaine/crack An illicit stimulant drug that is 
either snorted, inhaled, or 
injected (IV) and its fat-soluble 
form, which is heated and 
inhaled in its vaporized form. 
 
Ex: “…on coke, you just, you talk 
a lot, and you feel upbeat…”  
 
Marijuana A hallucinogenic drug that is 
smoked. It is derived from the 
Cannabis Sativa plant. This drug 
has been legalized for 
recreational use in 11 of the 
United States and legalized for 
medical use in 20 additional 
states.  
 
Ex: “I think they identify 
marijuana — it's not an opiate, 
it's not a stimulant, and I think 
that it’s a hallucinogenic.  yeah 
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and I see why they say that. I 
mean you just feel spaced.”  
 
Opiates/Opioids/Heroin A group of drugs derived from 
the poppy plant used legally by 
prescription and in a hospital 
setting for pain relief. Opioids 
are synthetic opiates.   
 
Ex: “I had when I was like 14 and 
15, I had gotten a lot of 
surgeries in one year and that's 
when I got introduced to 
Vicodin.”  
 
Reaction to substance Positive, negative, or neutral 
response experienced at 
initiation of drug use. May 
include physical, affective, 
and/or perceptual experiences.  
 
Ex: “…the first time it was just 
it's just (laughter) it's just the 
best feeling I ever felt — I 
wanted to feel like that all the 
time you know?”  
TREATMENT HISTORY: 
Settings in which someone 
with SUD receives 
therapeutic intervention 
for their illness, i.e., 
detoxification, inpatient, 
intensive outpatient, 
outpatient and counseling.   
Aborting treatment (AMA) “Against Medical Advice” - 
elopement or leaving treatment 
prior to completion; without 
having achieved maximum 
therapeutic benefit. 
 
Ex: “Once I knew that I could 
AMA from a place it was 




Hopelessness The descriptor used by addicts 
for their emotional state when 
they are unable to control their 
drug use despite multiple detox 
and treatment experiences. 
 
Ex: “I felt so hopelessly 
addicted.”  
 
Denial / TX refusal A psychological defense 
mechanism which interferes 
with the user’s ability to 
recognize their level of drug use 
as harmful or indicative of 
addiction. Individuals in this 
state of denial may be resistant 
to entering treatment as they 
don’t believe they have “a 
problem.” 
 
Ex: “I guess they realized that 
enough had to be enough and 
they tried to get me to go into 
treatment and I refused to go 





such as agonist / antagonist 
therapy (vivitrol, naltrexone) 
that reduce cravings and/or 
block the reinforcing effects of 
opioids. 
 
Ex: “When I was on the 
Suboxone program, when I was 
on Suboxone maintenance, I 
really was trying. I thought that 
that was the solution for me.”  
 
Treatment compliance Adherence to treatment 
recommendations during 




Ex: “I was one year straight. I 
was going to meetings for one 
year straight. I did real good. I 
was really good. It was 
consistent.”  
 
Treatment response The clinical response of the 
substance user’s treatment with 
regard to their disorder, i.e., 
remission, abstinence 
 
Ex: “I just did my 30 days there 
and just pretty much, pretty 
much, said whatever they 
wanted to hear, you know, and I 
completed. The first day I was 






Appendix B: Release of Information Form 
CONSENT TO INDIVIDUAL RECIPIENT 42 CFR Part 2 and HIPAA 
 
I,______________________________________________________________________ 
[patient’s name]                      
 
authorize________________________________________________________________ 
      [name or general designation of individual or entity making the disclosure] 
 
to disclose  
___________________________________________________________________  
              [describe how much and what kind of information may be disclosed, including 
an explicit description of what substance use disorder information may be disclosed; as 
limited as possible]                    
                    
to _____________________________________________________________________ 
                                   [name of individual(s) who will receive the information]  
 
for the purpose of 
________________________________________________________________________  
                                  [describe the purpose of the disclosure; as specific as possible] 
 
I understand that my substance use disorder records are protected under the Federal 
regulations governing Confidentiality and Substance Use Disorder Patient Records, 42 
C.F.R. Part 2, and the Health Insurance Portability and Accountability Act of 1996 
(“HIPAA”), 45 C.F.R. pts 160 & 164, and cannot be disclosed without my written 
consent unless otherwise provided for by the regulations. 
I understand that I may revoke this authorization at any time except to the extent that 
action has been taken in reliance on it. Unless I revoke my consent earlier, this consent 
will expire automatically as follows:  
 
_______________________________________________________________________  
           [describe date, event, or condition upon which consent will expire, which must be 
no longer than reasonably necessary to serve the purpose of this consent] 
 
I have been provided a copy of this form. 
 
Dated: _________   Signature of Patient _____________________________________                                                                         
 
 Signature of person signing form if not patient: ________________________________ 
 































Appendix D: Internal Motivation Code Tree with Linked Quotations 
 
